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Summary 
In this thesis, contrast agents for cardiovascular optical imaging at molecular level have been 
investigated. The investigation is mainly based on intravascular optical coherence tomography 
(IV-OCT), and the combination of IV-OCT and fluorescence imaging. Cardiovascular disease is 
the main cause of the death in the world. Until now, IV-OCT as an minimally invasive technique 
has been used for in vivo evaluation of unstable plaque in atherosclerosis and stent placement. The 
development of nanometric contrast agents for IV-OCT would help to visualize the atherosclerosis 
process at molecular level. By combining the IV-OCT with fluorescence imaging, the contrast 
agent would be fully used and provide a high resolution of cardiovascular imaging.  
First, the contrast enhancement provided by different kind of gold nanoparticles have been 
investigated by IV-OCT. The function of IV-OCT is determined by the static and pull back option 
in IV-OCT system. IV-OCT allows the detection of single gold nanoparticles due to its high 
sensitivity. 
Second, due to the IV-OCT signal is based on the scattering ability of the sample, the scattering 
properties of gold nanoshells (GNSs), nanorods, and nanostars have been systematically 
investigated by numerical simulation, photo-thermal method, infrared dark field microscopy, 
photoacoustic and IV-OCT. GNSs have been determined to be a good scatterers for IV-OCT. 
Third, the GNSs as contrast for cell and tissue imaging by IV-OCT have been investigated. The 
incubation of GNSs in HeLa and Jurkat cells produced a high OCT contrast enhancement. The 
internalized of GNSs in these cells have been confirmed by dark field microscopy and TEM. A 
OCT contrast enhancement after injected of GNSs in tissue is also obtained. 
Finally, the quantum dots (QDs) which can be excited by IV-OCT laser and show an emission 
in third biological window have been investigated. Due to the high sensitivity of IV-OCT, these 
QDs also give OCT contrast enhancement. The QDs used for OCT and fluorescence dual imaging 
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has been systematically investigated in colloidal, tissue and in the artery. From the fluorescence 
imaging of QDs excited by the pull-back IV-OCT laser could provide the morphology of artery. 
In conclude, the investigated GNSs and QDs would be very useful for cardiovascular optical 
imaging at molecular level. The functionalization of these nanoparticles would make them 
specially target to the cardiovascular disease site, and provide a high resolution imaging for 
visualization of atherosclerosis process. 
Key words: cardiovascular disease, atherosclerosis plaque, IV-OCT, fluorescence imaging, gold 
nanoshells, quantum dots. 
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Resumen 
En esta tesis se han investigado diversos agentes de contraste para imagen cardiovascular a nivel 
molecular. Las investigaciones se basan fundamentalmente en la técnica de Tomografía Óptica 
Coherente Intravascular (TOC-IV). Actualmente, las enfermedades cardiovasculares son la causa 
de la mayoría de los decesos en el mundo. Desde hace unos años, la TOC-IV se ha venido 
utilizando como técnica mínimamente invasiva para la implantación de stents y la detección y 
evaluación de placas de ateroesclerosis. El desarrollo de agentes de contraste nanométricos, 
ayudaría a detectar dichas placas a nivel molecular. Además, si se combinan las técnicas de TOC-
IV con la de imagen por fluorescencia, dichos agentes de contraste permitirán imágenes 
cardiovasculares de alta resolución. 
En primer lugar, se ha investigado el nivel de contraste en las señales de TOC-IV dado por 
diversas nanopartículas de oro, tanto a nivel de imágenes estáticas como a nivel de imágenes 
dinámicas, utilizando las distintas funciones que la TOC-IV proporciona. Se ha determinado que 
la TOC-IV es capaz de detectar nanopartículas de oro individuales, dada la gran sensibilidad de 
ésta técnica de imagen. 
En segundo lugar, dado que la TOC-IV se basa en la radiación esparcida por las diversas 
muestras, se han investigado diversos tipos de nanopartículas de oro (nano-bastoncillos, nano-
estrellas y nano-esferas dobles (sílice-oro)) mediante diversas técnicas, incluyendo microscopía de 
campo oscuro, espectroscopia foto acústica y, naturalmente, TOC-IV, concluyéndose que las nano-
esferas dobles (GNSs, de la traducción al inglés; “gold nano-shells”) son los mejores agentes de 
contraste para TOC-IV. 
En tercer lugar, se ha investigado el contraste producido por los GNSs tanto en células como en 
tejidos, dadas las excelentes propiedades de estas nanopartículas. Para ello, se han incubado en 
células HeLa cómo en células Jurkat, demostrando que se mejora el contraste en la señal de TOC-
IV dada por estas células una vez que se internalizan en ellas los GNSs. Este incremento de 
contraste se ha verificado también mediante microscopía de campo oscuro. Además, se ha 
demostrado que los GNSs insertados en tejidos incrementan el contraste en la señal de TOC-IV. 
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Finalmente, se han investigado nanopartículas de cristales semiconductores (puntos cuánticos) 
que emiten en la tercera venta biológica al ser excitados por el láser del sistema TOC-IV. Dada la 
alta sensibilidad del TOC-IV, estos puntos cuánticos aumentan el contraste de la señal tomográfica, 
de manera que actúan como dobles sondas ópticas, TOC y fluorescencia, tanto en sistemas 
coloidales como en arterias y tejidos. 
En consecuencia, las nanopartículas investigadas, tanto puntos cuánticos como nanopartículas 
de oro, podrían ser muy útiles para imagen cardiovascular a nivel molecular, siempre que se 
funcionalicen convenientemente para anclarse al sitio dañado. Esto proporciona altas posibilidades 
de imagen con alta resolución en la formación de placas de aterosclerosis. 
Palabras clave: Enfermedades cardiovasculares, placas de arterosclerosis, Tomografía óptica 
coherente, nanopartículas de oro, puntos cuánticos 
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1.1 Cardiovascular diseases 
Cardiovascular diseases (CVDs) are the main cause of death in the worldwide, representing 32% 
of all the death. The data was get from OECD. Stat,1 by selecting variables with causes of mortality 
and diseases of the circulatory system, years are from 2012 to 2014. In China, the problem is more 
serious, around 0.29 billion suffers, and a leading cause of death, which account for 42.61 % in 
the urban area, according to the report on cardiovascular disease in China (2016). The main 
dangerous factors for cardiovascular disease are hypertension, cigarette smoking, hyperlipidemia, 
diabetes, insufficient physical activity, and air pollution.  
 
Figure 1.1 The normal structure of the artery.2 
Atherosclerosis is the key pathogenesis of cardiovascular diseases. It refers to the development 
of atheromatous plaques in the arteries,2 notably in arterial branch points and bifurcations.3 The 
normal structure of the artery consists of three layers. The adventitia layer, which is connected to 
the tissue, contains mast cells, nerve ending and microvessels as shown in Figure 1.1.2 The tunica 
media composed of smooth muscle cells (SMCs) embedded in a complex extracellular matrix. The 
intimal layer, contains SMCs and an endothelial cell monolayer which exposures to the blood.2 In 
healthy conditions, the arterial endothelial cells resist the adhesion of circulating immune cells to 
them.4 Under atherogenic stimuli, such as hypertension, dyslipidaemia and cigarette smoking, the 
changes in the endothelial permeability and the composition of the extracellular matrix in the 
tunica media lead to entry and accumulation of low density lipoprotein (LDL) particles in the 
subendothelial, as shown in Figure 1.2.5, 6 Once trapped in the subendothelium, some of the LDL 
particles are oxidized, and thus cause the activation of the endothelial cells.7 The activated 
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endothelial cells express chemokines, that promote the recruitment of the monocytes to the vessel 
wall and directional migration by interact with cognate chemokine receptors on the monocytes, 
such as vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 
(ICAM-1). A number of monocytes in the early atherosclerotic lesions differentiate into 
macrophages, and ingest oxidized lipoproteins via scavenger receptors.5, 8, 9 The accumulation of 
lipid droplets in the cytoplasm of the macrophages, promote lipid-laden macrophages to become 
foam cells, denote the atherosclerosis. Foam cells can secrete additional extracellular matrix 
molecules. Extracellular matrix molecules are composed of certain collagen, elastin, proteoglycans 
and glycoproteins. They interact with cells and generate signals to control the behaviors of the 
cells.10 In atherosclerosis, they promote lipoprotein accumulation and recruitment of monocytes.8 
Under prolonged endoplasmic reticulum (ER) stress, foam cells die from apoptosis and necrosis 
and the cellular lipids are deposited in the artery. In the early atherosclerosis lesions, which is 
called inflammation resolution, efferocytosis (the process that dying or dead cells are cleared by 
phagocytic cells) is efficient and can rapidly clear the apoptotic macrophages. In advanced lesions, 
so called no inflammation resolution, the efferocytosis is not efficient, the apoptotic macrophages 
start undergo secondarily necrotic, and necrotic macrophages coalesce into necrotic cores. In the 
lipid-rich necrotic cores, the death of the smooth muscle cells and degrading cap collagen would 
thin the fibrous cap and promote the plaque vulnerable to rupture. In this process, two kind of 
proteases: matrix metalloproteinases (MMP) and cysteine proteases play an important role in 
arterial wall extracellular matrix degradation and remodeling.11-14 If there is no inflammation 
resolution, the fibrous cap breaches leading to the luminal thrombosis and arterial occlusion.8 
In the past few decades, molecular imaging has been developed to be a strong method to 
visualize specific molecular process in vivo due to the fast development in imaging agents and 
technologies. Molecular imaging can also make a significant contribution to the atherosclerosis 
imaging. Normally, the application of molecular imaging to a special disease need to address the 
following four question.15, 16 (1) Is there any molecular target corresponding to the disease of 
interest? (2) Is there an affinity ligand that will bind to the target? Usually, the suitable molecular 
target and ligand could be found in the literature. (3) What is the appropriate molecular imaging 
system to provide the optimal resolution, sensitivity, and depth penetration for the disease? (4) 
What kind of molecular agent is needed for the selected imaging system to detect the molecular 
target?  
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Figure 1.2 The development of an atherosclerotic lesion, potential targets for molecular imaging at each 
stage are listed on the top.6 
For the first and second questions, different diseases and processes have different molecular 
targets and ligands as shown in Figure 1.2.6 For example, in the early stages of atherosclerosis, 
the endothelial cell dysfunction and activation caused by the hemodynamic and inflammatory 
factors, lead to the expression of VCAM-1, ICAM-1 and selectins (P and E)7 on these 
dysfunctional cells. The corresponding antibodies could act as affinity ligands, such as VCAM-1-
targeting peptides.17, 18 In the inflammation, the macrophages differentiated from monocytes can 
be used as a target. Macrophages phagocytosis can be used as a target strategy to deliver the 
nanoparticles (NPs). For example, their phagocytosis of LDL in the atherosclerosis process has 
used the iron NPs conjugated with lectinlike oxidized LDL receptor-1 antibody to specifically 
target to the macrophages.19 In the angiogenesis, the target is v3 integrin.  
Molecular imaging studies of atherosclerosis are expected to be useful in the following clinical 
scenarios:20 (1) identifying patients with high-risk of cardiovascular complications, (2) 
characterizing the vulnerability of the lesions, (3) evaluating novel atherosclerotic therapies, and 
(4) selecting individualized treatment strategies for the particular vulnerable plaques. In the 
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following section, I will talk about the imaging techniques and corresponding contrast agents, and 
how they are used for the above clinical scenarios. 
1.2 Cardiovascular imaging techniques based on light 
1.2.1 Optical coherence tomography 
1.2.1.1 Theory 
Optical coherence tomography (OCT), which was discovered by David Huang and co-workers 
in 1991, is very similar to ultrasonic pulse-echo imaging.21 It uses low coherence interferometry 
to collect the scattering light from the tissue microstructures. OCT has very high resolution, around 
15 µm and can detect backscattered light as small as 10-10 times of the incident intensity.21 Due to 
these high resolution and sensitivity of the OCT, it has been widely used in medical areas, such as 
ophthalmology and vascular surgery.22-25  
In the particularly case of cardiovascular disease, the intravascular OCT (IV-OCT) was used. It 
uses a single optical fiber (catheter) that can illuminate to the artery by rotating and being pulled 
back along the artery,24 and at the same time, recording the backscattered light produced by the 
artery. The reflected light then interferes with the light from reflected mirror at coupler, and then 
is sent to the detector. The detector signal is converted to the reflectivity profile by using Fourier 
analysis.. 
1.2.1.2 Applications of IV-OCT 
Due to the high resolution of the OCT, it has been widely used to investigate the coronary 
atherosclerosis. The normal structure of the artery as seen by IV-OCT, is shown in Figure 1.3 (a). 
A healthy artery is formed by different layers, the intima (I), the internal elastic lamina (IEL), the 
media (M), the external elastic lamina (EEL) and the adventitia (A). In the figure inside the artery 
there is a catheter, with a diameter around 1 mm. In addition, the IV-OCT is also able to reveal the 
morphology of atherma plaques, as shown in Figure 1.3. Therefore, it is possible to distinguish 
different type of plaques, e.g. fibrous plaques with homogeneous and signal rich regions (Figure 
1.3 (a)), fibrocalcific plaques with well delineated and signal poor regions with sharp borders 
(Figure 1.3 (b)), and lipid rich plaques with signal poor regions and diffuse borders (Figure 1.3 
(c)).26 IV-OCT is also useful for measuring vessel lumen diameter, which is very important for 
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selecting a suitable size of stent at a target site and helping the stent placement.27 In Figure 1.3 (a), 
the diameter of the artery is around 2 mm. In Figure 1.3 (c), we see the fibrous cap, whose 
thickness plays an important role in the plaque rupture. It has been observed that if the cap 
thickness is less than 65 µm, the plaque can easy to break, and cause an acute thrombus.28 
Therefore, OCT has also been used to measure the thickness of the fibrous cap as a marker of the 
plaque vulnerability. A study about association of the statin therapy with reduced coronary plaque 
rupture by OCT, showed the OCT measured thickness of the fibrous cap under stain therapy (78µm) 
tend to increase than that of without stain therapy (49µm).29 In this case, after the stain therapy, 
the coronary plaques tend to become more stable. 
 
Figure 1.3 (a) OCT image of a fibrous coronary plaque showing a homogeneous, signal-rich interior (F). 
An area of intimal hyperplasia is seen opposite fibrous lesion, demonstrating intima (I, with intimal 
hyperplasia), internal elastic lamina (IEL), media (M), external elastic lamina (EEL), and adventitia (A). 
(b) OCT image of a fibrocalcific aortic plaque showing a sharply delineated region with a signal-poor 
interior. (c) OCT image of a lipid-rich carotid plaque showing a signal-poor lipid pool (L) with poorly 
delineated borders beneath a thin homogeneous band, corresponding to fibrous cap (arrows).26 Bar=500µm 
To avoid the attenuation that light suffers in the artery caused by the red blood cells, the blood 
is completely removed with a saline flush before taking the OCT image.24 Xu and coworkers 
probed that it is possible to identify the plaque composition from the IV-OCT signal by studying 
the attenuation and the backscattering coefficient of different plaques. They found that the 
backscattering coefficient had different values for calcification (4.9±1.5mm-1), for fibers 
(18.4±6.4mm-1) and for lipid pool (28.1±8.9mm-1), and the same happened to the attenuation 
coefficients (5.7±1.4mm-1, 6.4±1.2mm-1 and 13.7±4.5 mm-1, respectively).30  
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Other strategy for the characterization of atherosclerotic plaques is based on the study of 
macrophages. Macrophages are inflammatory cells and they can release tissue factors and cause 
plaque rupture.31 Some studies have shown that it is possible to detect the presence of macrophages 
by OCT.32-34 As shown in Figure 1.4, which compares a fibrous cap with low density of 
macrophages to one with high density of macrophages, the OCT intensity is much higher in the 
case of high macrophages content (d). Macrophages can be identified in the low content 
macrophage fibrous cap after doing the logarithm of the OCT image, and combining the images 
with the ones given by histology.  
 
Figure 1.4 Raw (a) and logarithm base 10 (b) OCT images of a fibroatheroma with a low density of 
macrophages within the fibrous cap. (c), Corresponding histology for (a) and (b) (CD68 immunoperoxidase; 
original magnification ×100). Raw (d) and logarithm base 10 (e) OCT images of a fibroatheroma with a 
high density of macrophages within the fibrous cap. (f), Corresponding histology for (d) and (e) (CD68 
immunoperoxidase; original magnification ×100).32 
Currently, the IV-OCT is widely used for characterization of plaque type, fibrous cap thickness, 
plaque rupture, and evaluation of intracoronary stenting.24, 35, 36 However, due to the lack of 
molecular contrast, the molecular process under the atherosclerosis, as we discussed in the first 
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part, can not be visualized by IV-OCT. Therefore, the use of contrast agent would help IV-OCT 
to detect the atherosclerosis process at molecular level. 
1.2.2 Photoacoustic imaging 
1.2.2.1 Theory 
Photoacoustic (PA) imaging has become a strong tool in biological imaging due to its high 
contrast, high resolution and high penetration depth. In PA imaging, the tissue is irradiated by a 
short pulse laser with a duration of nano-second. The absorption of the light energy by the tissue 
induces a slight temperature increment,37 which causes a thermoelastic expansion. This generates 
a sound or stress wave (acoustic wave) that can propagate through the tissue. Once the acoustic 
wave reaches to the tissue surface, it can be detected with an ultrasound transducer.38, 39  
Normally, PA imaging is considered dependent on the absorption coefficient due to small 
difference in the mechanical and thermodynamic properties of different tissues.39 The absorption 
coefficient spectrum of endogenous tissue chromophores is shown in Figure 1.5. The differences 
of the absorption coefficient of a single chromophore at different wavelength and chromophores 
at the same wavelength allow the differentiation of the tissue type by properly choosing the PA 
excitation wavelength.38 For example, by measuring the multiwavelength PA signal of the blood 
vessel, the obtained concentration of oxyhaemoglobin and deoxyhaemoglobin can be used to 
determine the blood oxygen saturation.40, 41 
 
Figure 1.5 Absorption coefficient spectra of endogenous tissue chromophores.42 
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For PA imaging, penetration depth is dependent on the attenuations of the light and the acoustic 
wave.42 In biological tissues, the light transfer is dominated by scattering.43 Therefore, the scattered 
light can go through into deep of the tissue even they almost lose their original incidence 
direction.43 However, these photons can still produce an acoustic wave, and this signal could still 
be detect by the transducer because the acoustic scattering in the tissue is two or three order of the 
magnitude weaker than that of light. Thus a high penetration depth for PA imaging is possible. For 
example, the reported penetration depth achieved in human breast is 4 cm.44 The spatial resolution 
is limited to sub-millimetric due to the acoustic attenuation, and also is determined by the width 
of the pulse laser, width impulse response and focal diameter of the transducer, and the center 
frequency of the received PA signal.37, 42 
1.2.2.2 Applications to cardiovascular diseases 
Due to its high penetration depth and not bad spatial resolution, PA imaging has been widely 
used in biomedicine.37, 38, 42 In the case of cardiovascular disease, intravascular PA (IV-PA) has 
been used for the identification of vulnerable plaque. In IV-PA, the axial resolution is 100µm, 
lateral resolution is 500µm and the penetration depth is 5 mm.38 In the absorption spectra shown 
in Figure 1.5, the absorption of lipid shows a strong absorption around 1200 nm. In 2010, by using 
a 1200 nm laser as light source for IV-PA imaging, Wang et.al successfully got ex vivo image of 
the lipid in atherosclerosis rabbit aorta based on the different optical absorption spectrum of the 
fat in the near infrared range.45 Furthermore, a big number of contrast agents have been used to 
get PA molecular images of the various stages of the atherosclerosis disease progression.46, 47 In 
lipid rich necrotic cores, the elevated expression of matrix metalloproteinase-2 is one of the clinical 
features. In 2016, Huan et.al used the GNRs conjugated with the matrix metalloproteinase-2 
antibody as a high efficient IV-PA probe to detect the matrix metalloproteinase-2 in 
atherosclerosis.48 The GNRs could target the matrix metalloproteinase-2 due to the antibody, and 
thus increased the absorption of the matrix metalloproteinase-2, and a high IV-PA enhancement 
was achieved which could provide a precise morphology to visualize the area of the distribution 
of matrix metalloproteinase-2 in the arterial walls.48 
IV-PA is currently undergoing refinement, although it has shown its capability of imaging the 
atherosclerosis disease. Many important aspects face the real-time clinical imaging still need to be 
solved, such as the optimal image acquisition sequence, laser source and catheter design.38 
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1.2.3  Fluorescence imaging 
1.2.3.1 Fluorescence imaging technique 
Fluorescence imaging is a technique that allows acquisition of data at high speed and 
visualization of biological process in the dynamic conditions.49 Typically it uses light source (a 
laser or white light with an excitation filter) to excite a fluorescent molecule, and the emitted 
signals with different spectral characteristics can be isolated by emission filter and captured by a 
CCD camera (detector range: 400 – 1000 nm) or an InGaAs camera (detector range 0.9-1.7 µm).50 
This technique has two challenges. First is the limited penetration depth due to the absorption and 
scattering of light due to the tissue. Therefore, it is very important to select the excitation and 
emission wavelengths in the region known as biological windows which are shown in Figure 1.6.51 
The first biological window (I-BW) extends from 700 to 950 nm, and corresponds to the end of 
the visible absorption band from hemoglobin to the beginning of water absorption band around 
980 nm.51 The second biological window (II-BW) is found from 1 to 1.35µm, in this window, the 
scattering coefficient is reduced and a deeper penetration depth is expected in this range. The third 
biological window (III-BW) is in the range from 1.5 to 1.8µm, the tissue autofluorescence is almost 
zero in this range, which could allow getting a high optical contrast after using a contrast agent 
that emits fluorescent signals in this range52. In second place is the need of appropriate contrast 
agents. Differently from OCT and PA that can image the tissue based on the scattering and 
absorption properties of the tissue without using exogenous agents, fluorescence imaging strongly 
depends on contrast agent, due to the weak fluorescence given by most tissues.53 The contrast 
agent has to be biologically stable in the organism, specially target the disease site, and produce 
fluorescence imaging contrast.54 Common contrast agents emitting in BW have been widely used 
for fluorescence imaging, such as ICG, cyanine dyes, quantum dots, single-walled carbon 
nanotubes and rare earth nanoparticles.55 
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Figure 1.6 Absorption spectrum of human skin showing the first (I-BW), second (II-BW) and third (III-
BW) biological windows 
1.2.3.2 Application to cardiovascular disease 
During the last ten years, the huge progress in clinical intracoronary optical imaging lead to the 
development of the near infrared spectroscopy catheter, which has been approved by the FDA.56, 
57 Intravascular near infrared fluorescence (NIRF) imaging is a catheter based technique, in which 
the excitation light is introduced to the artery by using a catheter, simultaneously, the emission 
signal from the tissue is collected by the catheter and sent to the detector. Two dimensional 
fluorescence images of the artery could be achieved by rotating and pull back the catheter. It has 
been used to measure the disease activity within the cardiovascular.58 In 2011, Claudio et al 
exploited the indocyanine green (ICG) as a contrast agent to imaging the atherosclerosis plaques.59 
ICG is a FDA approved dye, could be quickly absorbed by lipid-rich plaques and cells. In addition, 
ICG has a strong absorption in 785 nm, and emission at 815 nm, these absorption and emission 
band are located in the I-BW. Therefore, ICG is expected to produce a high fluorescence contrast. 
In this work, within 20 minutes injection, the sufficient contrast enhancement could be used in 
vivo detection of lipid-rich, inflamed, coronarysized plaques in atherosclerotic rabbits. What’s 
more, in vitro and human atheroma specimen studies showed that the ICG prefer to target the lipid 
rich macrophages. At the same year, a dual-modality (OCT and NIRF) intra-arterial catheter for 
simultaneous microstructural and molecular imaging in vivo was reported by Hongki et al.60 The 
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NIRF has a highly sensitive detection of Cyanine7 (Cy7), NIRF imaging of the fibrin-coated stent 
in vitro and in vivo, thrombus and heterogeneous protease activity have been obtained by using 
this technique.60  
However, most of the contrast agent for intravascular NIRF imaging are dyes that are highly 
susceptible to photobleaching, which will affect the sensitivity of the detection.53 Up to now, most 
of the emission of these dyes are located in the first biological window, and the autofluorescence 
of the tissue has a high effect on the NIRF signal. There, new contrast agent are strongly needed 
for intravascular NIRF imaging. 
1.3 Contrast agents 
Nowadays, it is assumed that an efficient fight against CVDs requires a great effort in social 
education for the introduction of healthy life habits and, in parallel, a significant improvement in 
the diagnosis techniques. These techniques should improve in two distinct directions: Firstly, cost 
reduction is mandatory, as convectional techniques (such as X-Ray assisted catheterization) 
require expensive and complicate apparatus. Secondly, these conventional techniques fail, in most 
of the cases, to provide molecular information of CVDs, so that the design and development of 
specifically designed therapies are not possible. Nanotechnology can simultaneously overcome 
these two challenges. The reduced size and high surface to volume ratio characteristic of 
nanoparticles (NPs), makes them especially suitable for molecular imaging.61, 62 It has been already 
demonstrated that NPs bound to specific affinity ligands, such as monoclonal antibodies, and so 
enabling non-invasive phenotypic characterization of atherosclerosis plaques. At the same time, 
the use of NPs also opens the door to the development of cost-effective and minimally invasive 
diagnosis and imaging tools. In particular, the use of optical NPs as a contrast agents, i.e. NPs 
capable of producing scattered light, luminescence or acoustic waves under light illumination, 
would allow the use of cost effective laser light sources for cardiovascular imaging instead of more 
complicated apparatus (such as MRI, X-Ray, SPET… and so on).61, 63-65 Because of these two 
reasons, the scientific community is already considering optical NPs as reliable and powerful tools 
for the next generation of imaging probes for the cardiovascular system.4, 66-68  
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1.3.1 Gold nanoparticles (GNPs) 
Nowadays, GNPs have received a particular attention for bio applications, such as photothermal 
therapy and medical imaging (OCT and PA). These widely applications of GNPs are due to the 
following respects. First, they can be easily synthesized with different shapes and with tunable 
optical properties. Second, they are biocompatible, can be functionalized with different ligand and 
delivered to the disease sites.69 This part, I will focus on optical properties of GNPs and their 
applications for cardiovascular disease. 
Optical properties of GNPs: Surface plasmon resonance is the most important optical property 
of the GNPs. It consists of a collective oscillation of conduction electrons induced by the 
electromagnetic field of light. As shown in Figure 1.7 (a), after irradiated by light, the conduction 
electrons oscillate coherently to the incident light. This results the absorption and scattering 
properties of the GNPs. The oscillations wavelength strongly depends on the morphology of the 
GNPs, for example, for GNRs, as shown in Figure 1.7 (b), they have two oscillations, transverse 
and longitudinal, thus induce two extinction peaks in the extinction spectra.70 Furthermore, the 
surrounding medium also affects the resonance wavelength.71 
 
Figure 1.7 (a) Schematic drawing of the interaction of an electromagnetic radiation with a gold nanosphere. 
A dipole is induced, which oscillates in phase with the electric field of the incoming light. (b) Transverse 
and longitudinal oscillation of electrons in a gold nanorod.70 
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Gustav Mie solved the Maxwell’s equations for small spheres (d ≪ λ) obtaining an expression 
that can predict the scattering and absorption properties of the particles.72, 73 The expression that 
he obtained for the extinction coefficient Cext can be written as: 
 𝐶𝑒𝑥𝑡 =
24𝑅3𝜀𝑚
3 2⁄
𝜆
𝜀2
(𝜀1 + 2𝜀𝑚)2 + 𝜀22
 (1.1) 
where R is the radius of the GNPs, εm is the medium dielectric constant, λ is the wavelength of the 
incident light, ε1 and ε2 are respectively the real and imaginary part of the complex dielectric 
function for small particles, and they are frequency dependent. Thus the extinction properties of 
the small particles strongly depend on the dielectric constants of the metal, its surrounding medium 
and its volume.51, 72 However, the Mie theory cannot be used to predict the optical properties of 
nanoparticles with size larger than 20nm or explain the near infrared extinction spectra of 
nanoparticles.51. In 1912, Gans developed a solution to explain the extinction properties of the 
prolate spheroid. 74.The estimated extinction coefficient given by Gans74 is: 
 𝐶𝑒𝑥𝑡 =
8𝜋2𝑅3𝜀𝑚
3 2⁄
3𝜆
∑
(1 𝑃𝐽
2⁄ )
{𝜀1 + [(1 − 𝑃𝑗) 𝑃𝑗⁄ ]𝜀𝑚}
2
+ 𝜀2
2
𝑗
 (1.2) 
where Pj includes the depolarization factors for the each axis of the particle; Pa, Pb and Pc. For 
gold nanorods (a > b = c), the depolarization factors are defined as  
 𝑃𝑎 =
1 − 𝑟2
𝑟2
[
1
2𝑟
ln (
1 + 𝑟
1 − 𝑟
) − 1] ; 𝑃𝑏 = 𝑃𝑐 =
1 − 𝑃𝑎
2
 (1.3) 
where r is corresponded to the aspect ratio (𝑟 = √1 − (𝑏 𝑎⁄ )2). The wavelength λmax longitudinal 
plasmon resonance depend on the aspect ratio and medium dielectric constant has been derivated 
by El-Sayed et al71: 
 𝜆𝑚𝑎𝑥 = 33.34𝜀𝑚
𝑏
𝑎
− 46.31𝜀𝑚 + 472.31 (1.4) 
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For more complicated GNPs, such as gold nanoshells (GNSs) and gold nanostars (GNSTs), 
some numerical methods have been developed to explain the absorption and scattering properties 
of these GNPs. For example, discrete dipole approximation (DDA), finite difference time domain 
and finite element method.75, 76 
 
Figure 1.8. Tunability of the plasmon resonance maximum in nanoparticles. Variation of surface plasmon 
extinction maximum λmax with (a) nanoshell total radius R2 at fixed R1/R2 = 0.857, (b) nanoshell core/shell 
ratio R1/R2 at fixed R2 = 70 nm, (c) nanorod effective radius reff at fixed aspect ratio r = 3.9, and (d) nanorod 
aspect ratio r at fixed reff = 11.43 nm (and straight line fit).77 
Based on the methods that have been developed to explain the extinction spectra of the GNPs, 
the extinction peak of the GNPs can be tuned to the near infrared region, in the biological windows, 
which is very useful for applications in biology and medicine. For example, GNPs can act as a 
contrast agent for bioimaging and be used for photothermal therapy72. For GNSs, the maximum 
plasmon extinction λmax can be tuned from 800 to 1200 nm, when increasing the nanoshell total 
radius R2 from 60 to 140 nm, while fixes the nanoshells core/total ratio R1/R2 at 0.857 as shown in 
Figure 1.8 (a). In addition, this tunable property can be achieved by fixing the R2 at 70 nm and 
increasing the ratio R1/R2 as shown in Figure 1.8 (b). In the case of the GNRs, the maximum 
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plasmon resonance can be shifted by changing the size (effective radius, which is given by 𝑟𝑒𝑓𝑓 =
(3𝑉 4𝜋⁄ )1 3⁄ ) and the aspect ratio (r) as shown in Figure 1.8 (c) and (d). Particularly, when fixes 
the effective radius, the maximum surface plasmon extinction increases linearly as function of the 
aspect ratio r. 
 
Figure 1.9 Interaction between light and GNPs 
As we already know, when the light excites the GNPs, it can be scattered and absorbed by the 
GNPs, or pass through the GNPs, as illustrated in Figure 1.9. The absorption cross section and 
scattering cross section determine the extinction cross section of the GNPs. Photothermal therapy 
and PA application strongly depend on the absorption property of the GNPs.69, 78 However, OCT, 
which detects the back scattered light of the material, is strongly dependent on the scattering 
coefficient of the GNPs69. Therefore, the understanding of the absorption and scattering properties 
of GNPs will make full use of the GNPs. In 2006, Prashant et al calculated the absorption and 
scattering properties of GNPs of different sizes, shapes and compositions.77 As shown in Figure 
1.10,77 for GNSs, when the core radius R1 is 120 nm, and the total radius R2 is 155 nm, the 
scattering cross section start to play a big role in the extinction cross section after the extinction 
wavelength at 600nm. They also gave a prediction to the scattering/absorption ratio (Csca/Cabs) of 
GNPs based the morphology of the GNPs. They found that the Csca/Cabs ratio of GNSs increases 
when increasing the total radius R2 while fixing the R1/R2 ratio. They also found that the ratio 
increases when increasing the R1/R2 ratio while fixing the R2. As for gold nanorods (GNRs), the 
aspect ratio r is the ratio of the nanorod dimension along the long axis to that along the short axis. 
The Csca/Cabs of GNRs increases when increasing the effective radius reff, while fixing the aspect 
ratio r. but it is very hard for Csca/Cabs ratio to increase to more than 1. The aspect ratio doesn’t 
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show a strong effect on the Csca/Cabs ratio when fixing the effective radius reff. Therefore, they 
conclude that the absorption cross section is always the dominant factor in the extinction cross 
section of the GNRs. 
 
Figure 1.10 Tunability of the ratio of scattering to absorption of nanoparticles. Variation of Csca/Cabs with 
(a) nanoshell total radius R2 at fixed R1/R2 = 0.857, (b) nanoshell core/shell ratio R1/R2 at fixed R2 = 70 nm, 
(c) nanorod effective radius reff at fixed aspect ratio R = 3.9, and (d) nanorod aspect ratio r at fixed reff = 
11.43 nm 
Applications: Due to their strong absorption and scattering cross section and their strong 
sensitivity to the environment, GNPs have been widely used for photo-thermal therapy, optical 
contrast for OCT and PA, and biosensing.69, 78-80 
In 2015, Adam de la Zerda et al used the GNRs for OCT imaging of living mice eyes, with an 
OCT operating 860 ±48nm wavelength. The quantifying GNRs detection limit in mouse cornea 
was achieved by injecting different concentration of GNRs (peaking at 780 nm) in mice corneas, 
the limit detection concentration is 0.5 nM. The OCT contrast enhancement was achieved after 
mice injected with 10 µL of GNRs at 50 nM indicated by the white arrow, compared to OCT cross 
section image of mice only injected with balanced saline solution (BSS) and non-injected mice as 
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shown in Figure 1.11. The contrast enhancement is due to the scattering of GNRs. Therefore, they 
demonstrated that GNRs could be used for OCT contrast enhancement.  
 
Figure 1.11 OCT detection of GNRs in living mice corneas. Left: Optical eye images for mice corneas 
were injected with 10 μL of GNR at 50 nM (lower), and control mice corneas were injected with 10 μL of 
balanced saline solution (BSS) (middle) or not injected at all (upper). Right: OCT cross section images 
through the mice eyes (left column, white dotted line).81 
In addition to GNPs as a contrast agent based on the scattering properties, they also can be used 
as a contrast agent based on the absorption properties. Gold nanocages, which has tunable 
extinction properties has been studied as an absorption contrast agent for OCT by Younan Xia’s 
group.82 As shown in Figure 1.12 (a), the gold nanocages show a high absorption coefficient, 
being the absorption efficiency and cross section calculated by DDA 87% and 7.63 × 10-11 cm2, 
respectively.82 The OCT image and signal distribution as function of depth showed a high OCT 
signal attenuation in deeper depth compared to that of portion without gold nanocages, as shown 
in Figure 1.8 (b) and (c). This is due to high absorption cross section and low scattering cross 
section of gold nanocages. 
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Figure 1.12 (a) DDA calculated extinction, absorption and scattering coefficients of gold nanocages based 
on the dimensions provided by the TEM image in the inset. (b) OCT image of a gelatin phantom embedded 
with TiO2. The left portion did not contain any gold nanocages, while the right portion contained 1 nM of 
gold nanocages. (c) Plots of the OCT signals on a log scale as a function of depth.  
Furthermore, GNPs have been used as optical contrast agent for PA imaging, due to their 
absorption cross section.46 In cardiovascular diseases, the matrix metalloproteinases play an 
important role in weakening the plaque caps and promoting rupture.48 Therefore, the quantification 
of the matrix metalloproteinases in atherosclerosis plaque is important in cardiovascular disease 
treatment. Qin et al used GNRs conjugated with matrix metalloproteinases-2 antibodies for IV-PA 
imaging detection of matrix metalloproteinases-2 in atherosclerosis plaque.48 The matrix 
metalloproteinase-2 antibody can lead the GNRs specially target to the matrix metalloproteinases. 
As shown in Figure 1.13, the IV-PA images show the structure of the aorta and the strong intensity 
area is produced by the GNRs, which indicate the area containing matrix metalloproteinase. The 
area of the bright PA signal region is almost the same as provided by the silver staining and 
immunofluorescence, thus GNRs can be used as a promising probe for IV-PA imaging quantitative 
detection of distribution of matrix metalloproteinases-2.48 
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Figure 1.13 (a) The photoacoustic image of the aorta containing plaque (b) Histological section of silver 
stained (for labeling GNRs) aorta containing plaque from rabbits intravenously (ear) injected with GNRs 
(1 mL, 1 mM) following 6 h circulation. (c) The immunofluorescence result of matrix metalloproteinases-
2 in the adjacent cross-sections. (d) Area of distribution of matrix metalloproteinases-2 measured using PA, 
histological section of silver staining, and immunofluorescence methods, respectively.48  
1.3.2 Quantum dots (QDs) 
QDs are nanosizes semiconductor crystals that have been extensively used in fluorescence 
imaging due to their small size, strong emission intensity and excellent photostability compared to 
the molecular probes.55, 83-86 Their tunable optical properties obtained by changing their size make 
them interesting for bioimaging, and their strong emission intensity could provide deep tissue 
imaging. In this part, I will focus on the optical properties of the QDs and their applications for 
cardiovascular imaging. 
Optical properties: For a bulk crystal, the optical properties of the material only depend on the 
chemical composition. However, when studying a nanosized crystal, the size of the particle starts 
to change the optical properties of the material. Particularly, in small semiconductors, the 
electronic structure changes from continuous bands to discrete or quantized electronic levels, due 
to the apparition of electron-hole bound system. The energy of the electron and hole quantized 
levels can be written as87 
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 𝐸𝑙,𝑛
𝑒,ℎ =
ℏ2𝜙𝑙.𝑛
2
2𝑚𝑒,ℎ𝛼2
 (1.5) 
where ℏ is the reduced Planck constant, 𝜙𝑙.𝑛 are the root of the Bessel functions, which depend on 
the principal quantum numbers n (1, 2, 3,…) and the angular momentum quantum number (0, 1, 
2, 3…, corresponding to s, p, d,…, orbitals)88, me,h is the electron and hole effective mass 
respectively, a is the crystal radius. Obviously, the energy of the electron and hole quantized level 
decreases when increases the nanocrystal size. 
Besides the quantization energy, the Coulomb interaction between the bounded electron and 
hole also affects the optical properties of the QDs.89 The Coulomb energy is on the order of 𝑒2 𝜀𝑎⁄ , 
where ε is the semiconductor dielectric constant. Comparing the quantization energy and Coulomb 
energy, they all increase with decreasing the radius of the semiconductor but in different order. 
Therefore, in large QDs, the Coulomb interaction is much more important than the quantization 
energy. On the contrary, when the radius of the QDs is very small, the quantization energy 
produces main effect to the optical properties of the QDs. 
Quantum confinement effects play an important role when the size of the nanocrystal reaches to 
the natural length of the electron and hole, this is known as Bohr radius aB, which is calculated in 
analogy to the hydrogen atom Bohr radius a0 (0.529nm). Thus aB is given as 
89 
 𝑎𝐵 = 𝜀
𝑚0
𝑚∗
𝑎0 (1.6) 
where m* is the effective mass, m0 is the mass of the electron. When the electron and hole are 
confined together, they can form an exciton. The effective mass of the exciton is 𝑚𝑒𝑥𝑐
∗ =
𝑚𝑒
∗ × 𝑚ℎ
∗ (𝑚𝑒
∗ + 𝑚ℎ
∗ )⁄ , 𝑚𝑒
∗  and 𝑚ℎ
∗  is the effective of the electron and hole, respectively. After 
introduced the effective mass of electron, hole and exciton in Equation (1.6), we can get the Bohr 
radius for electron, hole and exciton respectively. For example, for the CdSe QDs, 𝑚𝑒
∗  is 0.13 m0, 
𝑚ℎ
∗  is 0.45 m0, ε is 10.1, therefore, the exciton Bohr radius for CdSe QDs is 5.3 nm.90 In case of 
PbS QDs, , 𝑚𝑒
∗  is 0.087 m0, 𝑚ℎ
∗  is 0.083 m0, ε is 17, the electron, hole and exciton Bohr radius 
(aB,e, aB,h and aB, exc) for PbS QDs is 10, 11 and 21 nm respectively.
91, 92 The Bohr radius 
determinates three kinds of quantum confinements regime.91 When a > aB, there is a weak 
confinement regime. In the intermediate confinement regime, the QDs crystal radius is less than 
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the electron Bohr radius but larger than the hole Bohr radius (aB,h, < a < aB,e). Strong confinement 
regime happens when the QDs crystal radius is less than Borh radius (a < aB), In this case, the 
exciton energy is given by  
 ℏ𝜔𝜈 = 𝐸𝑔 + 𝐸𝑣
ℎ(𝑎) + 𝐸𝑣
𝑒(𝑎) − 1.8
𝑒2
𝜀𝑎
 (1.7) 
where Eg is the energy gap of the semiconductor and it also depends on the size of the QDs, the 
Coulomb interaction is calculated by the first order perturbation theory87. 
 
Figure 1.14 (a) Carton drawing and TEM a ZnS/CdSe QD. (b) Core size of ZnS/CdSe QDs and their 
corresponding fluorescence imaging and emission spectra. (c) The corresponding energy gap and energy 
level of the ZnS/CdS QDs corresponding to their core size.93 
Figure 1.14 shows the optical properties of ZnS/CdSe QDs.93 In Figure 1.14 (b), when the size 
of the core changes from 2.7 nm to 4.8 nm, the emission spectra show a red shift from 510 nm to 
610 nm. Also in Figure 1.14 (c), the quantum confinement of the exciton lead to a decreasing 
energy band gap when increases the core size. Therefore, by changing the size of the QDs, we can 
get the emission we want for specific applications. In the case of the PbS, as shown in Figure 1.15, 
the emission peak can be tuned from 752 to 1520 nm when increasing the size of PbS QDs from 
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2.35 to 5.61 nm.94 Thus the emission spectra of PbS can be tuned from I-BW to III-BW, which 
will be very useful for different applications. 
 
Figure 1.15 (a) Different size of PbS QDs. (b) Normalized absorption of PbS QDs. (c) Normalized 
emission spectra of PbS QDs.94 
Applications 
Compared to fluorescent dyes, QDs have some advantages, such as long Stokes shift, broad 
band excitation spectra, narrow emission bands and high photostability, thus they has been widely 
used for high resolution cellular imaging, single particle tracking of biological process and ex and 
in vivo imaging.95, 96 Furthermore, different QDs can be excited by single light source, therefore, 
QDs can be used for simultaneously multicolor imaging.97 
Particularly, QDs have been used for cardiovascular imaging. In 2016, Chenxin Wu and his 
coworkers used ICG@PEG-Ag2S for atherosclerosis targeting and imaging in vivo.
98 The Ag2S 
QDs show a strong emission in NIR-II (peaking at 1200 nm).99 As shown in Figure 1.16, the 
infrared fluorescence imaging of the aortas show two bright areas, which indicate the 
atherosclerotic plaques and macrophages, these are due to the lipophilicity of the Ag2S QDs 
surface to the atherosclerosis environment.98 The existence of the macrophages and atherosclerosis 
in these areas were convinced by the Hematoxylin–eosin (H&E) and mouse F4/80 antibody 
staining of the dissected aortas as shown in Figure 1.16 (b) and (c). 
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Figure 1.16 (a) NIR-II fluorescence imaging of the aortas, the aortas were harvested from the ApoE-/- mice 
after intravenous injection of ICG@PEG-Ag2S. (b, c) Hematoxylin–eosin (H&E) and mouse F4/80 
antibody staining of the dissected aortas corresponding to panel (a). White arrows indicate macrophages 
and red arrows indicate atherosclerotic plaques.98  
1.4 Targeting strategy 
Targeting strategy is very important for improving the efficiency of NPs localizing to the disease 
site and avoiding the fast clearance of NPs by the liver. Based on the properties of NPs and 
different pathologies of disease, there are several targeting strategies that have been used to deliver 
the NPs to the disease sites. 
1.4.1 Passive targeting strategy 
Enhanced vascular permeability: Enhanced vascular permeability is one of the main 
mechanisms for passive targeting of diseases. This effect has been well investigated in cancer 
therapy, it also exists in atherosclerosis due to the inflammation and rapidly formed of the leaky 
microvessels in intima of the plaque. The vascular permeability allows NPs to penetrate the 
vascular wall and accumulate in the inflammation sites.100 There are several factors that should be 
taken into consideration, such as the size, shape and surface coating of the NPs,101, 102 and these 
factors affect the clearance and circulation time of NPs in the vascular.100 
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Magnetically guided nanoparticles: The magnetic NPs could be used to image the 
atherosclerosis plaque as they can be guided to the disease site by using an external magnetic 
field.103, 104 This is the so called magnetically guided nanoparticles strategy. It is based on the 
enhanced vascular permeability, and could improve the margination and accumulation of NPs in 
the inflammation place.100 
Shear induced target: For advanced atherosclerosis, one of the symptoms is the stenosis, which 
results in the change of the wall shear stress. Take advantage of this effect, the shear stress sensitive 
NPs can specially targeting to the plaques. Rui et al reported the use of up conversion NPs for 
molecular imaging of vulnerable atherosclerosis.105 Based on the different wall shear stress in the 
mouse, the NPs can specially target low shear stress site, where has vulnerable plaques. These 
results have been confirmed by optical and MRI imaging, and the histological analyses.  
1.4.2 Active targeting strategy 
An scheme of the active targeting strategy has been given in Figure 1.2. The specially 
functionalized NPs could be used to target specific disease sites. In this section, some examples of 
using NPs to target endothelial cells and microphages have been discussed. More targeting 
strategies related to different imaging techniques are shown in Table 1.1. 
Endothelial cells: Due to their directly exposure to the bloodstream, endothelial cells has been 
the main target of conjugated NPs for cardiovascular disease. Andrew et al studied the molecular 
imaging with OCT by using microparticles conjugated with different antibodies.106 First they used 
tumour necrosis factor (TNF-) to activate the human umbilical endothelial cells (HUVECs), this 
step helps the expression of the VCAM-1, platelet endothelial cell adhesion molecule (PECAM-
1) and E-selectin on endothelial cells. The results show that under static conditions, NPs 
conjugated with antibody bind to PECAM-1, E-selectin, VCAM-1 and E-selectin+VCAM-1. 
Under flow conditions with increasing shear stress, PECAM-1-NPs bind great numbers than other 
antibody-NPs. Furthermore, the binding of NPs to endothelial cells has been study in ex-vivo 
coronary arterioles under different shear stress. The VCAM-1-NPs specially targeted to the TNF-
 simulated arterioles. Due to the scattering properties of this NP, the binding of E-
selectin+VCAM-1-NPs to the simulated endothelial cells show a high OCT intensity than basal 
without any binding NPs under different shear stress. Therefore, the OCT molecular imaging was 
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achieved by active targeting strategy.106 By using another technique, photoacoustic imaging, 
Seunghan et al successfully detected and monitored the inflammatory response of HUVECs. After 
simulated by TNF-, HUVECs could be expressed by cell adhesion molecules such as the ICAM-
1 and E-selectin. The antibody-GNRs were used to target these molecules, due to the specific 
targeting and high absorption properties of these GNRs, a high PA signal was achieved for the 
simulated HUVECs, Therefore, PA imaging could be used to monitor the inflammation response 
by combining the active targeting strategy. 
Table 1.1 Contrast agents (CAs) for cardiovascular imaging 
CAs 
Imaging 
techniques/conditions 
exc (nm) em(nm) Functionalization Targeting Disease Refs 
Cy 5.5 
In vivo fluorescence 
imaging 
550 680 Thrombin NA Thrombosis 107 
Cy7 
Ex vivo fluorescence 
imaging 
485 525 Fibrin NA Atherosclerosis 108 
Cy5.5 
In vivo and ex vivo 
fluorescence imaging 
NA NA Profilin-I NA Atherosclerosis 109 
NaGdF4:Yb,Er 
Visible fluorescence 
imaging.  
980 400-750 Osteopontin NA Atherosclerosis 105 
ICG@Ag2S 
Fluorescence imaging 
(ex vivo) and PA (in 
vivo) 
800 1200 C18/PEG NA Atherosclerosis 110 
Gadolinium(III)–
GNRs  
PA (In vitro, in vivo 
and ex vivo ) 
NA 520, 710 mPEG-SH Macrophage 
Atherosclerotic 
inﬂammation 
111 
GNRs PA (Ex vivo) 695 700 
polyclonal matrix 
metallopeptidase-2 
antibody 
Polyclonal 
matrix 
metallopeptidase-
2 
Atherosclerotic 
plaques 
48 
GNRs PA (In vitro) 700 700 anti-ICAM-1 
Human umbilical 
vein endothelial 
cells (HUVECs) 
Inflammatory 112 
GNSs 
PA (In vitro and in 
vivo) 
NA 710 VCAM-1 antibody NA 
Atherosclerotic 
plaque 
113 
GNPs 
IV-PA (Phantom and 
ex vivo) 
680 530 PEG Macrophage 
Atherosclerotic 
plaques 
114 
GNRs PA (In vitro) 715;800 715;800 
anti-ICAM-1 
antibody and anti-
E-selectin antibody 
Human umbilical 
vein endothelial 
cells (HUVECs) 
Endothelial 
inflammation 
115 
PbS QDs OCT (Ex vivo) 1320 1550 
DSPE-PEG-amine-
coated 
NA NA 116 
Nanorose 
Photothermal OCT 
(Ex vivo) 
1328 NA Dextran Macrophage NA 117 
Magnetic 
microspheres 
Intravascular 
Magnetomotive-OCT 
1310 nm NA RGD αvβ3 integrins 
atherosclerotic 
plaque 
118 
Microparticles of 
iron oxide 
OCT (In vitro and ex 
vivo) 
1250-
1350 
NA 
Anti-VCAM-1, E-
selectin, PECAM-1 
HUVEC 
atherosclerotic 
plaque 
106 
NA: Not available 
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Macrophages: Macrophages play an important role in the atherosclerosis progression because 
they ingest the oxidized lipoproteins and lead to their differentiation into foam cells. Therefore, 
macrophages imaging could be serve as biomarker of the atherosclerosis processes.119 High-
density lipoprotein HDL in macrophages helps the transport of the cholesterol to the liver for 
excretion. Therefore, HDL-based contrast agents could be used to visualize macrophages. In 2013, 
Marrache and co-workers developed (HDL)-mimicking NPs to detect macrophages apoptosis in 
vitro. The core of these NPs contain QDs, which is used for optical imaging. The fluorescence 
microscopy imaging showed the apoptotic macrophages by using these NPs compared to the 
nontargeted NPs.120  
1.5 Motivation 
IV-OCT is a high resolution clinical technique to characterize the atherosclerosis plaque. 
However, due to lack of contrast agent, the molecular processes under atherosclerosis progression 
can not be visualized by IV-OCT. A strong demand of contrast agent to improve the IV-OCT 
contrast has been called by the physicians. Based on the OCT technique, which collects the 
backscattered light, NPs that could provide high backscattered light can be used to enhance the 
OCT contrast. Therefore, the GNPs with high backscattered efficiency visualized by IV-OCT are 
discussed in Chapter 3. The scatter properties determination of GNPs by photo-thermal method, 
numerical simulation, dark field microscopy, PA are included in Chapter 4. Molecular OCT 
imaging of the cells and tissue produced by GNSs was also achieved, the results and discussion 
are given in Chapter 5. The fluorescence imaging of the atherosclerosis which is based on the 
contrast agent could provide the molecular imaging of the atherosclerosis procession. Thus, the 
combination of the fluorescence imaging and IV-OCT imaging could help to improve the accurate 
treatment of the CVD. In this case, PbS QDs were evaluated as a contrast agent for fluorescence 
imaging and IV-OCT in Chapter 6. 
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2.1. Preparation of nanoparticles 
2.1.1. Synthesis and functionalization of GNPs 
GNSTs (surfactant-free) were synthesized by Dionysia Tsoutsi (Integrative Biomedical 
Materials and Nanomedicine Lab, Department of Experimental and Health Sciences (DCEXS), 
Pompeu Fabra University (UPF)). The synthesis process followed a seed-mediated growth 
protocol, as previously reported by Yuan et al.121 The following chemicals were used: 
Tetrachloroauric acid tetrahydrate (HAuCl4·4H2O), trisodium citrate dihydrate (C6H5O7Na·2H2O), 
silver nitrate (AgNO3), L(+)-ascorbic acid, and hydrochloric acid (HCl), all of them purchased 
from Sigma-Aldrich and used without further purification. Water was purified using a Milli-Q 
system (Millipore). Aqua regia was used to clean all the glassware prior to use. Gold spheres, used 
as seeds, were prepared by adding 15 mL of 1 wt % citrate solution to a 100 mL boiling solution 
of HAuCl4 (1 mM) under stirring and additional boiling for 15 min. This is a standard citrate-
stabilized protocol producing wine-red colored gold sols with an average diameter of around 12 
nm. Next, 1 mL of the above seed solution was added to a 100 mL of 0.25 mM HAuCl4 solution 
containing 100 μL of 1 M HCl at room temperature and under moderate stirring. Immediately 
afterwards, the addition of 1 mL of 0.01 M AgNO3 and 500 μL of 0.1 M ascorbic acid was 
performed simultaneously and the solution was stirred for 30 s producing dark blue-black colloids. 
The nanostar dispersions were centrifuged at 4500 rpm for 20 min, redispersed in MiliQ-water and 
kept in the dark at 4 °C for long-term storage. 
2.1.2. Synthesis and functionalization of QDs 
Commercial CANdots® Series C (λem ~ 1600 nm) PbS QDs in a toluene dispersion (10 mg/mL, 
1 mL) were added after careful sonication to CHCl3 (5 mL) while stirring at 23 ºC. In a second 
flask 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000] 
ammonium salt (DSPE-PEG-amine) (21 mg) was dissolved in CHCl3 (10 mL) and after complete 
dissolution added dropwise to the first mixture. The combined mixtures were stirred for 2 h at 23 
ºC and then the organic solvent was removed under reduced pressure. The obtained DSPE-PEG-
amine-coated QDs were then dispersed in distilled H2O  
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2.2. Basic characterization 
2.2.1. Transmission electron microscopy (TEM) 
TEM is a microscopy technique in which an electron beam is accelerated and focused in a 
specimen (thickness <100 nm). The directions of the electrons change when they interact with the 
atoms in the specimen, the scattered electrons thus produces an image. After magnified and 
focused, the image can be seen on a fluorescence screen. The resolution of the TEM is higher 0.1 
~ 0.2 nm, due to the de Broglie wavelength of the electrons.122 TEM is now widely used in the 
chemistry, physics and biology. 
The TEM we used in this work is a JEOL JEM 1010 microscope operating at 80 kV. Samples 
were prepared by placing one drop of a diluted suspension of the nanoparticles in water onto a 
carbon coated copper grid and leaving it to dry at room temperature. The size distribution of NPs 
were determined by using ImageJ software. 
2.2.2. Total reﬂection X-ray ﬂuorescence (TXRF) 
The concentration of PbS QDs was determined by using TXRF. TXRF uses X-ray to excite the 
sample, which is put on the reflector, the angle between the incident beam and the reflector is less 
than the 0.06°,123 thus the total incident photons are reflected. The X-ray fluorescence from the 
sample is detected by putting a detector above the reflector. The detection limits is less than 10-12 
g.124  
The Pb-content was determined on a Bruker TXRF S2 PicoFox system, excitation by a Mo K 
radiation. Calculations based on the size of the QDs and the PbS structure revealed the 
concentration after ligand-addition as 0.6 mg/mL. 
2.2.3. Extinction spectroscopy 
The room temperature extinction spectrum of the colloidal solutions of nanoparticles were 
measured with a double beam absorption spectrometer (Perkin Elmer Lambda1050). 
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2.2.4. Photoluminescence spectroscopy 
The emission spectra of the PbS QDs was measured under excitation with a single mode fiber-
coupled 1280 nm laser diode. A long pass filter 1350 nm was put at the entrance slit of the Andor 
Sahmrock 193i spectrometer to remove the excitation laser. After being analyzed by the 
monochromator, the luminescence signal was collected by an InGaAs camera (Andor Idus 
DU490A). 
2.2.5. Dark field microscopy (DFM) imaging system 
The DFM imaging system used in this thesis, shown in Figure 2.1 is composed of optical 
microscope (NIKON Eclipse E400), dark field condenser (Nikon, dry NA 0.95-0.80), and different 
objectives 50X (SLMPlan N, NA 0.35 WD 18 mm ), 40X (NA0.65, WD 0.65 mm), 20X (NA 0.40, 
WD 3.8 mm), and 10X (NA 0.25, WD 6.1 mm). The signal is collected by InGaAs infrared camera 
(top) and monochromatic (Shamrotic 193i). The visible image is detected by the EMCCD camera 
(iXon Ultra Andor) which is connected to the monochromator, and the infrared emission is 
detected by an iDus InGaAs detector (Andor). A filter wheel (Thorlabs) is located in front of the 
infrared camera, in order to select the wavelength at which DFM are acquired. This DFM is 
specially designed for experiment under flow conditions. A syringe pump is used to inject the 
solution of GNPs in the flowing chamber. Meanwhile, a temperature controller (Warner, TC-324C) 
is used to maintain the temperature in the flow chamber temperatures compatible with cell 
aviability. The flow chamber (RC-30WA) is located on the platform bewteen the dark field 
condenser and the objective.  
The DFM working principle is shown in Figure 2.2 (a). A halogen lamp is used to illuminate 
the specimen in the flowing chamber, and the central part of beam is blocked, so that only the light 
scattered by the specimen can enter the objective. In our case, the specimen is located in the flow 
chamber. The components of the chamber are shown in Figure 2.2 (b), which contains a pressure 
plate on the top, a top coverslip plate, a top cover slip, a chamber forming gasket, a bottom cover 
slip, a base, and a stage adapter. Vacumn grease is used to connect the coverslip to the top coverslip 
plate and base. The temperature of the base is kept constant by the temperature controller (Figure 
2.1). The cells are cultured on the bottom cover slip or top cover slip.The GNPs are introduced in 
the flow chamber by the small tube in the top coverslip plate. 
Chapter 2. Experimental techniques 
33 
 
 
 
Figure 2.1 Dark field microscopy imaging system and flowing configuration (a) front and (b) back side. 
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Figure 2.2 (a) DFM schematic for flowing experiment. (b) RC-30WA flowing chamber  
2.2.6. Photothermal method and experiments 
 
Figure 2.3 (a) Schematic diagram of the experimental set-up used for the determination of the 
scattering efficiency of GNPs under optical excitation in the II-BW. (b) Representative heating 
and cooling curve obtained from an aqueous solution of GNRs under 1280 nm optical excitation. 
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The photo-thermal experiments were used to determine the absorption and scattering 
efficiencies of the GNPs. The experimental setup is shown in Figure 2.3.  
Briefly, a laser beam of power P0 at the required wavelength is directed onto a cuvette containing 
a water solution with a certain concentration of GNPs (from now on the sample). A power meter 
measures the output power P at the exit face of the sample. A fraction of the incident laser power 
is attenuated by the GNPs depending on their scattering and absorption properties.125 Hence, the 
transmitted power can be defined as follows: 
 𝑃 = 𝑃010
−𝑂𝐷 (2.1) 
where OD is the optical density of the sample that can be determined at different wavelengths from 
the experimentally measured extinction spectra of each sample. We used three different continuous 
wave (CW) laser diodes emitting at 808 nm, 980 nm, and 1280 nm. The fraction of laser power 
absorbed by the sample will result in an increment in sample´s temperature that is measured by 
using a thermal camera (FLIR E40bx) and record by FLIR tool program, as it is schematically 
indicated in Figure 2.3 (a). The laser was kept on about 10 minutes (heating part of the Figure 2.3 
(b)) until the temperature of the dispersion had reached a steady value. Then, it was turned off and 
the temperature was monitored until it was equal to the room temperature, thus we obtained the 
heating/cooling cycles, as the one shown in Figure 2.3 (b). The experimental determination of 
𝜂𝑎(𝜆) requires the determination of temperature heating, (𝛥𝑇)𝑚𝑎𝑥 = 𝑇𝑚𝑎𝑥 − 𝑇𝑎𝑚𝑏 (where Tmax is 
the maximum temperature and Tamb the ambient temperature) and the cooling decay time (𝜏). Both 
magnitudes are schematically indicated in Figure 2.3 (b). The heat rate balance equation 
accounting for these processes can be written as follows126: 
 𝑚𝐶𝑝
𝑑𝑇
𝑑𝑡
= 𝑄𝐺𝑁𝑃 + 𝑄𝑟 − 𝑄𝑒𝑥𝑡 (2.2) 
where m is the solvent mass, CP the constant pressure heat capacity, T the sample temperature and 
QGNP the heat power delivered by the gold nanoparticles in the water solution. In Equation (2.2), 
Qr is the heat power delivered by the solvent and the cuvette walls that can be measured for each 
particular case, and Qext represents the external heat power losses, due to the temperature difference 
ΔT between the sample and the surrounding environment. This term can be expressed as: 
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 𝑄𝑒𝑥𝑡 = ℎ𝐴∆𝑇 (2.3) 
where h is the heat-transfer coefficient and A is the cross sectional area for radiative heat transfer. 
As we have assumed (no luminescence) that the heat power delivered due to the GNPs is equal to 
the absorbed power, we can write: 
 𝑄𝐺𝑁𝑃 = 𝑃𝑎𝑏𝑠 = 𝑃0(1 − 10
−𝑂𝐷)𝜂 (2.4) 
When the laser is turned off (QGNP=Qr=0), Equations (2.2) and (2.3) lead to: 
 𝑑𝑡 = −
𝑚𝐶𝑝𝑑𝑇
ℎ𝐴∆𝑇
 (2.5) 
whose solution is: 
 𝛥𝑇 = (𝛥𝑇)𝑚𝑎𝑥 ∙ 𝑒
−𝑡 𝜏⁄  (2.6) 
where the experimentally measurable decay time constant, τ, is given by: 
 τ =
𝑚𝐶𝑝
ℎ𝐴
 (2.7) 
To determine the heating efficiency we can rewrite Equation (2.1) under steady state conditions 
(i.e. dT/dt=0) taking into account Equations (2.3) and (2.4):  
 𝜂𝑎 = 1 − 𝜂𝑠 =
𝑚𝐶𝑝∆𝑇𝑚𝑎𝑥
𝜏 − 𝑄𝑟
𝑃0(1 − 10−𝑂𝐷)
 (2.8) 
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2.2.7. Optical coherence tomography 
 
Figure 2.4 (a) IV-OCT system. (b) IV-OCT catheter and rotary and pushing motor. (c) IV-OCT cross-
sectional image of artery. 
For the experiments, the IV-OCT system used in this work is a commercially available system 
for intravascular imaging ((Dragonfly™ OPTIS™ Imaging Catheter. St Jude Medical.)), which is 
used for the treatment of patients at the Interventional Cardiology Unit University Hospital. Figure 
2.4 show the real IV-OCT system in our lab, which is consist of computer system, rotary and 
pushing motor and IV-OCT catheter. A cross-sectional image of artery is also presented in Figure 
2.4 (c), in which we can see the IV-OCT catheter, the structure of the artery, a stent that is used to 
expand the artery and metallic guide that is used to introduce the IV-OCT catheter. Figure 2.5 (a) 
shows a schematic diagram of the OCT clinical system. A compact 1320 nm wavelength laser is 
coupled to a single mode fiber (SMF) that is in turn incorporated into a 0.9 mm diameter catheter. 
The SMF inside the catheter is optically coupled to a frequency domain interferometric system 
that is constituted by different lenses and a rotating micro reflector that deviates the 1320 nm laser 
beam 90º in respect to the SMF. The whole optical system is externally driven so that it can to 
rotate at a constant angular frequency. As a consequence, as it is illustrated in Figure 2.4, the OCT 
catheter is continuously scanning the 1320 nm beam over a cross sectional plane perpendicular to 
it. The same optical system is used to collect the back-scattered 1320 nm signal and to couple it 
into the SMF. The collected signal is then sent to a fixed-arms interferometer equipped with a low 
Chapter 2. Experimental techniques 
38 
 
loss spectrometer for frequency domain OCT. The nominal axial resolution of the clinical 
intravascular OCT used in this work was close to 15 µm. In addition, the hydrophobic coated OCT 
catheter is mechanically and optically coupled to a motorized unit, allowing for pull-back imaging 
by retracting the catheter a total length of 5 cm at a speed of 20 mm/s. The scan diameter of the 
OCT is 10 mm. The maximum frame rate and lines per frame achievable by our OCT system are 
100 and 500, respectively. The emission spectrum of the OCT laser is included in Figure 2.5 (b). 
The OCT spectrum consists of two lines, one at 1320 nm and another one at around 650 nm. This 
second line arises from the fact that the OCT catheter incorporates a visible (red) laser that it is 
used by clinicians to check if the catheter is fully operative before introducing it into the patient. 
 
Figure 2.5 (a) Clinical IV-OCT set-up used all along in this work. (b) OCT laser spectra of the IV-OCT 
The basic scheme of the low coherence interferometry (Michelson interferometry) used in OCT 
is shown in Figure 2.6. The light source is a polychromatic plane wave with the electric field 𝐸𝑖 =
𝑠 (𝑘, 𝑤)𝑒𝑖(𝑘𝑧−𝑤𝑡) . Here, 𝑠 (𝑘, 𝑤) is the electric field amplitude, 𝑘 is the wavenumber and w is 
angular frequency. The incident light is split by the beamsplitter into the sample and reference 
arms into two equal electric field. After returning from the reference reflector and the sample, the 
electric field for each arm is 𝐸𝑅 =
𝐸𝑖
√2
𝑟𝑅𝑒
𝑖2𝑘𝑧𝑅 and 𝐸𝑆 =
𝐸𝑖
√2
[𝑟𝑆(𝑧𝑆) ⊗ 𝑒
𝑖2𝑘𝑧𝑆], respectively. Where 
rR and rS(zS) are the electric field reflectivity of the reference reflector and samples, zR and zS are 
the distance from the reference and sample arms to the beamsplitter, ⊗ denotes convolution, the 
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factor of 2 in the exponential is due to the path length in each arms. The returned light from the 
sample arm is called backscattered light. It interferes after the beam splitter and the result of the 
interference is detected by the detector, and produce a photocurrent, which can be expressed as 
𝐼𝐷(𝑘, 𝑤) =
𝜌
2
〈|𝐸𝑅 + 𝐸𝑆|
2〉. Here, ρ is sensitivity of the detector, the factor of 2 reflects the second 
pass of each field through the beamsplitter.127 The received electric signal indicates the reflectivity 
profile at different depth of the sample, this reflectivity profile is called A scan, which contains 
information of spatial dimensions and location of structure. When the sample arm scans in lateral, 
a cross-sectional tomography at each depth is achieved, this is B scan. Thus two dimensional cross-
sectional image of the sample is achieved by the OCT. 
 
Figure 2.6 Schematic of Michelson interferometry used in OCT127 
Normally, the electric field reflectivity rS(zS) in the biological tissue is continuous. Therefore 
the rS(zS) could be written as 𝑟𝑆(𝑧𝑆) = ∑ 𝑟𝑆𝑛𝛿(𝑧𝑆 − 𝑧𝑆𝑛)
𝑁
𝑛=1 , where rSn corresponds to its electric 
field reflectivity rS1, rS2…, and pathlength from the beamsplitter to sample zS1, zS2…. The power 
reflectivity from each reflector in the sample and from reference reflector is given by the 
magnitude squared of the electric field reflectivity,127 such as 𝑅𝑅 = |𝑟𝑅|
2  and 𝑅𝑆1 = |𝑟𝑆1|
2 , 
therefore, 𝑟𝑆 = √𝑅𝑆(𝑧𝑆). The rS is reintroduced into the electric field from sample arm, thus 𝐸𝑆 =
𝐸𝑖
√2
[∑ 𝑟𝑆(𝑧𝑆)𝑒
𝑖2𝑘𝑧𝑆𝑛𝑁
𝑛=1 ], and the detector current can be given: 
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 𝐼𝐷(𝑘, 𝑤) =
𝜌
2
〈|
𝑠(𝑘, 𝑤)
√2
𝑟𝑅𝑒
𝑖(2𝑘𝑧𝑅−𝑤𝑡) +
𝑠(𝑘, 𝑤)
√2
∑ 𝑟𝑆𝑛𝑒
𝑖(2𝑘𝑧𝑆𝑛−𝑤𝑡)
𝑁
𝑛=1
|
2
〉 (2.9) 
The angular frequency w is eliminated because the oscillation is so fast that the detector is not 
able to respond. Therefore, by using the Euler’s rule: 𝑒𝑖𝑥 = cos 𝑥 + sin 𝑥, the detector current can 
be written:127 
                 𝐼𝐷(𝑘)
=
𝜌
4
[𝑆(𝑘)(𝑅𝑅 + 𝑅𝑆1 + 𝑅𝑆2 + ⋯ )] "𝐷𝐶 𝑡𝑒𝑟𝑚𝑠"
+
𝜌
2
[𝑆(𝑘) ∑ √𝑅𝑅𝑅𝑆𝑛(𝑐𝑜𝑠[2𝑘(𝑧𝑅 − 𝑧𝑆𝑛)])
𝑁
𝑛=1
] "𝐶𝑟𝑜𝑠𝑠 − 𝑐𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 𝑇𝑒𝑟𝑚𝑠"
+
𝜌
4
[𝑆(𝑘) ∑ √𝑅𝑆𝑛𝑅𝑆𝑚(𝑐𝑜𝑠[2𝑘(𝑧𝑆𝑛 − 𝑧𝑆𝑚)])
𝑁
𝑛≠𝑚=1
] "Auto
− correlation Terms". 
(2.10) 
Here, 𝑆(𝑘) = 〈|𝑠 (𝑘, 𝑤)|2〉, which represents the power spectral dependence of the light source.127 
In Equation (2.10), the DC terms consists of the power spectral dependence of the light source 
multiplied by the power reflectivity of the reference reflector plus the sum of the sample 
reflectivities. It is an offset that is pathlength-independent to the detector current. The cross 
correlation terms, also called the interferometric terms, strongly depend on the light source 
wavenumber and the path length difference between the sample and reference arms. This is an 
interesting part for OCT imaging and is less intense than the DC terms. The auto-correlation terms 
is produced by the interference between the different sample reflectors. The best way to decrease 
the auto-correlation effect is to select the proper reference reflectivity to increase the contribution 
of the DC and interferometric terms in detector current. Therefore, a real detector current as 
function of wavenumber is well explained. 
There are two kinds of OCT system, time domain OCT (TDOCT) and Fourier domain OCT 
(FDOCT). In TDOCT system, the light source is a broadband continous wave. The reference arm 
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consists of a mirror, which scans in length (zR) in order to reconstruct the sample reflectivity profile, 
the reflected light from the reference and sample are recombined after pass the beamsplitter, and 
their interference fringes are detected by a single channel photoreceiver. The detector current ID(zR) 
in TDOCT can be obtained by the integration of Equation (2.10) over all k: 
 
𝐼𝐷(z𝑅) =
𝜌
4
[𝑆0(𝑅𝑅 + 𝑅𝑆1 + 𝑅𝑆2 + ⋯ )] "DC terms"  
                            +
ρ
2
[S0 ∑ √RRRSne
-(zR-zSn)
2
∆k
2
(cos[2k(zR-zSn)])
N
n=1
] 
"𝐹𝑟𝑖𝑛𝑔𝑒 𝐵𝑢𝑟𝑠𝑡𝑠". 
(2.11) 
Here, 𝑆0 = ∫ 𝑆(𝑘)𝑑𝑘
∞
0
 is the integrated power of the light source. When the reference reflector 
distance zR is equal to the sample distance zS1, for sample at position zS1, the detector current is 
𝐼𝐷(z𝑅) =
𝜌
4
[𝑆0(𝑅𝑅 + 𝑅𝑆1)] +
ρ
2
[S0√RRRS1], as shown in Figure 2.7. In OCT system, a Gaussian-
shaped light source spectrum is used due to the Fourier transform properties. The power of light 
source S(k) and its inverse Fourier transform γ(z) are  
 γ(z) = 𝑒−𝑧
2∆𝑘2
𝐹
↔ 𝑆(𝑘) =
1
∆𝑘√𝜋
𝑒−[
(𝑘−𝑘0)
∆𝑘
]
2
. (2.12) 
Here, k0 (k0=2π/λ0) is the central wavenumber of the Gaussian shaped light source spectrum. Δk is 
spectral bandwidth, which is equal to half-width of the spectrum at 1/e of its maximum intensity. 
For the inverse Fourier transform γ(z), the full width at half the maximum (FWHM) is called 
“coherence length”, lc. Based on (2.12), we use 1/2 to substitute γ(z), then 1/2 lc is √ln (2)/∆𝑘.The 
coherence length in OCT is also called axial resolution, which can be expressed as  
2√ln(2) 𝜆0
2/𝜋Δ𝜆.127, therefore, the coherence length lc is:  
 𝑙𝑐 =
2√ln(2)
∆𝑘
=
2√ln(2)
𝜋
𝜆0
2
Δ𝜆
. (2.13) 
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Figure 2.7 A scan resulting from TDOCT127, it includes DC offset, and the fringe burst between the light 
from the reference beam and sample beam at different distances (ZS1 and ZS2). 
In the case of FDOCT, the reference beam is fixed, and the detector current is depend on the 
wavenumber. A Fourier analysis is used to reconstruct the reflectivity profile. There are two kinds 
of OCT based on the light source and detector. Spectral domain OCT (SDOCT), where a 
broadband light source and detector array are used, which allows the simultaneously capture of all 
spectral components of ID(k), and swept source OCT, also called optical frequency domain 
imaging (OFDI), where a narrowband swept laser source is used. When the wavenumber of the 
source is swept, the spectral component of ID(k) are captured in a single detector as function of 
time.127 
Given the Fourier transform relation 
1
2
[(𝛿(𝑧 + 𝑧0) + 𝛿(𝑧 − 𝑧0))]
𝐹
↔ cos 𝑘𝑧0  and the 
convolution property of Fourier transforms x(z) ⊗ y(z)
𝐹
↔ 𝑋(𝑘)𝑌(𝑘) , the inverse Fourier 
transform of Equation (2.10) will be  
 
 𝑖𝐷(𝑘) =
𝜌
4
[𝛾(𝑧)(𝑅𝑅 + 𝑅𝑆1 + 𝑅𝑆2 + ⋯ )] "DC terms" 
                   +
𝜌
4
[𝛾(𝑧) ⊗ ∑ √𝑅𝑅𝑅𝑆𝑛 (𝛿(𝑧 ± 2(𝑧𝑅 − 𝑧𝑆𝑛)))
𝑁
𝑛=1
] 
"Cross-correlation Terms" 
(2.14) 
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                               +
𝜌
8
[𝛾(𝑧) ⊗ ∑ √𝑅𝑆𝑛𝑅𝑆𝑚 (𝛿(𝑧 ± 2(𝑧𝑆𝑛 − 𝑧𝑆𝑚)))
𝑁
𝑛≠𝑚=1
]  
"𝐴𝑢𝑡𝑜 − 𝑐𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 𝑇𝑒𝑟𝑚𝑠". 
The resulting Fourier domain “A-scan” is shown in Figure 2.8.127 At the zero position, only DC 
term appears in the detector current, this means the reflectivity profile appears at position of zR, 
this is different from that of TDOCT, which appears at the beamsplitter. The distance different 
between the reference reflector and the sample is doubled, this is due to the fact that the 
interferometer measures the go and back distance to both reflectors.  
 
Figure 2.8 A-scan resulting from FDOCT.127 
Table 2.1 Comparison between TDOCT and FDOCT 
Specifications TDOCT FDOCT 
Axial scans/s 5,000–10,000 ～100,000 
Lines/frame ～200 ～500–1,000 
Max. frame rate, fps 20 ～200 
Max. pullback speed, mm/s 2 20 
Axial resolution, µm 15 10-15 
Lateral resolution, µm 90 20-40 
Tissue penetration, mm 1.5-3 2-3.5 
 
Let’s see the differences between TDOCT and FDOCT, the specifications of the TDOCT and 
FDOCT are shown in Table 2.1.24 First, both of them show a high axial resolution than that of 
intravascular ultrasound (IVUS), in IVUS, the axial resolution is around 100µm.128 Second, the 
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FDOCT system is faster than TDOCT, which is due to the fixed mirror in the reflector arms and 
the variable frequency light source or swept laser in FDOCT system. The IV-OCT is developed 
based on the FDOCT. 
IV-OCT cross-sectional image analyze 
Integrated OCT intensity: The IV-OCT video was imported in the ImageJ software, then an area 
without catheter , but inside the tubing was selected in the IV-OCT cross sectional image, we 
added this selected area in the ROI, and used the multi measure option to measure the intensity. 
The integrated intensity, intensity per pixel, maximum and minimum intensity could be obtained 
at the same time. 
Individual spot analysis: Here we show you an example of how we analyzed the HeLa cells 
incubated with GNSs. The IV-OCT video was imported in the ImageJ software, first we need 
select the area where has GNSs and cells (inside the tubing) by change the contrast of the tubing 
and the catheter to zero (Brightness /Contrast option, adjust the minimum from 0 to 255). Then we 
change the image type to 8-bit. After this, we adjust the threshold from 0-255 to 37-355, because 
the threshold is the OCT intensity, and the intensity of the background is around 37, therefore, we 
adjust the threshold to remove the effect of the background. The statistics are carried out by using 
the analyze particles option, the size (pixel^2) is set to 3-30, as the size of the GNSs and cells are 
large than 1 pixel. Select the display results, and press ok, you will have the number of spots and 
max intensity per spot. Save it, import it to origin and do the frequency counts, you will have the 
number of spots for each spot intensity. 
2.2.8. Infrared fluorescence imaging 
For fluorescence imaging, the IV-OCT laser was used as an excitation source, a XEVA-320 
infrared camera was used to take the infrared fluorescence imaging. This camera is based on an 
InGaAs two-dimensional array cooled down to 0 ºC that makes the detection of fluorescence 
images in the 900-1700 nm spectral range possible. A long pass filter 1350 nm was used to remove 
the effect from IV-OCT laser. 
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2.2.9. Photoacoustic experiment 
The photoacoustic experiment was carried out in Optoelectronics and Laser Technology Group 
(GOTL), Universidad Carlos III de Madrid. With the permission from Prof. Horacio Lamela 
Rivera, and help by Luca Leggio and Daniel Gallego. 
The photoacoustic signals were obtained by using a fiber-coupled Nd:YAG laser operating at 
1064 nm and providing 8 ns width pulses as excitation source. The laser had a repetition rate of 1 
kHz and a pulse energy of 10.5 µJ, leading to an average power of 10.5 mW. The GNPs were 
placed in a cuvette with thickness of 4 mm. In order to perform comparable measurements, the 
concentration of GNPs in the solutions was adjusted to provide an optical density (O.D.) of 10 at 
the laser wavelength (1064 nm). The photoacousti signals generated in the sample were detected 
by an ultrasound transducer mechanically attached to the cuvette. The signal generated by the 
ultrasound transducer was sent to a 40 dB pre-amplifier and collected by a digital oscilloscope.129 
Basically, PA is also called optoacoustic or thermoacoustic imaging. In optoacoustic imaging, 
the photoacoustic signal is induced by the light, while in thermoacoustic imaging, the PA signal is 
produced by the radiofrequency.37 For intravascular photoacoustic imaging (IV-PA), the light is 
delivered by an optic fiber and the signal is collected by the transducer in the same optic fiber. 
This technique is used for imaging the plaque structure and its composition in atherosclerosis. 
An image of the tissue can be achieved by scanning the ultrasound.38 The PA source strength p0 
can be estimated by 
 𝑝0 = (𝛽𝑐
2/𝐶𝑝)𝜇𝑎𝐹 = ΓA, (2.15) 
where  is the isobaric volume expansion coefficient, c is the speed of the sound in vacuum, Cp is 
the specific heat at constant pressure of the sample, µ is the absorption coefficient of the sample, 
F is local energy density,  is the Grüneisen parameter: Γ = 𝛽𝑐2/𝐶𝑝 , A is the local energy 
deposition density: A = 𝜇𝑎𝐹.
37, 38 
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2.3. In vitro experiment 
2.3.1. HeLa and Jurkat cells; culture and incubation with Gold Nanoshells (GNSs) 
Two different cell lines were investigated, i.e., HeLa cells and Jurkat cells. HeLa cells are an 
immortal cell line derived from human cervical cancer cells, with an epithelial phenotype. These 
cells divide an unlimited number of times in vitro under minimal survival conditions; accordingly, 
they are commonly used for cancer research130. In addition, as is typical for cancer cells, they are 
able to take up nanoparticles by passive targeting, usually by endocytosis. HeLa cells (ATCC 
CCL-2) were grown in Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum (FBS). 
Jurkat cells are an immortalized line of human T lymphocytes. They (ATCC TIB 152) were grown 
in RPMI 1640 medium with 10% FBS. Both cell lines were cultured at 37 °C under 5% CO2 and 
95% humidity. Cells in exponential growth were used throughout all experiments. Incubation 
experiments were performed at 37 °C for 24 h using PBS solutions containing various 
concentrations of GNSs (0.05, 0.1, 0.5, 2.5, and 5 µg/mL). After incubation, cells were washed 
several times to remove excess GNSs that did not adhere or were not internalized by the cells. 
After incubation with GNSs, HeLa cells were trypsinized. The detached cells were resuspended in 
PBS and centrifuged at 1,000 rpm at 4 °C for 5 min. This step was repeated three times to eliminate 
excess NPs. Jurkat cells were resuspended without trypsinization in PBS and subjected to three 
cycles of centrifugation in order to eliminate excess GNSs. 
2.3.2. Human Mammary Epithelial Cells culture, activation and evaluation of molecular 
expression 
Human microvascular endothelial cell line (HMEC-1) was obtained from the American Type 
Culture Collection (Teddington, UK; ATCC, No CRL-3243) and was grown in 5% CO2 at 37 °C 
in a medium containing endothelial basal medium MCDB 131 (Gibco), 10% heat-inactivated FBS, 
1% L-glutamine, 100 μg/ml each penicillin and streptomycin, 100 nM hydrocortisone (Corning), 
and 10 ng/ml human epidermal growth supplement (EGF; Gibco BRL). For flow cytometry assay, 
the cells were cultured on 6-well plates (FALCON, USA). Only cells with less than 12 passages 
were used in the present study.  
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Figure 2.9 Flow cytometer analysis of the expression of ICAM-1, ICAM-1 Sb and VCAM-1 in (and 
without) TNF--activated HMEC-1. Data in histograms are also displayed in bar graphs in the bottom of 
this figure. 
HMEC-1 (200,000 cells/well) in six-well plates (Costar, Cambridge, MA, USA) were 
stimulated with 40 ng/mL TNF- (DakoCytomation, Glostrup, Denmark) for 18 h. To evaluate 
the expression of ICAM-1 or VCAM-1 after exposure to TNF-, three kinds of molecules were 
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used for the expression, ICAM-1 purified, ICAM-1 supernatant of hybridome (Sb) and VCAM-1, 
the cells were detached with a solution of 0.05% trypsin-EDTA, which was afterwards neutralized 
by the addition of MCDB131 complete medium. Then, the cells were washed in ice-cold PBS by 
centrifugation (5 min at 4°C) and resuspended in PBS containing mouse monoclonal anti-human 
VCAM-1/CD106 (MCA907. BIORAD) or mouse anti-human ICAM-1 monoclonal antibody 
(TONBO, San Diego. CA). After incubation for 1 h at 4°C, the cells were washed with ice-cold 
1% BSA-PBS to remove the unbound antibody. The cell pellet was recovered by centrifugation (5 
min, at 4°C) and resuspended in cold PBS containing FITC-conjugated rabbit anti-mouse Ig (1/40) 
(Dako, Den- mark). After washing, the cells were resuspended in PBS before being analyzed by 
flow cytometry with a FACScan flow cytometer (model FACS- Calibur, Becton Dickinson, San 
Jose, CA, USA) with the CellQuest analysis program (BD Biosciences, San Diego, CA, USA). 
Flow cytometry was performed using the appropriate single-stained samples for compensation 
setting. The number of cells expressing adhesion molecules was determined according to a forward 
light scatter/side light scatter gating combined with an FL-1 channel for immunostaining. The 
results are shown in Figure 2.9, before the HEMC-1 activated by TNF-, the expression of ICAM-
1 and ICAM-1 Sb are 80% and 70%, respectively. After activated by TNF-, the expression of 
these two molecules have reached to 100%. In case of VCAM-1, the expression efficiency is very 
low, only 10% after TNF- activated. 
2.3.3. Cell viability study 
In order to evaluate the cellular toxicity of GNSs used in the my thesis, the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium reduction assay was used in 
all the cases. Metabolically active cells are capable of converting MTT to formazan, which is a 
water-insoluble compound with dark blue color. While the dead cells lose the ability to produce 
formazan from MTT. When the formazan is formed in culture medium, they precipitate inside 
cells and being deposited inside the culture medium due to their insoluble properties in water. Here, 
Dimethylsulfoxide (DMSO), an organic medium, is used to stabilize the formazan and avoid 
evaporation.131 Thus formazan can be quantified by from the optical absorption of the dispersion 
at 540 nm, and finally the number of living cells are obtained compared to the control. 
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In this thesis, the cell viability was studied on HeLa cells. To carried out these test, the cells 
were cultured in a plate with 24 wells at 37 °C in controlled atmosphere (5% of CO2). After 48 
hours, the culture medium was replaced by new culture medium in which NPs had previously been 
dispersed at different concentrations. The HeLa cells were incubated with GNSs for 24 hours. At 
the end of the incubation period, the culture medium with NPs was removed and medium without 
NPs was added to these wells. After 24 hours, 0.5 mL of an 0.05 mg/mL MTT dispersion was 
added to each wells and incubation was continued in controlled atmosphere for 3 hours, after that, 
the culture medium were discarded. The formazan crystals were dispersed in 0.5 mL of DMSO.  
Finally, the optical density of the samples at 540 nm was measured using a reader of microplates 
(Espectra Fluor 4, Tecan). Based on it, the percentage of feasibility of cells incubated with NPs 
with respect to the control case was calculated by using the following expression: 
 Viability (%) =
𝐴𝑁𝑃𝑠
𝐴𝑐𝑜𝑛𝑡𝑟𝑜𝑙
× 100 (2.16) 
Where ANPs is the absorption of formazan produced by cells after incubated with NPs, and 
Acontrol is the absorption of formazan produced by cells without incubation. 
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3.1. Introduction 
Although IV-OCT systems have already demonstrated to be an outstanding for both diagnosis 
and assistance for stent implantation, their unsurpassed sensitivity, resolution and speed suggest 
that they are also suitable for application in other fields such as intravascular flow studies or 
imaging of vessel walls at the molecular scale.60 Nevertheless, such novel applications would 
require the use of optical probes capable of providing additional optical contrast at the operating 
OCT wavelength of 1.3 µm. At the present time few OCT contrast agents have been already 
developed, including gas-filled microbubbles and micrometer-sized droplets of oil with embedded 
silica particles on their interface.132, 133 However, their clinical application is somehow limited due 
to their micrometric size. Such limitation can be easily overcome by using nano-sized OCT 
contrast agents, in particular by using gold nanoparticles (GNPs).  
GNPs have shown to be excellent contrast agents for a variety of imaging techniques.69, 134 In 
addition, they display a number of advantages for biomedical applications.135 (i) They are inert, 
biocompatible 136 and can be properly functionalized with specific biological markers, allowing 
specific targeting and making possible the so-called “personalized diagnosis”. (ii) GNPs can been 
easily synthesized by a variety of methods leading to different shapes (spheres, rod, cages, prisms, 
and stars) and sizes,72, 77, 137 as well as combined core (dielectric)/shell (gold) spherically 
nanostructures, usually called gold nanoshells (GNSs). (iii) The morphology of GNPs determines 
the spectral position of their localized surface plasmon resonance (LSPR), which is related to the 
collective oscillations of free electrons confined at the dimensions of such nanometric particles. 
By tuning GNPs morphology, their optical response can be custom-made depending on the 
application.78 Indeed, it is possible to shift the LSPR of GNPs from the visible to the BWs (700-
950 nm, 1-1.3 µm, 1.5-1.8 µm), to enable in vivo applications. (iv) The scattering and absorption 
properties of GNPs can also be tuned depending on the selected NP’s geometry.138, 139 Thus, 
enabling the use of GNPs as photo-thermal transducers for in in-vivo treatments, as contrast agents 
for optical imaging (multiphoton excited fluorescence imaging and scattering based imaging 
techniques), for PA imaging and for X-Ray Computed Tomography.46, 51, 69, 80, 140-142 
In fact, nowadays, it is possible to find out numerous examples on the use of GNPs to increase 
contrast in OCT images. In most of cases non-clinical OCT equipment working at wavelengths 
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close to 800 nm were used, so that gold nanorods (GNRs) with LSPR  800 nm were used as 
contrast enhancers.143 Despite the variety of results published dealing with GNPs as contrast agents 
for OCT imaging, these nanoparticles have not been evaluated yet as contrast enhancers in OCT 
cardiovascular imaging.  
In this chapter, a systematic investigation on the potential use of GNPs as contrast agents for 1.3 
µm wavelength based clinical IV-OCT systems for cardiovascular imaging was conducted. The 
importance of the spectral overlap between the OCT laser and the GNP extinction spectra is 
investigated by performing experiments with GNRs and GNSs water solution displaying LSPR 
ranging from 800 up to 1300 nm. The function of IV-OCT system has been investigated by static 
and pull back operation after the injection of GNSs inside the tubing. 
3.2. Characterization of GNPs 
I will focus on the study of different GNPs with surface plasmon resonance wavelengths in the 
NIR, not far from 1.3 µm, as this is the operating wavelength of our IV-OCT system. Two types 
of commercial GNPs showing plasmonic extinction in this wavelength were used: GNRs and 
GNSs. GNRs were purchased from Nanopartz Inc., whereas GNSs were purchased from 
nanoComposix Inc. Figure 3.1(a) includes representative TEM images of the different GNPs 
obtained from these two companies. Table 3.1 summarizes their main characteristics, including 
dimensions, nominal localized surface plasmon resonance wavelength (LSPR), effective radius, 
and mass per GNP. As can be observed, up to a total of six different GNPs were studied; four 
GNRs with nominal LSPR wavelengths peak at 800, 1064, 1200 and 1300 nm and two GNSs with 
resonances peak at 856 and 986 nm. The extinction cross section spectra of the different GNPs 
used in the thesis are shown in Figure 3.1(b) for GNRs and Figure 3.1(c) for GNSs. The emission 
spectrum of the IV-OCT laser is included in both cases for the sake of comparison. The extinction 
cross section at the particular IV-OCT operating wavelength (ext (OCT)) for each type of GNP 
has also been included in Table 3.1. From the Figure 3.1(b), it is clear that GNRs show relevant 
extinction cross sections not only at the plasmon resonance wavelength (at which extinction cross 
section peaks) but over a quite broad spectral range. There is a shoulder peaking at around 500 nm 
for these GNRs, this is due to the transverse plasmon resonance, the other one correspond to the 
longitudinal plasmon resonance.71 The spectral broadening of the extinction cross section spectra 
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is mainly attributed to the existence of GNRs of slightly different sizes and shapes in the water 
dispersion (polydispersity). As the morphology (size and aspect ratio) of GNRs determine the 
spectral location of their LSPR wavelength, such polydispersity leads to an inhomogeneous line 
broadening in the extinction spectra.77, 144, 145 As a consequence of this spectral broadening, all 
GNPs present a non-vanishing extinction cross section at the OCT wavelength (𝜎𝑒𝑥𝑡(𝜆𝑂𝐶𝑇), see 
detailed values in Table 3.1). Note that all the GNRs here investigated showed extinctions cross 
sections at OCT in the order of 10-12 cm2 per nanoparticle. In the case of GNSs, as shown in Figure 
3.1 (c), much broader spectra are obtained in comparison to GNRs. Such broad extinction spectra 
are expected for GNSs due to the optical activation of surface charge oscillations of different 
orders.77, 146, 147 Due to this superior broadening, although both GNSs have their LSPR below 1000 
nm, they show non-vanishing extinction cross section values at OCT, more than two orders of 
magnitude larger than those obtained for GNRs, being in the order of 10-10 cm2 per nanoparticle 
for both GNSs.  
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Figure 3.1 (a) TEM images of the different gold nanoparticles investigated in the thesis (b) and (c) show 
the extinction cross section spectra obtained for the GNRs and GNSs, respectively. The OCT laser spectrum 
is displayed in (b) and (c) as a black line.  
Table 3.1 Optical and physical properties of the different types of GNPs studied in the thesis. The 
OCT intensity (dB) per nanoparticle is also included. 
GNP 
NSPR 
(nm) 
Dimensions 
(nm) 
reff 
(nm) 
Mass/GNP 
(gr/GNP) 
ext @OCT 
(cm2) 
abs 
sct @OCT 
(cm2) 
dB/GNP 
GNR 800 800 25×90 21.9 7.72×10-16 3.66×10-12 0.66 1.24×10-12 9.80×10-11 
GNR 1064 1064 10×67 10.8 9.80×10-17 3.24×10-12 0.96 0.12×10-12 1.71×10-11 
GNR 1200 1200 21×171 24.2 7.84×10-17 1.83×10-12 0.76 0.44×10-12 2.30×10-11 
GNR 1300 1300 10×100 12.3 1.47×10-16 5.31×10-12 0.96 0.20×10-12 3.00×10-11 
GNS 856 856 15.5×117.8 74.1 1.67×10-14 3.61×10-10 0.34 2.40×10-10 3.96×10-9 
GNS 986 986 16.4×198.1 115.5 6.80×10-14 7.63×10-10 0.37 4.84×10-10 1.15×10-8 
 
Previous works pointed out the relevant role played by the scattering cross section (an in 
particular by the backscattering cross section) of nanoparticles in their OCT enhancement 
capability;148, 149 the higher value of backscattering coefficient the higher OCT intensity gain. Thus, 
in order to make a proper interpretation of OCT images, the scattering cross section at OCT 
(𝜎𝑠𝑐𝑡(𝜆𝑂𝐶𝑇)) for each type of GNP has been estimated. These cross section values have been 
determined from the experimental value of the extinction cross section and the particular 
absorption efficiency of each type of GNP. The absorption efficiency of any GNP is defined as the 
ratio between the absorption and extinction cross section, i.e. 𝜙𝑎𝑏𝑠 =
𝜎𝑎𝑏𝑠(𝜆𝑂𝐶𝑇)
𝜎𝑒𝑥𝑡(𝜆𝑂𝐶𝑇)
.51, 150 This 
efficiency can be estimated by using the discrete dipole approximation method and, in particular, 
the open-source Fortran-90 software package Discrete Dipole Scattering (DDSCAT) 7.3.76 Once 
𝜙𝑎𝑏𝑠 is known, the scattering cross section can be estimated from the extinction cross section by 
taking into account that 𝜎𝑒𝑥𝑡 = 𝜎𝑎𝑏𝑠 + 𝜎𝑠𝑐𝑡. Thus, we can write: 
 𝜎𝑠𝑐𝑡(𝜆𝑂𝐶𝑇) = (1 − 𝜙𝑎𝑏𝑠)𝜎𝑒𝑥𝑡(𝜆𝑂𝐶𝑇) (3.1) 
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Table 3.1 includes both the absorption efficiencies and the estimated scattering cross sections 
at OCT operating wavelength for all the GNPs under study. It is clear that GNSs display the largest 
values of 𝜎𝑠𝑐𝑡(𝜆𝑂𝐶𝑇) among all the studied GNPs, this fact is due to their larger extinction cross 
section values (when compared to GNRs) as well as to their reduced absorption efficiencies (i.e. 
to their large scattering efficiencies).  
Previous works clearly stated that the OCT contrast enhancement provided by nanoparticles 
basically depends on the relative change in the backscattering coefficient between the nanoparticle 
and the medium.143, 151 For instance, in highly scattering media, nanoparticles with low scattering 
cross sections have demonstrated to lead to a maximum OCT contrast.143 In this case, a weakly 
scattering medium was used, and so, the achievement of high OCT contrast would require the use 
of nanoparticles with high scattering cross section and, in particular, with high back-scattering 
cross section, σbsct.21 In this respect, the DDSCAT code allows also for estimating σbsct for any 
GNPs. The estimated values using this code are also listed in Table 3.1. GNSs are expected to be 
those providing the largest OCT contrast over all the GNPs here considered. In order to corroborate 
this prediction, the OCT contrast generated per individual GNP was systematically investigated 
for all the GNPs isotonic saline solution. 
3.3. Static OCT imaging experiments 
The experimental procedure followed all along the chapter for the visualization of GNPs is 
schematically represented in Figure 3.2. Basically, the IV-OCT catheter is introduced in a plastic 
tubing of 3 and 3.6 mm of internal and external diameter, respectively. GNPs were then injected 
in the proximity of the OCT catheter by using a subcutaneous needle (Figure 3.2 (a)). A volume 
of 5 µL of a solution of GNPs in isotonic saline solution was injected. Solutions containing 
different concentrations of GNPs were used. After the injection, three different types of 
experiments for GNP visualization were performed, schematically drawn in Figure 3.2 (b-d). A 
representative IV-OCT slice provided by IV-OCT system was also included in Figure 3.2 (e). It 
shows two cross-sectional images, one is the cross-sectional image of the tubing filled with GNPs, 
the other one is the axial cross-sectional image obtained from the line crossed the tubing and 
catheter. More information, such as the IV-OCT scan time, the date of the experiment, the 
morphology of the tubing and the table where the tubing was put can be obtained from this image. 
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Particularly, I will focus on the OCT cross-sectional image contained in the dotted line circle, 
which contains a cross-sectional image of GNPs obtained by IV-OCT system.  
 
 
Figure 3.2 (a) The procedure here used for the injection of GNPs into the IV-OCT system. (b) The 
arrangement for “static measurements”, in which OCT images are obtained with both the GNPs solution 
and catheter under static conditions. (c) The procedure followed for the acquisition of three dimensional 
OCT images; The OCT catheter is moved while keeping the GNPs solution remains under static conditions. 
(d) The procedure for the acquisition of OCT images of flowing GNPs; the OCT catheter is kept at fixed 
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position while the solution containing GNPs is pushed forward. (e) A representative IV-OCT slice obtained 
from S-OCT video. 
Static OCT imaging experiments (S-OCT): In order to evaluate the contrast enhancement 
produced by the GNPs, static images where obtained, in which the IV-OCT catheter remains in 
the same axial position while performing cross sectional imaging of the tubing in absence of any 
flow , i.e. under static condition (see Figure 3.2 (b)). The detection limit of the IV-OCT system 
for each type of GNPs was systematically investigated by injecting solutions with different GNPs 
concentrations (ranging from 5×10-2 down to 5×10-6 mg/mL).  
 
Figure 3.3 (a) S-OCT images of the conduit when it was filled with a saline solution (Control) and with 
solutions containing different GNPs. In all the cases the GNP concentration was set to 0.05 mg/mL of GNPs. 
(b) Integrated OCT signal as obtained for the different GNPs. (c) OCT signal normalized per the density of 
GNPs as obtained for the GNPs investigated in the thesis. Note that OCT images are taken by a clinical 
OCT system and so including some measuring tools (lines, reference points) that are used by clinicians that 
cannot be removed from the images  
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After injection of different GNPs solutions, the static OCT videos were recorded. The static 
OCT (S-OCT) cross-sectional images, which were obtained from the S-OCT videos, are shown in 
Figure 3.3 (a). For the sake of comparison, the S-OCT image obtained when the tubing was filled 
with only saline solution (control) is also included. From the S-OCT images included in Figure 
3.3 (a), it is clear that, for all cases, the presence of GNPs in the tubing leads to a relevant 
enhancement in the OCT contrast, but the amount of induced enhancement is found to be strongly 
dependent on the particular type of GNP used. At this point, it should be mentioned that to estimate 
the OCT enhancement, OCT intensities were first calculated, for each case, by defining a 
measuring area inside the tubing in which the OCT signal was uniform. Then, using the ImageJ 
software, I integrated the signal inside this area. The same procedure (same area and same 
integration procedure) was applied for all the images. Thus, from these analyses, the OCT contrast 
enhancement (as measured in dB, dB = 10 × log( 𝐼𝑂𝐶𝑇 𝐼𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑)⁄ ) for each particular GNP can 
be obtained. Figure 3.3 (b) shows the OCT signal enhancement as obtained from the S-OCT 
images included in Figure 3.3 (a). It is clear that for the same mass concentration in the GNPs/ 
solution (0.05 mg/mL) GNSs present the largest OCT contrast. This is further evidenced in Figure 
3.3 (c) that shows the OCT signal enhancement normalized to the GNPs concentration for each 
case; the data are included in Table 3.1. Figure 3.4 shows the OCT enhancement signal per GNP 
as a function of the back-scattering cross section at the OCT wavelength (given by each particular 
GNP). As expected, the OCT signal enhancement monotonously increases with the back-scattering 
cross section given by each type of GNPs. A linear fir to the data given in Figure 3.4, lead to an 
almost linear dependence: d𝐵~𝜎𝑏𝑠𝑐𝑡
0.8 . Thus, from Figure 3.4 and the data given in Table 3.1, it is 
clear that, generally speaking, GNSs present scattering cross sections (at OCT wavelength) two 
orders of magnitude larger than GNRs. Such difference accounts for the different OCT signal 
enhancement generated by GNSs and GNRs. In particular the dominant role of back-scattering 
processes in the enhancement of OCT contrast induced by GNPs is clearly manifested. 
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Figure 3.4 OCT signal enhancement per GNP as a function of backscattering cross section. The solid line 
indicates the best linear fit to the data. 
Once GNSs have been identified as the optimum GNPs ones for enhanced OCT contrast, I 
proceed to evaluate the potential ability of IV-OCT detection and imaging of individual GNSs 
under both static and dynamic conditions. As a first step, and in order to determine the detection 
limit of our clinical OCT apparatus, I conducted systematic OCT imaging experiments using saline 
solutions with different concentrations of GNSs 986 (the best scatterers). The results are 
summarized in Figure 3.5. Figure 3.5 (a) shows the S-OCT images obtained for three 
representative GNSs concentrations. On one hand, for elevate GNSs concentrations (0.05 mg/mL, 
leading to a GNSs density of 1.2×109 GNSs/cm3) the S-OCT image is characterized by a 
homogeneous and high contrast signal all along the cross section of the tubing. As one GNSs 
occupying a volume of 833.33 µm3 (1×1012 µm3/1.2×109 GNSs), in this case, the movement of 
single GNSs were thought to be in this volume, the shape of this volume is thought to be a cubic, 
thus the size of the cubic is 833.33 µm3, the length of its side is 9.4 µm. The average separation 
between GNSs was estimated to be around 9.4 µm for this concentration, which is below the axial 
resolution of our OCT system (15 µm, according to the manufacturer). Therefore, for such large 
concentrations, the detection of isolated/individual GNS is not possible, and the image appears as 
a pseudo-homogeneous high-contrast medium. On the other hand, when the GNSs concentration 
is reduced by several orders of magnitude, the OCT image appears as constituted by different 
bright spikes corresponding to the local OCT enhancement caused by individual GNSs (see the 
zoom of the OCT image obtained from the solution containing GNSs 986 at a concentration of 
5×10-5 mg/mL). Such low concentration corresponds to a GNS density of 1.2×106 GNSs/cm3 that 
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leads to an average distance between GNSs close to 94 µm (One GNSs will occupy 8.33×105 µm3, 
and has a length of 94 µm). Indeed, this interparticle distance is more than six times the nominal 
axial resolution of our OCT system. Thus, under these conditions, the visualization of individual 
GNSs becomes possible as it is experimentally demonstrated in the OCT images of well diluted 
solutions included in Figure 3.5 (a). These results reveal the ability of nanosized individual 
particles as local contrast agents for OCT and supports conclusions of previous works that pointed 
out the potential capacity of OCT for imaging at the nanoscale.152-154 
 
Figure 3.5. (a) S-OCT images of the conduit when it was filled with saline solutions containing GNSs at 
different concentration levels. A detailed zoom of the S-OCT image of the 5×10-5 mg/mL concentrated 
solution is also included. (b) OCT integrated intensity as a function of the concentration of GNSs. Dots are 
experimental data obtained from S-OCT images and dashed line is a guide for the eyes. The background 
OCT signal is indicated by the gray area. Detection limit is estimated to be 3×10-6 mg/mL. Note that OCT 
images are taken by a clinical OCT system and so including some measuring tools (lines, reference points) 
that are used by clinicians that cannot be removed from the images. 
The dependence of the OCT intensity as a function of GNS concentration is displayed in Figure 
3.5 (b), which constitutes a basis to estimate the detection limit of our OCT system for GNP 
detection. The background level in our experimental conditions is also indicated by the grey area. 
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From Figure 3.5 (b) it is clear that our clinical OCT system is able to detect the presence of 
colloidal GNSs with a detection limit close to 5×10-6 mg/mL that corresponds to a GNSs density 
close to 1.2×105 GNS/cm3. This constitutes a relevant improvement in respect to the detection 
limits previously reported for OCT imaging of GNRs and GNSs that were established to be close 
to 1×1011 GNRs/cm3 and 6.2×109 GNSs/cm3.143, 151 In other words, it is here demonstrated the 
superior performance of clinical OCT scans for intravascular detection of single GNPs. At this 
point, such improvement is due to the special sensitivity of our experimental OCT system together 
with the use of highly scattering GNSs.  
3.4. Three dimensional imaging of GNPs 
Three dimensional imaging of GNPs (3D-OCT): The potential application of the clinical OCT 
for real three dimensional localization of GNPs was demonstrated by using the pull-back imaging 
option of the clinical OCT system. In this case the fluid inside the tubing was set to be under static 
conditions (no pressure applied at the end of the tubing). Then a sequence of OCT images were 
recorded during pull-back of the OCT catheter over a 5 cm path length, i.e. cross-sectional images 
of the tubing were measured at different axial positions within the tubing as it is schematically 
indicated in Figure 3.2 (c). Subsequent analysis of the image sequence was performed by ImageJ 
software, allowing for a three dimensional reconstruction of the GNP distribution along the tubing. 
The obtained images were then used to estimate the density of GNPs (number of particles per unit 
volume) 
In other to unequivocally assign the bright spots appearing in the OCT images of low 
concentrated solutions to the presence of individual GNSs, a 3D-OCT experiment was performed 
along a tubing partially filled with a water solution containing, nominally, 3×107 GNSs/mL. As 
schematically indicated in Figure 3.2 (c), for these particular measurements the OCT catheter was 
initially positioned inside the GNSs injected volume and it was then scanned along the tubing for 
a total distance of 5 mm, so that at the end of the scan the catheter reaches a tubing volume without 
GNSs (i.e. just filled with saline solution). The 3D-OCT image of the GNSs was obtained by 
importing the x, y and z coordinates of GNSs in the IV-OCT videos into Origin software and 
drawing 3D scatter. Thus 3D-OCT image is shown in Figure 3.6 (a). Note that the interface 
between the volume containing the GNSs and the volume filled with just the solution is found to 
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be close to Z = 1 mm. From the analysis of this 3D-OCT image I have computed a total number of 
GNSs close to 4.2×104. The volume containing those GNPs is estimated to be 8.6×10-3 mL, leading 
to a GNSs concentration of 0.5×107 GNSs/cm3. This is of the same order of magnitude, but six 
times lower, than the nominal concentration of the injected solution (3×107 GNSs/cm3). The 
relative good agreement between measured and nominal GNP concentration results reasonable, 
specially taking into account that when measuring the 3D-OCT images the catheter is moving 
along the axial (Z) direction while scanning radially the xy plane so that it is doing a spiral-shape 
3D scan that would result in a slight underestimation of the actual GNSs concentration. Figure 3.6 
(b) shows a detailed zoom of the 3D-OCT image in the surroundings of the water-GNSs solution 
interface. From this figure, it is evidenced the nonhomogeneous distribution of GNSs along this 
interface. From Figure 3.6 (b) (in which the z scale has been enlarged) it is also possible to localize 
well-isolated GNSs behind the interface, i.e. in the pure aqueous volume (see red arrows). Data 
included in Figure 3.6 demonstrate the potentiality of clinical OCT cardiovascular systems for the 
3D localization of single GNPs. 
 
Figure 3.6 (a) 3D-OCT image of the conduit partially filled with an injection of a saline solution containing 
GNSs 856 at a concentration of 5×10-4 mg/mL. Each pixel providing a OCT signal larger than background 
level has been identified as a single GNS, indicated by a dot. (b) Detailed 3D-OCT image of the interface 
between the GNS solution and water. The presence of individual and isolated GNSs in the non-injected 
volume of the tubing are evidenced by red arrows. 
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3.5. OCT imaging of flowing GNPs 
OCT imaging of flowing GNPs (F-OCT): In order to demonstrate the potential ability of the IV-
OCT system under dynamical conditions, a pressure syringe filled with the isotonic saline solution 
was connected to the end of the tubing, containing both the OCT catheter and the injected solution 
of GNPs. This syringe allowed us to apply, in a controlled way, a given pressure in one end of the 
tubing and, hence, an intra-tubing flow, as it is schematically indicated in Figure 3.2 (d). As a 
consequence of this flow, the solution containing the GNPs was pushed from one extreme to the 
other extreme of the tubing. In these experiments, the OCT catheter remained in a fixed position. 
A 5 s video was recorded during the flushing out procedure of the GNPs. Analysis of this video 
by ImageJ software allowed us to plot the time evolution of the GNPs distribution at the position 
of the OCT catheter. 
 
Figure 3.7 (a) F-OCT images of the conduit when it was filled with saline solution containing GNSs 986 
at a concentration of 0.05 mg/mL as obtained at different times. (b) OCT integrated intensity as a function 
of time during the F-OCT procedure. Dots are experimental data obtained from S-OCT images and dashed 
line is a guide for the eyes. (c) Time evolution of the cross sectional OCT image during the F-OCT 
procedure as obtained with a GNSs 986 concentration of 5×10-6 mg/mL. 
Figure 3.7 (a) shows three representative F-OCT images corresponding to a 0.05 mg/mL 
concentrated water solution of GNSs 986, as obtained at different times after establishment of an 
intra-tubing evacuating flow. In this figure t = 0 s, the interface between the water and GNSs water 
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solution start crossing the OCT cross sectional detection plane. Before t = 0 s, the F-OCT image 
showed a homogeneous bright signal, indicating the presence of homogeneously distributed 
flowing GNSs inside the tubing. Just after t = 0 (t = 0.1 s) the F-OCT signal becomes highly 
inhomogeneous, indicating that, at the position of OCT catheter, the GNSs are no longer 
homogeneously distributed. Indeed, this reveals that the solution containing the GNRs at the 
interface is mixing with water in a non-homogeneous way, as it was already evidenced in Figure 
3.6 (c). For times larger than 0.2 s, the F-OCT contrast signal has been completely removed, as 
can be observed in Figure 3.7 (b). The complete suppression of OCT contrast signal unequivocally 
indicates that the solution containing the GNSs has been fully replaced by pure water and, thus, all 
GNSs have been pushed out from the cross sectional OCT detection section. Appropriate analysis 
of the F-OCT images obtained under flowing conditions allowed us to plot the position of single 
GNSs in a certain cross-sectional area as function of time. A representative of plot is included in 
Figure 3.7 (c). It can be observed how GNSs have been removed after 0.2 s pushing from the 
studied cross-sectional image. Thus constitutes a solid proof of the potential ability of intravascular 
OCT systems for detecting single GNPs under non-static conditions. This ability could be very 
useful for a great variety of applications, including the localization and evaluation of intravascular 
obstructions via detection of flowing GNPs, the accurate measurement of blood velocity and, even, 
the indirect determination of intravascular pressure gradients. 
3.6. Conclusions 
In summary, I have experimentally demonstrated how gold nanoshells showing multipolar 
plasmonic excitations in the 1000-1500 nm spectral range are excellent contrast agents for 
frequency based intravascular OCT catheters, working at 1320 nm. This ability is mostly based in 
the large scattering (backscattering) cross section values that these nanoparticles provide at this 
specific wavelength, which are two orders of magnitude larger than those given by the gold nano-
rods traditionally used as OCT enhancers. The outstanding OCT contrast provided by gold 
nanoshells has allowed for detecting individual nanoparticles under both static and dynamical 
conditions. I firmly believe that the results here presented open a new avenue for novel potential 
applications of intravascular optical coherence tomography.  
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On the other hand, it is important to stand out the high sensitivity of IV-OCT system. It can be 
used for visualizing individual NPs both in static and dynamical conditions. This has open an 
avenue of possibilities for future work. 
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4.1. Introduction 
After the selection of GNPs, the first step for the functional validation of these GNPs as contrast 
agents for IV-OCT is a full understanding of their infrared optical properties including the 
wavelength dependence of their absorption and scattering efficiencies. Such knowledge is 
imperative for of IV-OCT images analysis, as well as to evaluate the thermal loading during 
intravascular image acquisition. Until now there are only few experimental studies dealing with 
the scattering/absorption efficiency of GNPs in the BWs. Remind that the efficiency that were 
previously determined in Chapter 3 was based on the spectral simulation. Indeed, most of the 
studies describing optical properties of GNPs are dealing with their response in the visible domain 
or in the I-BW.155-157 The geometry dependence of the GNPs scattering efficiency has been 
experimentally determined at 808 nm,158 as this one is the working wavelength OCT systems for 
ophthalmology.159, 160 There are numerous predictive models on the optical response of different 
GNPs in the II-BW. However, an experimental validation of the wavelength dependence of both 
scattering and absorption efficiencies of GNPs in the BWs has not been demonstrated yet. 
Providing this experimental data is crucial for the functional validation of GNPs as contrast agents 
for advanced IV-OCT. 
In this chapter, the scattering efficiency of three types of GNPs (gold nanorods, gold nanoshells 
and gold nanostars) displaying LSPR with significant extinction at around 1.3 µm (the operating 
wavelength of clinical IV-OCT apparatus) have been experimentally determined. By means of a 
well-stablished photo-thermal method,126, 157, 161 the scattering efficiency has been measured at 
three different wavelength, namely at 808 nm, 980 nm and 1280 nm. These multi-wavelength 
experimental data have been compared with numerical simulations performed in Chapter 3, we 
will see that simulation failed to reproduce reliable values at long wavelengths. This fact stands 
out the importance of an experimental determination of the scattering and absorption efficiencies. 
The geometry dependence of scattering efficiency determined by the photo-thermal method has 
been corroborated by the combination of IV-OCT, infrared dark field microscopy (IR-DFM) and 
infrared optoacoustic (IR-OA) spectroscopy. The optimum GNPs geometry for IV-OCT contrast 
enhancement has been determined and the importance of the experimental determination of the 
spectral dependence of infrared scattering efficiency has been clearly evidenced. 
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4.2. Characterization of the GNPs 
 
Figure 4.1 (a) TEM images of the GNSs, GNSTs and GNRs used along this chapter. (b) Size distribution 
of GNSs, GNSTs and GNRs 
Three kind of the GNPs with different shape were used in this chapter; GNRs, GNSs and gold 
nanostars (GNSTs). GNRs and GNSs were the same describe before, whereas GNSTs were 
synthesized at Pompeu Fabra University (UPF). Figure 4.1 shows the representative TEM images 
and size distribution of these GNPs. Here, the TEM of the GNRs and GNSs are shown again due 
to the new batches of GNRs and GNSs were used here (their TEM images were previously shown 
in Chapter 3). GNRs have a diameter of 11±2 nm and a length of 90±20 nm. GNSs have a total 
average diameter of 220±23 nm. GNSTs consist in solid gold nanospheres with an average 
diameter of 28±4 nm together with different lobes (in average 14) with an average length of 14±3 
nm. 
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The extinction cross section spectra of these three structures are included in Figure 4.2. The 
extinction cross section spectra shape of GNRs and GNSs are the same as they were described in 
Chapter 3. The extinction cross section of GNSTs is constituted by a plasmonic band peaking at 
about 800 nm and extends in the IR spectral region from about 500 nm to 1600 nm. Such LSPRs 
are electric dipole resonances stemming from the collective oscillations of Au electrons. As such, 
they are sensitive to nanoparticle shape (except for very small nanoparticle), especially along the 
direction of electric field polarization of the incident light. GNSTs are not spherically symmetric; 
however, for a sufficiently large number of star tips pointing to all directions, they are nearly 
polarization independent.162,121, 163 Due to broad extinction spectra of these GNPs, the relevant 
infrared wavelengths were investigated in this chapter; 808 nm, 980 nm and 1280 nm (the IV-OCT 
working wavelength). 
 
Figure 4.2 Extinction spectra obtained from colloidal suspensions of GNSs, GNSTs and GNRs. 
4.3. Experimental determination of infrared scattering efficiency 
The experimental determination of the wavelength dependence of the scattering efficiency (𝜂𝑠) 
is based on the experimental determination of the photo-thermal heating conversion efficiency (𝜂ℎ) 
at each particular wavelength (808, 980, 1280 nm). 𝜂ℎ  is defined as the fraction of extinct 
(scattered or absorbed) energy by a single nanoparticle that is converted into heat. For non-
luminescent nanoparticles, as it is our case, all the absorbed energy by a single nanoparticle is 
converted into heat, so that the photo-thermal conversion efficiency is equal to the absorption 
efficiency (𝜂𝑎) (i.e. 𝜂ℎ = 𝜂𝑎 ), as defined in Chapter 3. At a given wavelength (𝜆), it can be 
written: 
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 𝜂ℎ(𝜆) = 𝜂𝑎(𝜆) =
𝜎𝑎𝑏𝑠(𝜆)
𝜎𝑎𝑏𝑠(𝜆) + 𝜎𝑠𝑐𝑡(𝜆)
=
𝜎𝑎𝑏𝑠(𝜆)
𝜎𝑒𝑥𝑡(𝜆)
, (4.1) 
where 𝜎𝑎𝑏𝑠(𝜆), 𝜎𝑠𝑐𝑡(𝜆) and 𝜎𝑒𝑥𝑡(𝜆) are the absorption, scattering and extinction cross sections at 
a wavelength 𝜆, respectively. If the photo-thermal conversion efficiency 𝜂ℎ is known, then the 
scattering efficiency, as described in Chapter 3, can be written: 
 𝜂𝑠(𝜆) = 1 − 𝜂𝑎(𝜆) = 1 − 𝜂ℎ(𝜆). (4.2) 
The photo-thermal conversion efficiency can be evaluated by measuring the input/output heat 
balance under transient illumination, as previously reported.126, 157, 164 Figure 2.3 (a) shows the 
experimental arrangement used all along this work to measure 𝜂ℎ(𝜆). The method is described in 
detail in Chapter 2 Experimental techniques. It is based on the measurement of the heating and 
cooling curve of a solution containing the GNPs when it is optically excited by a fiber coupled 
laser diode. A representative heating/cooling curve is shown in Figure 2.3 (b). From this curve, it 
is possible to estimate the absorption efficiency, which it is given by: 
 𝜂𝑎 = 1 − 𝜂𝑠 =
𝑚𝐶𝑝∆𝑇𝑚𝑎𝑥
𝜏 − 𝑄𝑟
𝑃0(1 − 10−𝑂𝐷)
, (4.3) 
where 𝑚, 𝐶𝑝 and 𝑂𝐷 are the mass, specific heat and optical density of the solution containing the 
GNPs. 𝑃0 is the incident laser power, ∆𝑇𝑚𝑎𝑥 is the maximum temperature increment (indicated in 
Figure 2.3 (b)) and 𝜏 is the relaxation time of the cooling process (also indicated in Figure 2.3 
(b)). Equation (4.3) gives the photo-thermal efficiency (equal to the absorption efficiency) from 
parameters that are either known or can be experimentally measured. For instance, the specific 
data shown Figure 2.3 (b) corresponds to the heating and cooling cycle of an aqueous solution of 
GNRs excited at 1280 nm and for the particular values m = 0.5 g, P0 = 160 mW, OD = 1.075, 
ΔTmax = 9.92 ºC and τ = 104.3 s. Substituting these values in Equation (4.3), an absorption 
efficiency of 0.95 was obtained, and therefore, a scattering efficiency of ƞs: 1-0.95 = 0.05.  
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Figure 4.3 Cooling curves of the GNPs under excitation at different wavelength. 
Table 4.1 Parameters to calculate absorption efficiency 
Laser 
wavelengt
h (nm) 
P0 
(mW) 
Qr 
(mW) 
s 
GNSs 
OD 
GNSs 
ΔT(°C) 
GNSs 
η(±10%) 
GNSs 
Average 
η 
Simulated η 
GNSs 
1280 
125 45 120.5 
0.406 
4.81 51 
49 32 142 52 126.0 5.85 52 
160 60 126.8 6.31 45 
980 
245 70 135.12 
0.67 
6.55 16 
16 22 280 80 129.91 7.41 18 
310 100 124.83 8.12 15 
808 
180 16 96.00 
0.55 
2.97 38 
32 28 218 18 118.00 3.61 29 
257 22 118.50 4.21 28 
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Laser 
wavelength 
(nm) 
P0 
(mW) 
Qr 
(mW) 
s 
GNRs 
OD 
GNRs 
ΔT(°C) 
GNRs 
η(±10%) 
GNRs 
Average 
η 
Simulated η 
GNRs 
1280 
125 45 121.40 
1.075 
8.07 82 
88 95 142 52 114.00 9.11 88 
160 60 104.30 9.92 95 
980 
245 70 123.60 
0.25 
8.53 69 
77 95 280 80 116.72 10.43 87 
310 100 121.73 11.65 74 
808 
180 16 130.00 
0.125 
3.60 93 
95 95 218 18 124.10 4.61 100 
257 22 124.80 4.78 91 
 
Laser 
wavelength 
(nm) 
P0 
(mW) 
Qr 
(mW) 
s 
GNSTs 
OD 
GNSTs 
ΔT(°C) 
GNSTs 
η(±10%) 
GNSTs 
Average 
η 
Simulated η 
GNSTs 
1280 
115 35 90.97 
1.06 
4.5 65 
56 91 130 45 101.28 5.07 49 
148 55 89.42 5.52 55 
980 
155 32 77.17 
3.9 
6.28 89 
84 87 350 80 73.82 13.06 83 
540 120 73.87 19.53 80 
808 
187 18 79.08 
4.835 
7.62 98 
90 87 290 40 79.43 11.4 90 
420 50 80.14 15.48 84 
 
In order to obtain an accurate statistical value of the scattering efficiency, experiments were 
carried out at different input powers for each one of the three illumination wavelengths here 
investigated (see Figure 4.3 and Table 4.1). Note that once the scattering efficiency at a given 
wavelength (𝜆) is experimentally determined, it is possible to get the scattering extinction cross 
section at this wavelength, since: 
 𝜎𝑠𝑐𝑡(𝜆) = 𝜂𝑠𝑐𝑡(𝜆) · 𝜎𝑒𝑥𝑡(𝜆), (4.4) 
where 𝜎𝑒𝑥𝑡(𝜆) is the extinction cross section at wavelength 𝜆 as experimentally determined from 
the extinction spectra included in Figure 4.2. In Table 4.2, the averaged scattering efficiencies, 
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extinction cross section and scattering cross section as obtained for each GNP (at the three 
wavelengths) are listed. Inspection of Table 4.2 reveals that the largest scattering efficiencies and 
cross sections are provided by GNSs. Actually, the scattering efficiency of GNSs is higher than 
50%, for the three wavelengths investigated in this work. Consequently, these results indicate that 
GNSs are the most suitable nanoparticles for scattering based imaging techniques, such as OCT 
and optical microscopy.127, 165 This is in good agreement with the scattering efficiency estimated 
by means of simulation in Chapter 3. Data included in Table 4.2 also reveal that the scattering 
efficiency is strongly wavelength dependent for all GNPs. Although GNSTs show very low 
scattering efficiencies at 800 and 980 nm they present a scattering efficiency close to 50% at 
around 1.3 µm. 
Table 4.2. Experimentally determined scattering efficiency and scattering cross sections at three 
wavelengths investigated. 
 
808 nm 980 nm 1280 nm 
ηsct σext (cm
2) σsct (cm
2) ηsct σext (cm
2) σsct (cm
2) ηsct σext (cm
2) σsct (cm
2) 
GNSs 0.68 1.50×10-9 1.02×10-9 0.84 1.81×10-9 1.52×10-9 0.51 1.09×10-9 5.56×10-10 
GNRs 0.05 1.64×10-12 0.82×10-13 0.23 5.00×10-12 1.15×10-12 0.12 1.42×10-11 1.70×10-12 
GNSTs 0.10 2.55×10-11 2.55×10-12 0.16 2.06×10-11 3.30×10-12 0.44 5.59×10-12 2.46×10-12 
 
4.4. Numerical calculations and comparison with experimental data 
In this chapter, new numerical calculations were provided by Diego Romero and José A. 
Sánchez-Gil (Instituto de Estructura de la Materia (IEM-CSIC), Consejo Superior de 
Investigaciones Cientificas). The calculation process is illustrated below. 
Full electrodynamic methods were used to calculate the spectral dependence of the extinction, 
absorption and scattering cross sections. For GNSs, the simulation method is the same as described 
in Chapter 3. For more complex shapes, such as GNRs and GNSTs, numerical calculations were 
carried out by means of a free software implementation, called SCUFF166 (open-source software 
package for analysis of electromagnetic scattering problems using the method of moments). Gold 
permittivity data were obtained from Johnson and Christy measurements167 and the medium 
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permittivity is assumed to be the water (n = 1.33). Thus, GNRs were considered as cylinders with 
given length and radius, with endcaps terminated as hemispheres with the same radius.  
For the particular case of GNSTs the situation is more complex and a crucial issue is how to 
define the nanostar geometry. In this regard, the definition of a nanostar shape is inspired by the 
TEM images (Figure 4.1). Rather than exploiting analytical formulation (as in Ref.162, which poses 
some difficulties in the meshing procedure), each nanostars is assumed contain a spherical core, 
with fourteen elongated tips with semi-ellipsoidal shape, as shown in Figure 4.4 (a). Due to the 
structural inhomogeneities shown in the TEM images of the GNTSs, the spherical core radius was 
fixed as R = 15 nm, and the tip ellipsoidal cross section (along two short axes) as a circle with 
radius r = 5 nm. The tip length L (long axis of the ellipsoid) is then allowed to vary between 12-
25 nm (which nearly corresponds to the tip length and angle (θ = atan(r/L)), as observed in the 
TEM images. The resulting calculated cross sectional spectra are shown in Figure 4.4 (b) for 
monochromatic plane waves, with varying vacuum wavelength impinging onto the nanostars along 
the x direction, and with linear polarization along the vertical axis (with respect to the nanostar 
shown in the inset). Strong LSPRs appear with narrow width in the range 700-950 nm, with a ratio 
between absorption and extinction of ~ 87%. In this regard, it should be emphasized that, despite 
the anisotropic shape of the nanostars, the resulting spectra are nearly isotropic and polarization 
independent. This was verified (though not shown) by varying the angle of incidence and the 
electric field polarization. Actually, this was also pointed out in reference,163 even for smoother 
nanostars with fewer tips. The reason is that the LSPR, being essentially a dipolar resonance, is 
excited mostly at any angle of incidence, due to fact that the electric field vector stretches along 
the direction between any of the opposing nanostar tips, whose length (~2R+2L) in turn controls 
the LSPR wavelength. As a matter of fact, upon the nanostar tip length increases, the LSPR is red-
shifted, covering the spectral range between 700-950 nm, consistently with the broad LSPR width 
measured experimentally (Figure 4.2). To shed light on such inhomogeneous broadening, a 
smoothed weighted average was carried out over all the spectra of different tip lengths, assigning 
approximate weighs according to the statistics of GNSTs shapes. The resulting simulated spectra 
have been included in Figure 4.4.  
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Figure 4.4 (a) Schematic draw of a nanostar, containing an spherical core with fourteen elongated tips with 
semi-ellipsoidal shape. (b) Calculated extinction and absorption spectra considering a spherical core radius 
R = 15 nm, with fourteen elongated tips with semi-ellipsoidal shape with r = 5 nm short axes and varying 
long axis L = 12, 13.5, 15, 16.5, 18, 20, 25 nm. A weighted average over all the spectra for different tip 
lengths is also shown (smoothed over ±5 nm), with approximate weighs extracted from the statistics of 
GNST shapes (TEM images, Figure 4.1): L = 12 (13%), 13.5(22%), 15(22%), 16.5(22%), 18(22%), 
20(17%), 25(4.4%) nm. 
 
Figure 4.5 Experimental extinction, calculated extinction, absorption and scattering cross section spectra 
of GNSs, GNRs and GNSTs in the I and II-BW. 
The numerically calculated extinction, absorption and scattering cross section spectra in the 
spectral range 400-1600 nm (i.e covering BWs) are included in Figure 4.5 as calculated for GNSs, 
GNRs and GNSTs. By comparing these data with the experimentally obtained extinction spectra, 
GNSs are in good agreement, while the spectral shapes are not properly reproduced neither for 
GNRs nor for GNSTs. For GNRs the calculated extinction cross section spectrum (peaking at about 
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1300 nm) appears shifted to longer wavelengths in respect to the experimental one (peaking at 
about 1200 nm). In addition, the calculated spectrum is narrower than the experimental one. For 
GNSTs, while the peak position is certainly reproduced, the calculated spectrum appears much 
narrower than the experimental one, and so leading to a large inaccuracy when determining the 
cross section values and the scattering efficiencies at long wavelengths. This experimental 
broadening is likely due to the non-uniform nanostar geometries (e.g. wide distribution of aspect 
ratio), as well as the finite-size effects, which broaden and dampen the resonance but do not 
influence the plasmon band position.121 It should be borne in mind that this experimental 
broadening has been reported elsewhere also in connection with star-shaped nanoparticles,121 as 
stemming from both the nonuniform nanostar geometries, and finite-size effects at the tip edges 
(shorter electron scattering mean free path). The former mechanism has been somehow taken into 
account through the average over GNSTs shapes inspired by the TEM images (Figure 4.1 (a)). 
Nevertheless larger shape variations and/or particle aggregation (not evidenced in the TEM images) 
might be responsible for the discrepancies. In addition, the other mechanism mentioned above, 
finite-size effects, also typically broadens resonance; it is due to increased electron damping 
resulting from electron scattering at the narrow tips, similar to what occurrs within GNSs thin 
shells.168, 169 
 
Figure 4.6 Wavelength dependence of scattering efficiency of GNSs, GNSTs and GNRs. Solid line shows 
results extracted from calculations whereas the dots correspond to the experimental data obtained in this 
work (see Table 4.2). 
By using the calculations included in Figure 4.5, the wavelength dependence of scattering 
efficiency can be also numerically calculated for all the investigated GNPs. Results of these 
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calculations are included in Figure 4.6 together with here obtained the experimental data at the 
three used wavelength. According to these numerical calculations, the scattering efficiency is 
weakly dependent on wavelength for GNRs and GNSTs but strongly wavelength dependent for 
GNSs. While a good agreement between numerical simulations and measured efficiencies occurs 
at 800 nm and 980 nm, a clear disagreement is observed at around 1.3 µm (the IV-OCT wavelength) 
for GNSTs. At this specific wavelength, calculations predict a scattering efficiency of 0.09, much 
lower than that experimentally measured (0.44). While the origin of this discrepancy is not fully 
understood, the physical phenomenon behind this must be the same that leads to the appearance 
of the long wavelength tail in the extinction spectrum. It was assumed that the existence of 
interaction between individual GNSTs via agglomeration or slight contact between tips, could lead 
to dimer structures with completely different optical properties. In particular, the presence of such 
interacting structures could lead to red-shifts in the plasmon resonance and to larger scattering 
efficiencies. Regardless of the origin of these discrepancies, this highlight the importance of 
performing direct experimental measurements for the scattering efficiency at different 
wavelengths, as it was done in this chapter. 
4.5. Infrared scattering experiments 
To gain insight into the actual scattering efficiency of GNPs at long wavelengths, where the 
calculated and measured data display the largest discrepancy, two set of imaging measurements 
were carried out. In particular I investigated the infrared scattering abilities of the three types of 
GNPs by infrared dark field microscopy (IR-DFM) and IV-OCT. The results obtained in each case 
are described in the following. 
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4.5.1. Infrared dark field microscopy  
 
Figure 4.7 (a) Schematic representation of the experimental set up designed to evaluate the ability of GNSs, 
GNSTs and GNRs as contrast agents in a dark field configuration. (b) Band pass spectra around 1300 nm 
after substract the long pass light after 1250 nm by long pass light after 1350 nm. 
For IR-DFM experiments the GNPs were deposited and dried onto the microscope slides. The 
microscope slides containing the GNPs were visualized by using the home-made IR-DFM, the 
schematically was drawn in Figure 4.7 (a). In order to just get the infrared DFM Image (i.e. just 
record the dispersed light around 1280 nm), two long pass filters of cutting wavelengths 1250 nm 
and 1350 nm were used (see the experiemtal set up in Figure 4.7 (a)). In detail, the following 
transmission spectra; (1) after putting long pass filter 1250 nm and (2) after putting long pass filter 
1350 nm were obtained. In such a way, a narrow band pass spectrum peaking around 1300 nm was 
obtained after substract (1) by (2), as shown in Figure 4.7 (b). Therefore, only the infrared radiaton 
sattered by the GNPs in the wavelength range from 1250 nm to 1350 nm was obtained. 
Consequently, the here employed IR-DFM system is able to visualize individual GNPs by using 
their scattering abilities at 1300±50 nm. Figure 4.8 (a) shows the IR-DFM images obtained for 
the three GNPs studied in this chapter. Up to the best of my knowledge, these are the first ever 
reported IR-DFM images of GNPs in the II-BW. As can be observed, all GNPs can be detected by 
IR-DFM, revealing a non-vanishing scattering cross section in the three cases (in accordance with 
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the experimental data included in Figure 4.6). The largest IR-DFM contrast has been provided by 
GNSs, being significantly larger than those provided by GNSTs and GNRs. This is more clearly 
evidenced in Figure 4.8, in which I have included the average IR-DFM intensity per spot generated 
by GNSs, GNRs and GNSTs. The results included in Figure 4.8 are, therefore, in qualitative 
agreement with the experimentally determined and numerically calculated values of the scattering 
cross section (see Table 4.2). These experimental data confirm that GNSs provide the largest 
infrared scattering cross section among the all geometries here studied.  
 
Figure 4.8 (a) Infrared dark field images obtained at 1.3 µm by using GNSs, GNRs and GNSTs as potential 
contrast agents. Scale bar is 20 µm in all the cases. (b) Average intensity per nanoparticle generated by 
GNSs, GNRs and GNSTs as obtained from the statistical analysis of IR-DFM images.  
4.5.2. Intravascular optical coherence tomography 
The infrared scattering ability of the different GNPs at around 1.3 µm (the IV-OCT laser 
wavelength) has also been investigated by performing IV-OCT experiments. In this case, a 
colloidal solution of each type of GNP was injected into a tubing (see Experimental techniques). 
Once the aqueous solutions of GNPs were inside the tubing (mimicking an artery), the IV-OCT 
Chapter 4. Experimental evaluated scattering properties of gold nanoparticles 
81 
 
catheter was introduced into the tubing allowing for the static detection of the individual GNPs, 
by means of their back-scattering efficiency.24 It should be noted that the advantage of this 
interferometric technique OCT is that it provides an indirect measure of the infrared back-
scattering cross section at the single wavelength of 1.3 µm. Figure 4.9 shows the IV-OCT cross 
sectional images for the colloidal solutions containing the three investigated GNPs. Again, the 
three geometries here studied produced a significant IV-OCT signal. This again reveals a non-
vanishing infrared scattering cross section at around 1.3 µm. It is also evident from Figure 4.9 (a) 
that the IV-OCT contrast is provided by each type of GNP. Figure 4.9 (b) includes the averaged 
OCT intensity (contrast) provided by individual GNPs, as obtained for each type of GNP. Again, 
and as we also obtained in Chapter 3, it is found that the largest contrast is provided by GNSs, 
revealing their superior scattering cross section. 
 
Figure 4.9 (a) OCT cross section images of colloidal solutions containing GNSs, GNSTs and GNR. (b) 
OCT intensities of single GNSs, GNSTs and GNRs obtained from the statistical analysis of figures included 
at the left column.  
At this point, the concordance between experimental data included in Figure 4.9 and those of 
Table 4.2 can be discussed. For a sample of thickness d containing a certain numer of GNPs, i.e. 
N, the Lambert-Beer exctinction law gives the fraction of scattered intensity: 
 
𝐼0 − 𝐼
𝐼0
= 1 − 𝑒−𝜎𝑠𝑐𝑡𝑁𝑑, (4.5) 
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where I0 is the incident light intensity and I the light intensity transmitted through the sample. For 
low values of the exponential exponent, and assuming the same thickness for all measurements 
(same geometrical conditions), Equation (4.5) can be written as: 
 
𝐼0 − 𝐼
𝐼0
≈ 𝜎𝑠𝑐𝑡𝑁𝑑, (4.6) 
thus the OCT intensities (per GNP) given in Figure 4.9 (b) should be proportional to the fraction 
of scattered light and so to experimental values of 𝜎𝑠𝑐𝑡 (indeed to the backscattering cross section) 
given in Table 4.2. Now, the OCT intensity per GNP (Ioct,) (for each type of GNP) normalized to 
that given by the GNSs (the best scatterers) was compared. From the data given in Figure 4.9, I 
obtained: 
 
𝐼𝑜𝑐𝑡(𝐺𝑁𝑆𝑇𝑠)
𝐼𝑜𝑐𝑡(𝐺𝑁𝑆𝑠)
⁄ = 5 × 10−3 (4.7) 
and  
 
𝐼𝑜𝑐𝑡(𝐺𝑁𝑅𝑠)
𝐼𝑜𝑐𝑡(𝐺𝑁𝑆𝑠)
⁄ = 2 × 10−3. (4.8) 
These values are indeed close to the ratio between the scattering cross sections experimentally 
obtained and listed in Table 4.2, that leads to: 𝜎𝑠𝑐𝑡(𝐺𝑁𝑆𝑇𝑠) 𝜎𝑠𝑐𝑡(𝐺𝑁𝑆𝑠)⁄ ≈ 4.42 ×
10−3and 𝜎𝑠𝑐𝑡(𝐺𝑁𝑅𝑠) 𝜎𝑠𝑐𝑡(𝐺𝑁𝑆𝑠)⁄  ≈ 3.05 × 10
−3. In fact, the slight discrepancy could be due 
to the different geometries that lead to different backscattering/scattering ratios. Therefore, at this 
point, the IV-OCT experimental results confirm the validity of the scattering efficiencies (and so 
the scattering cross sections) experimentally determined in this thesis by the photo-thermal method. 
In fact, the results here reported highlight the need of a direct experimental determination of the 
scattering efficiency, particularly at longer wavelengths (as for the OCT wavelength), where 
numerical calculations for GNRs and GNSTs fail to explain the experimentally obtained extinction 
cross section (see Figure 4.2 and Figure 4.5). Therefore, the experimental determined scattering 
efficiencies are crucial to provide reliable values. 
4.5.3. Optoacoustic experiments 
An indirect estimation of the geometry dependence of the scattering efficiency of GNPs can be 
also obtained by the performance of IR-OA experiments.170 For this purpose I prepared colloidal 
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solutions containing the three types of GNPs with exactly the same OD at 1064 nm (this being the 
wavelength used in our IR-OA experiments), as shown in Figure 4.10 (a). Each solution was 
introduced in a quartz cuvette mechanically attached to a piezo transducer, connected to signal 
amplifier and to a digital oscilloscope. In absence of any fluorescence (as in our case) the 
magnitude of the IR-OA signal is proportional to the fraction of absorbed pump power (𝑃𝑎𝑏𝑠 =
𝑃0 · (1 − 10
−𝑂𝐷)), where 𝑃0 is the incident pump power that is converted into heat. In other words, 
the OA signal is expected to be proportional to 𝜂𝑎𝑏𝑠 · 𝑃𝑎𝑏𝑠. Therefore, we can write: 
 𝐼𝑂𝐴 = 𝑘 · (1 − 𝜂𝑠𝑐𝑡) · 𝑃0 · (1 − 10
−𝑂𝐷), (4.9) 
where 𝑘 is a coupling constant that depends on the Grüneisen parameter and the experimental 
conditions such as the gain of the piezo transducer.171 From Equation (4.9), it is clear that the IR-
OA signal is proportional to (1 − 𝜂𝑠𝑐𝑡) in such a way that those GNPs with largest scattering 
efficiencies and with the same OD should give the lowest IR-OA signal. Figure 4.10 (b) shows 
the IR-OA signals generated by the three GNPs studied in this work. The three geometries generate 
measurable IR-OA signals even though with quite different amplitudes. The averaged IR-OA 
amplitudes obtained for the three cases are displayed in Figure 4.10 (c). In this case, the lowest 
IR-OA signal was generated by the GNSs. This is in close agreement with the experimental data 
displayed in Figure 4.6 and with Equation (4.9) that predicts the lowest IR-OA for the GNPs with 
the largest scattering efficiency. Data included in Figure 4.10 (c) allows for a quantitative 
estimation of the relation between the infrared scattering efficiencies of the different GNPs studied 
in this work. Equation (4.9) can be rewritten to get a formal expression for the OA intensity ratio 
between GNSTs and GNSs, so that: 
 𝑅𝑂𝐴 (
𝐺𝑁𝑆𝑇𝑠
𝐺𝑁𝑆𝑠
) =
𝐼𝑂𝐴(𝐺𝑁𝑆𝑇𝑠)
𝐼𝑂𝐴(𝐺𝑁𝑆𝑠)
=
1 − 𝜂𝑠𝑐𝑡(𝐺𝑁𝑆𝑇𝑠)
1 − 𝜂𝑠𝑐𝑡(𝐺𝑁𝑆𝑠)
. (4.10) 
Analogously, Equation (4.10) can be written for the ratio that compares GNRs and GNSs, as 
follows: 
 𝑅𝑂𝐴 (
𝐺𝑁𝑅𝑠
𝐺𝑁𝑆𝑠
) =
𝐼𝑂𝐴(𝐺𝑁𝑅𝑠)
𝐼𝑂𝐴(𝐺𝑁𝑆𝑠)
=
1 − 𝜂𝑠𝑐𝑡(𝐺𝑁𝑅𝑠)
1 − 𝜂𝑠𝑐𝑡(𝐺𝑁𝑆𝑠)
. (4.11) 
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From the experimental IR-OA data, I obtained 𝑅𝑂𝐴 (
𝐺𝑁𝑆𝑇𝑠
𝐺𝑁𝑆𝑠
) ≈ 𝑅𝑂𝐴 (
𝐺𝑁𝑅𝑠
𝐺𝑁𝑆𝑠
) ≈ 6 . From the 
experimentally determined scattering efficiencies (Table 4.2), I obtained 𝑅𝑂𝐴 (
𝐺𝑁𝑆𝑇𝑠
𝐺𝑁𝑆𝑠
) ≈
𝑅𝑂𝐴 (
𝐺𝑁𝑅𝑠
𝐺𝑁𝑆𝑠
) ≈ 4. Therefore, it is found that the infrared scattering efficiencies determined by the 
transient photo-thermal method, are in good agreement with optoacoustic experiments of the GNPs 
studied in this work.  
 
Figure 4.10 (a) Optical density of GNRs (red), GNSTs (green) and GNSs (blue). (b) Time evolution of the 
IR-OA signals generated by the three GNPs after laser excitation. (c) Average IR-OA amplitudes obtained 
for the three GNPs. 
4.6. Conclusions 
An experimentally determination of infrared scattering efficiency and scattering cross section 
of GNPs with three different geometries: nanorods, nanoshells and nanostars was carried out in 
this chapter. Multi-wavelength thermal loading experiments have been used to experimentally 
determine the spectral dependence of the scattering efficiency of these three geometries. 
Comparison between experimental data and numerical simulation, reveals good agreement in all 
cases, except for GNSTs that present an unexpected large scattering efficiency at long wavelengths. 
This discrepancy has been explained in terms of size inhomogeneities as well as particle-particle 
interactions. Both GNSs and GNSTs show scattering efficiencies strongly dependent on the 
wavelength, thus evidencing the importance of considering the spectral operating range when 
choosing the appropriate geometry for each particular imaging application. It is also 
experimentally found that, in the whole infrared spectral range investigated in this work (800-1400 
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nm), GNSs show the largest scattering efficiency and cross section. This explains, why they are 
best cardiovascular imaging probes, as we also concluded in Chapter 3. 
The superior performance of GNSs as scattering units in the infrared has been confirmed by 
means of infrared dark field imaging, optical coherence tomography and optoacoustic experiments. 
In all the cases, the experimental data confirm the previous conclusions extracted from photo-
thermal experiments. They also reveal the multifunctional character of these GNPs that are capable 
of efficient light scattering and acoustic generation under infrared optical excitation.  
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5.1. Introduction 
IV-OCT imaging is nowadays used as a minimally invasive technique for the in vivo 
identification and assessment of unstable atheroma plaques as well as for the guidance of 
interventional procedures, such as atherectomy and stent placement.24, 172-175 The possibility of 
adding molecular contrast to available IV-OCT systems opens a new door to extend the impact of 
OCT to cardiovascular clinical applications, as it would enable functional biomolecular imaging 
together with available morphological imaging. Indeed, IV-OCT with molecular contrast would 
enable site-specific cardiovascular imaging and therefore would allow for the early detection and 
localization of atherosclerotic lesions, which is not possible by using current IV-OCT imaging 
techniques. Thus, this intravascular molecular imaging modality would contribute substantially to 
the future development of personalized medicine for cardiovascular diseases.  
A common strategy to improve OCT contrast at the molecular level involves the use of 
nanoparticles (NPs) that enhance OCT contrast and, at the same time, can be properly 
functionalized with antibodies to target specific molecules overexpressed by the tissue/cells to be 
detected.106, 176 In this respect, GNPs of different geometries and sizes have been successfully 
applied as OCT contrast enhancers.82, 149, 177-181 GNPs are particularly suitable for OCT contrast 
improvement as their extinction spectra can be precisely tuned over a broad spectral range by 
solely controlling their size and geometry. In addition, the gold surface of GNPs is particularly 
suitable for functionalization with specific targeting ligands and therefore provides the opportunity 
for molecular targeting.181 Owing to these properties, GNPs have already been deployed as contrast 
agents in different OCT imaging modalities.81, 182, 183 Moreover, as gold is an inert and 
biocompatible noble metal, these GNPs are considered nontoxic, although some concerns have 
been raised, especially related to the long-term effect of gold accumulation in the organism or 
cellular modifications.184 
In Chapter 3, it was described how different types of commercial GNPs, including gold 
nanorods and gold nanoshells (GNSs), with plasmon resonances in the proximity of 1320 nm, 
could act as efficient IV-OCT enhancers when suspended in biomedical fluids.179 In particular, 
GNSs consisting of a dielectric silica core of about 200 nm and an ultrathin metal shell of about 
15 nm, resulted in the largest IV-OCT contrast enhancement based on their superior backscattering 
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cross-section (0.7 × 10-10 cm2) at the IV-OCT wavelength.179 As a result, GNSs dispersed in 
physiological solutions could be individually observed by IV-OCT, even under dynamic flow 
conditions. Despite these promising features, the potential use of GNSs for the selective 
enhancement of live cell imaging by IV-OCT must be explored, though it would constitute the 
first step towards the use of IV-OCT for molecular imaging.  
In this chapter, a systematic investigation of IV-OCT contrast in living cells and its enhancement 
by passive incubation with GNSs is presented. Experiments were conducted in two different cell 
lines; HeLa and Jurkat cells. (i) HeLa cells constitute an immortal cell line, as they can divide 
many times in cell culture plate under minimal survival conditions. Thus, they have been widely 
used for scientific research. What’s more, as cancer cells, they are capable to uptake NPs by 
endocytosis. (ii) Jurkat cells are T lymphocytes and can be found in the blood stream. Recent 
studies have shown that they play an important role in protecting against cardiovascular diseases 
by responding to inflammatory cues.185, 186 Therefore, the investigation of these two cell lines for 
OCT molecular imaging is important. Intensity analysis of IV-OCT was used to discriminate the 
population of living cells in which an efficient incorporation of GNSs was achieved and to 
determine the relationship between the incorporation efficiency and the incubation parameters. 
The results extracted from the IV-OCT images of cell dispersions were compared to the images 
obtained by transmission electron microscopy (TEM) and dark field microscopy (DFM), in order 
to unequivocally correlate the contrast enhancement observed in the IV-OCT images with the 
incorporation of GNSs in living cells. Future implications of the results for the application of IV-
OCT to intracoronary molecular imaging are also discussed. 
1.1. Static OCT imaging of HeLa and Jurkat cells incubated with GNSs 
As indicated in the Introduction, and with the purpose of studying IV-OCT contrast for living 
cells and its enhancement by passive incubation with GNSs, cytotoxicity was initially examined 
using various concentrations of GNSs incubated on HeLa cells for 24 h. MTT assay was then used 
to evaluate the cytotoxicity of the GNSs, more details can be found in Experimental techniques. 
The results of these experiments are shown in Figure 5.1. For all the concentrations (0.05, 0.1, 0.5, 
2.5, and 5 µg/mL), the cell viability was never less than 94% relative to the control. Therefore, the 
GNSs did not show any relevant toxicity to the HeLa cells under these experimental conditions. 
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Figure 5.1 Cell viability of HeLa cancer cells after incubation with several concentrations of GNSs. Each 
bar corresponds to the mean value ±standard deviation (SD) obtained from 4 replicates for each 
experimental condition. 
 
Figure 5.2 (a) IV-OCT cross-sectional images of GNSs suspended in PBS , nonincubated HeLa and Jurkat 
cells in PBS, HeLa and Jurkat cells incubated for 24 h with a dispersion of GNSs in PBS. (b) Histograms 
of intensity, as calculated from the IV-OCT images. Note that free GNSs and free (nonincubated) Jurkat 
and HeLa cells yielded single Gaussian distributions centered at about 65 uarb (GNSs) and 60 uarb (free 
cells), whereas the incubation of HeLa and Jurkat cells with GNSs led to the appearance of high-intensity 
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bands centered at about 120 uarb. The different fits to Gaussian distributions are shown as solid lines. ×3 
and ×10 indicate the magnification factor. (c) Representative IV-OCT cross-sectional images of HeLa cells 
incubated with 5 µg/mL GNSs for 24 hours, obtained by injecting the sample (1, 2 and 3) and its duplicate 
(4, 5 and 6) in the tubing at different times, and moving the IV-OCT catheter in 3 positions along the tubing.  
After the negligible toxicity of the GNSs was proved, the GNSs were incubated in cells (HeLa 
and Jurkat) to evaluate their viability as OCT contrast agents. HeLa cells were incubated with 2.5 
µg/mL of GNSs for 24 hours, while Jurkat cells were incubated with 1.0 µg/mL of GNSs for 24 
hours. Both of them were washed for three times in order to remove the excessed GNSs, and then 
they were dispersed in PBS. Then 200 µL of the incubated cells/PBS solution were injected in a 
tubing containing the IV-OCT catheter. In order to make a comparison, the following control 
samples were also prepared and then injected into the tubing: (i) PBS solution, (ii) 2.5 µg/mL of 
GNSs in PBS, (iii) non-incubated HeLa and Jurkat cells in PBS solution. Figure 5.2 (a) shows 
OCT cross-sectional images of the tubing filled with these solutions. As we have seen in Chapter 
3, individual GNSs can be visualized by IV-OCT when using a low concentration of GNSs. The 
different bright spots in the cross-sectional images are due to the backscattered light of the OCT 
laser produced by (i) individual GNSs, (ii) individual cell, (iii) cell containing GNSs. Thus, the 
cross-sectional images in Figure 5.2 (a) must be carefully analyzed. For this purpose, the spot 
intensity distribution of these cross-sectional images was carefully analyzed. Figure 5.2 (b) shows 
the spot intensity distribution (spot frequency as a function of the OCT spot intensity) obtained for 
the different samples. The data analysis process is described in detail in Experimental techniques. 
Each distribution was obtained by analyzing the intensity of 120 images taken along the tubing. 
To guarantee the accuracy, the experiment was repeated at least 6 times for each concentration by 
injecting each sample and its duplicate (another solution with same GNSs concentration) in the 
tubing, and moving the IV-OCT catheter to 3 different positions along the tubing. An example of 
these repeated experiments for HeLa cells incubated with GNSs is shown in Figure 5.2 (c). In 
these six IV-OCT cross sectional images, bright spots and less bright spots can be clearly seen, 
giving no significant differences in the spot intensity distribution, thus demonstrating that the data 
obtained in these experiments are reproducible. For the solution containing only GNSs, a single 
distribution of spot intensities was observed around a central spot intensity of about 65 uarb (in the 
contrast units given by the IV-OCT software, hereafter uarb) with a full width at half maximum 
(FWHM) of 50 uarb. This distribution resembled a Gaussian one, as depicted by the best-fit curve 
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displayed over the distribution. Cross-sectional images of the PBS solutions containing HeLa and 
Jurkat cells also show bright OCT spots, demonstrating the ability of IV-OCT to detect individual 
cells. The corresponding spot diagrams are shown in the right panel of Figure 5.2. In both cases, 
Gaussian distributions with peaks at about 59 uarb and an FWHM close to 26 uarb were obtained. 
Thus, when compared to the histogram of IV-OCT signal intensities provided by colloidal GNSs, 
it was clear that suspended cells (either HeLa or Jurkat) produce much narrower distributions, 
peaking at slightly different OCT intensities. Figure 5.2 (b) also includes the intensity histograms 
corresponding to the IV-OCT cross-sectional images obtained for cells that were incubated with 
GNSs for 24 h. It can be clearly observed that the incubation process results in the appearance of 
a number of OCT spots at higher intensities than those obtained for single GNSs and for 
nonincubated cells. In these cases, the intensity histogram can be effectively described by the 
superposition of two Gaussian distributions as follows: 1) the dominant contribution corresponds 
to a Gaussian distribution centered at 62 uarb with an FWHM close to 25 uarb. As the distribution 
peak is located at 65 uarb for free GNSs and at 59 uarb for cells only, we can consider that this 
contribution is associated to free GNSs, cells that did not incorporate GNSs, and cells incubated 
with several GNSs. A possible explanation of these results will be given when describing the dark 
field images results. 2) The experimental data reveal an additional Gaussian distribution with a 
peak at about 125 uarb and a FWHM of 50 and 26 uarb for HeLa and Jurkat cells, repectively. This 
second Gaussian distribution is associated with cells that internalized GNSs, or GNSs that are 
adhered to the cells during the incubation procedure. Note that in these cases, the backscattering 
signal is expected to be higher, since it represents two different contributions, i.e., the 
backscattered signals produced by the medium–cell interface and by intracellular GNSs. 
1.2. Additional confirmation of the internalization of the GNSs into the cells 
Dark field microscopy (DFM), which collects the scattered light produced by an specimen, is a 
good technique to localize and monitor good light scatterers, like plasmonic nanoparticles.187 
Therefore, the DFM was used to confirm the intracellular incorporation of GNSs, as shown in 
Figure 5.3. Figure 5.3 (a) and (c) show, as relevant examples, DFM images of HeLa and Jurkat 
cells obtained after 24 h of incubation with GNSs in PBS at of 2.5 and 1 µg/mL, respectively. In 
this case, the DFM images were taken by uEye camera (Germany). According to previous studies 
based on DFM visible imaging, the color of GNPs in the DFM is dependent on the scattering 
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spectra of the GNPs. For example, gold nanoparticles with scattering spectrum peaking at 547 nm 
show green color in DFM, while the GNRs with scattering spectrum peaking at 687 nm show a 
red color in the DFM.188 However as GNSs display a stronger scattering intensity in the infrared 
region, they might not be properly imaged by a visible camera. Fortunately, due to the broad 
scattering spectra of GNSs from 600 to 1400 nm (as discussed in Chapter 4), a visible camera can 
still be used to image the GNSs, and the color is expected to be red. As observed in the DFM 
images in Figure 5.3 (a) and (c), the red spots are thus associated with GNSs. Therefore, DFM 
images provide solid evidence for the incorporation of GNSs in both HeLa and Jurkat cells. In 
addition, the visualization of cells incubated with GNPs by TEM have been widely used,189, 190 due 
to the different contrast and morphology that cells and GNPs show in TEM. Therefore, TEM was 
used to further support the conclusions obtained by DFM. Figure 5.3 (b) and (d) show 
representative TEM images of HeLa and Jurkat cells obtained after incubation with GNSs, clearly 
showing the presence of GNSs in the cytoplasm of the cells. 
 
Figure 5.3 Dark-field microscopy and bright field microscopy images (merged) of HeLa (a) and Jurkat 
cells (c) incubated in a dispersion of GNSs in PBS at 2.5 and 1 µg/mL, respectively. TEM image of a HeLa 
(b) and a Jurkat cell (d) incubated in a solution of GNSs in PBS at 2.5 and 1 µg/mL, respectively. The 
intracellular incorporation of GNSs in cells is corroborated.  
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1.3. Incubation efficiency of GNSs incubated into the cells 
The data summarized in Figure 5.2 clearly demonstrate how the incubation of the GNSs in cells 
leads to complex bright spots distributions in the cross-sectional OCT images. It has been shown 
that a Gaussian fitting can be used to discriminate the cells that has been efficiently incorporated 
with GNSs. In order to see how the internalization efficiency was affected by the concentration of 
the GNSs, IV-OCT cross-sectional images of cells incubated for 24h with GNSs at various 
concentrations (from 0.05 µg/mL to 5 µg/mL) were analyzed. Figure 5.4 (a) shows the cross-
sectional IV-OCT images obtained for HeLa cells incubated with 0.05, 0.1, 0.5, 2.5 and 5 µg/mL 
of GNSs. The IV-OCT image of control (cells not incubated with nanoparticles) is also shown in 
Figure 5.4 (a) for comparison. With the increase of the GNSs concentration, more spots appeared 
in the cross-sectional images and more bright spots were observed. The spot intensity distributions 
obtained for different incubated concentrations are displayed in Figure 5.4 (b). It was previously 
demonstrated that the cells that have internalized GNSs give signals in the 120-190 uarb range (red 
Gauss fitting as shown in the Figure 5.2 (b)). Therefore, by direct computation of the total number 
of spots with intensities in the 120–190 uarb range, it is possible to obtain a relative measure of the 
population of cells with GNSs in their cytoplasm. The results obtained from the analysis of the 
intensity histograms in Figure 5.4 (b) are included in Figure 5.4 (c). This figure demonstrates that 
the sub-population of HeLa cells that internalizes GNSs increases as the concentration of GNSs 
increases in the culture medium. IV-OCT images revealed that for GNS concentrations below 0.5 
µg/mL the internalization efficiency strongly depends on the GNS concentration, whereas for 
larger concentrations, the internalization efficiency tends to saturated and so is only slightly 
dependent on the incubation concentration. Interestingly, the number of incubated cells (>120 uarb) 
reaches a maximum for the highest concentration of GNSs (2656) that is quite similar to the same 
number of HeLa cells (2735) in the control. Therefore, it can be considered that OCT can be 
efficiently used for imaging of HeLa cells. 
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Figure 5.4 (a) IV-OCT cross-sectional images of nonincubated HeLa cells and HeLa cells incubated for 
24 h with various concentrations of GNSs. (b) Intensity histograms as calculated from the IV-OCT cross-
sectional images for spots intensities larger than 120 uarb. (c) Number of cells with intensity above 120 uarb 
generated from HeLa cells incubated with various concentrations of GNSs for a fixed time of 24 h. 
A similar trend was observed when the internalization efficiency of GNSs by Jurkat cells was 
determined based on IV-OCT images, as shown in Figure 5.5 (a). The spot intensity distributions 
obtained for various incubated concentrations are displayed in Figure 5.5 (b), where the intensity 
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range was restricted to 100-160 uarb. Interestingly, in the case of Jurkat cells, which present a lower 
phagocytosis ability than HeLa cells, the GNSs were incorporated in the cells in a sufficient 
amount to increase the OCT signal, enabling the discrimination between individual cells and cells 
with GNSs. The integrated OCT intensity with spot intensity above 100 as function of GNSs 
concentrations is shown in Figure 5.5 (c). The integrated OCT intensity shows also a similar trend 
with increase of GNSs concentrations to that observed for incubated HeLa cells (see Figure 5.4 
(c)). 
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Figure 5.5 (a) IV-OCT cross-sectional images of nonincubated Jurkat cells and Jurkat cells incubated for 
24 h with various concentrations of GNSs. (b) Intensity histograms as calculated from the IV-OCT cross-
sectional images for spots intensities larger than 100 uarb (associated only with signals of cells that have 
incorporated GNSs). (c) Integrated OCT intensities generated from Jurkat cells incubated with various 
concentrations of GNSs for a fixed time of 24 h. The OCT signal was calculated by integrating the 
frequency distribution signals for spot intensities above a threshold intensity of 100 uarb (IV-OCT signal of 
successfully incubated cells). 
 
Figure 5.6 Dark-field microscopy images of HeLa cells incubated with various concentrations of GNSs. 
Incubation time was 24 h in all cases: The scale bar is 20 µm. 
A comparison of data obtained by IV-OCT and those obtained by DFM was performed for HeLa 
cells. The DFM images obtained for HeLa cells incubated with various GNSs concentrations were 
systematically studied, representative images are shown in Figure 5.6. These images clearly 
indicate that the number of red spots in cells increases with the concentration of GNSs in the 
incubation medium. The analysis of DFM images also allows for a qualitative evaluation of the 
adhesion efficiency of GNSs, by computing the average number of “red spots” per cell as a 
function of the GNS concentration. Assuming that each “red spot” corresponds to an individual 
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GNSs, it can be discussed how the number of GNSs incorporated to cells changes with the GNSs 
concentration as shown in Figure 5.6. The concentration-dependent incubation efficiencies, 
determined by DFM, for HeLa cells are included in Figure 5.7, together with the OCT trends 
obtained from Figure 5.4 (b) (i.e. the spots with OCT spot intensity above 120 uarb). The average 
number of GNSs in cells were calculated by counting the red spots in the HeLa cells, using the 
images shown in the Figure 5.6 It is clear that the DFM results were consistent with the IV-OCT 
results. The DFM images also reveal that the incorporation (or adhesion) efficiency of GNSs in 
living cells increases monotonically as the concentration of the GNSs in the culture medium 
increases. It can be also observed a tendency towards saturation for concentrations larger than 0.5 
µg/mL, in very good agreement with the data extracted from IV-OCT images. This saturation 
behavior, evidenced by both DFM and IV-OCT, was in accordance with previous studies showing 
that the cellular uptake efficiency displays a saturation behavior as the concentration of 
nanoparticles increases.51, 191 This is due to the limited number of available serum proteins in cells, 
which plays an important role in the internalization of gold nanoparticles.191 In the DFM image of 
HeLa cells incubated with 0.05 µg/mL of GNSs, there are only 2 GNSs per cells (in average). By 
observing the corresponding OCT signal (Figure 5.4 and Figure 5.7), there are no spots with 
intensity above 120 uarb. Thus, HeLa cells incubated with 2 GNSs do not lead a contrast 
enhancement in the OCT cell imaging; the signal must be so low that it is impossible to detect the 
HeLa cells incorporated with GNSs. For HeLa cells incubated with 5 µg/mL of GNSs, the spots 
outside the cells are due to GNSs that have not been removed by the washing process. Note that 
some HeLa cells do not have as many GNSs as other HeLa cells, thus they may lead to the different 
OCT intensity in the OCT cross-sectional. For example, HeLa cells incubated with 1 or 2 GNSs 
result in a low OCT intensity (below 120 uarb), and HeLa cells incubated with 10 to 45 GNSs 
produce a high OCT intensity (above 120 uarb). This fact may give a reasonable explanation to the 
blue Gauss fitting in Figure 5.2 (b) with OCT intensity distribution from 40 to 120 uarb. This OCT 
intensity distribution must be due to the backscattered light produced by the free GNSs, 
nonincubated HeLa cells, and HeLa cells incubated with several GNSs. 
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Figure 5.7 Average OCT spot intensities and number of GNSs in cells generated from HeLa cells incubated 
with various concentrations of GNSs for a fixed time of 24 h. The average OCT spot signal was calculated 
from the frequency distribution signals for spot intensities above a threshold intensity of 120 uarb (IV-OCT 
signal of successfully incubated cells), the number of GNSs in cells were calculated from DFM images.  
1.4. Contrast enhancement at cellular and tissue level 
Finally, it should be noted that the unequivocal relation between OCT spots with intensities 
larger than 120 uarb and GNS internalization in cells allows for not only detailed studies of the 
incubation efficiency, but also for the three-dimensional localization of cells with GNSs in their 
cytoplasm. An example of this imaging capacity is given in Figure 5.8. In Figure 5.8 (a), the raw 
IV-OCT image of a suspension of HeLa cells after incubation for 24 h with 2.5 µg/mL of GNSs is 
shown. The IV-OCT raw image shows a large density of spots with a wide variety of intensities 
ranging from 40 to 180 uarb. As discussed above, these spots reveal a high density of GNSs, 
suspended HeLa cells and suspended HeLa cells that have internalized GNSs. In order to isolate 
the images of HeLa cells that have internalized GNSs efficiently, the raw IV-OCT images were 
treated by filtering the spots above a single threshold level. Figure 5.8 (b) shows filtered the IV-
OCT image corresponding to the data shown in Figure 5.8 (a) after removing the OCT spots with 
intensities below 120 uarb. Since OCT intensities above 120 uarb are only generated by HeLa cells 
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with internalized GNSs, Figure 5.8 (b) corresponds to an image of the sub-population of HeLa 
cells containing GNSs (they have been labeled in green color). Therefore, IV-OCT could be used 
for molecular imaging of internalized cells. As explained in the Experimental techniques section, 
the clinical IV-OCT system could also be used for three-dimensional imaging by pulling back the 
catheter. This possibility, together with the threshold level filtering, was exploited to obtain a three-
dimensional image of the sub-population of HeLa cells with internalized GNSs. The pull back 
video was imported to ImageJ program, after setting a threshold level filtering, HeLa cells with 
internalized GNSs were distinguished, and then their coordinates (x, y, z) were saved and imported 
to the Origin program. The three dimensional image was drawn by means of 3D scatter program. 
Thus, the three dimensional image of the sub-population of HeLa cells with internalized GNSs is 
shown in Figure 5.8 (c). The red spots correspond to HeLa cells with internalized GNSs, the 
coordinates x and y correspond to the position of HeLa cells in the OCT cross-sectional image, and 
z coordinate is obtained from the OCT video (540 slices correspond to 54 mm of the pull back 
distance). This result indicates the possibility of real-time, three-dimensional tracking of living 
cells in the intravascular system by employing specifically targeted GNSs.  
 
Figure 5.8 (a) Raw cross-sectional IV-OCT image of a suspension of HeLa cells after incubation with 
GNSs for 24 h. The concentration of GNSs in the culture medium during incubation was 2.5 µg/mL. (b) 
IV-OCT cross-sectional image of the same cell suspension used in (a), but after applying a threshold 
filtering to the raw image. The intensity threshold was set to 120 uarb, so that observed spots correspond to 
HeLa cells that internalized GNSs. (c) Three-dimensional IV-OCT image of the suspended HeLa cells that 
internalized GNSs. Each pixel providing a IV-OCT signal larger than 120 uarb was identified as a single 
HeLa cell with internalized GNSs. Scale bar represents 1 mm. 
OCT 
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As mentioned above, many clinical applications also require contrast enhancement within 
tissues. In order to demonstrate the potential application of GNSs to enhance the OCT contrast 
inside a tissue, a final experiment was designed in which the IV-OCT catheter was positioned 
inside a muscular tissue (Gallus gallus domesticus). Then, two injections (0.5 mL per injection) of 
an aqueous solution of GNSs (50 µg/mL) were performed in the proximity of the OCT catheter 
(see Figure 5.9 (a)). The cross-sectional images of the muscular tissue obtained before and after 
the injection of GNSs are shown in Figure 5.9 (a) and (b). The circle in the center of the image 
corresponds to the catheter. The red yellow area around the IV-OCT catheter is due to the 
backscattered light produced by the tissue and the GNSs. According to the optical scattering 
properties of soft tissues reported by Joseph,192 tissues show a high scattering coefficient from 600 
to 1400 nm, and so giving a high OCT intensity around the catheter. In addition, the OCT intensity 
decreases from the OCT catheter to deeper tissue. A detailed comparison of these figures reveals 
a contrast enhancement at the injection locations. This is clearly manifested in Figure 5.9 (c), 
which includes the average OCT intensity (IOCT) against depth profiles obtained along the scan 
direction represented by the green arrows in Figure 5.9 (a) and (b), i.e., along two scan directions 
crossing the GNS injection areas. Figure 5.9 (c) clearly demonstrates that OCT intensity decrease 
as function of the depth due to the scattering and absorption properties of the tissue. In addition, 
the presence of GNSs leads to an OCT contrast enhancement between 0.8 and 1.6 mm, in good 
agreement with the location of the injected GNSs. This result is more clearly observed when the 
OCT depth profile obtained prior to the injection is subtracted from the profile obtained after 
injection (IOCT), shown in Figure 5.9 (d). This figure shows the relevant enhancement in the OCT 
contrast produced by the GNSs inside the tissue. Indeed the distribution of GNSs as function of 
depth can be observed. Thus, the data included in Figure 5.9 clearly demonstrate the potential use 
of GNSs as contrast agents for OCT imaging of tissues using cardiovascular clinical systems.  
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Figure 5.9 (a) Cross-sectional OCT image of a tissue prior to the injection of GNSs. An aqueous solution 
of GNSs (0.5 mL; 50 µg/mL) was injected in the areas delimited by the blue dashed lines. (b) Cross-
sectional OCT image of the same tissue shown in (a) after the injection of an aqueous solution of GNSs. 
(c) OCT intensity (IOCT) versus depth in the tissue, as obtained along the scan lines, is indicated by the green 
arrows in (a) and (b). (d) Difference between the OCT intensity obtained prior to and after the injection of 
GNSs (IOCT) as a function of the penetration depth in the tissue. The spatial extension of the GNSs within 
the tissue is indicated by the gray areas included in (c) and (d). 
1.5. Internalization of GNSs in HMEC-1 cells under flow conditions 
HMEC-1 is a human microvascular endothelial cell line, and the dysfunction of this cell line 
related to cardiovascular disease. Evaluation of internalization of GNSs in HMEC-1 under flow 
conditions is a very important step for clinical application of GNSs in cardiovascular disease. 
Therefore, I have settled a flow setup as described in Experimental techniques. Due to the limited 
time of project, the functionalization of GNSs is not available. In this case, commercial GNSs 
coated with PEG without functionalization and HMEC-1 without activated were used to evaluate 
the flow system. The DFM images (taken by EMCCD camera) of GNSs and HEMC-1 at different 
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flow times are shown in Figure 5.10. The morphology of HEMC-1 can be clearly seen. The 
movement of GNSs 1 and 2 can be tracked as labeled by red arrows. The internalization of GNSs 
in HEMC-1 haven’t been found due to the non-specific functionalized of GNSs and non-activated 
HEMC-1. More work needed to be done in order to see in the internalization of GNSs in HEMC-
1 under flow condition. 
 
Figure 5.10 DFM images of GNSs and HMEC-1 cells at different flow time (0 s and 1 s). The positions of 
GNSs 1 and 2 at different flow time were labeled by red arrows. 
1.6. Conclusions 
In summary, in this chapter, I have shown how clinical IV-OCT allows for the detection of 
individual cells suspended in biological fluid. The experimental results indicated that the 
backscattering contrast of individual cells could be substantially enhanced by the intracellular 
incorporation of specifically designed GNSs with high scattering cross-sections at the IV-OCT 
operating wavelength (1320 nm). A detailed intensity analysis of IV-OCT images enabled the 
identification and discrimination of different sub-populations within a suspension of living cells. 
In particular, an analysis of the intensity histograms from IV-OCT images allowed for the detection 
of living cells in which GNSs attachment occurred, and made it possible to estimate the attachment 
efficiency and its relationship to the concentration of GNSs in the culture medium. These results 
were in excellent agreement with those obtained using alternative techniques, such as DFM and 
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TEM. Finally, the tissue contrast enhancement by OCT, achieved after the injection of GNSs inside 
the tissue was demonstrated. 
As GNSs are easy to functionalize with biomolecules to target specific cell sites, the results of 
this study provide a new path for reliable molecular imaging by IV-OCT, and thus constitute the 
first step towards the development of new diagnostic procedures at the clinical level.  
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6.1. Introduction 
Up to now, silica-coated gold nano-shells with plasmon resonance close to the IV-OCT laser 
wavelength (1.3 µm) and high back-scattering cross sections were demonstrated as the best nano-
contrast agents, showing significant IV-OCT contrast enhancements in suspensions and tissues.179 
In addition, these nanoparticles have been used for OCT molecular imaging of several cell lines.193 
The potential application of OCT contrast agents would further benefit if the NPs, in addition to 
the OCT contrast enhancement, could provide simultaneous photoluminescence (PL) contrast. 
This would open the possibility of achieving multimodal intracoronary imaging that would be 
immensely helpful, for instance, in the understanding of the relation between atherosclerotic 
plaque microstructures and the molecular mechanisms that underlie their formation and instability, 
leading to acute coronary syndromes.194 A pioneering work of H. Yoo and co-workers60 
demonstrated that the simultaneous acquisition of multimodal OCT+(PL) intracoronary images 
allowed for microstructural and molecular functional image, an essential information to the 
correlation of coronary artery disease and vessel wall healing. These authors used the Cy7 
fluorophore to provide fluorescence imaging while intracoronary OCT images were constructed 
from the inherent contrast provided by the artery.195, 196 However, this approach implied the use of 
two laser sources (one to excite the fluorophore and the other for OCT),60 increasing the 
complexity of the experimental arrangement. Solving this drawback implies the use of a contrast 
agent capable of providing both luminescence and back-scattering contrast just under single laser 
excitation at 1.3 µm. Furthermore, if a NP is to be used as a multimodal OCT+PL agent in 
cardiological applications, its luminescence should be produced within the so-called infrared 
biological windows,51 where human tissues become partially transparent allowing high penetration 
in in vivo fluorescence imaging.197-199 In, addition, NPs is much more stable than the fluorophores 
and doesn’t have photobleach.53 
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Figure 6.1 Schematic representation of a NP capable of OCT+PL imaging under single laser line excitation 
at 1.3 µm. 
In this chapter, the potential use of Infrared emitting Quantum Dots (IR-QDs) as OCT+PL 
multimodal intracoronary imaging agents under single line laser excitation was evaluated. The 
operating scheme is shown in Figure 6.1. Thus under OCT laser excitation, the IR-QDs can scatter 
the OCT laser light, the backscatter light can be collected by the IV-OCT catheter, and thus 
produces OCT signal. In addition, the IR emission of QDs can be generated under OCT laser 
excitation, and thus the fluorescence image produced by the IR-QDs can be obtained by using a 
near infrared camera. The simultaneous capacity of these dots for back-scattering and fluorescence 
generation in III-BW52 under single 1.3 µm laser excitation was evaluated in aqueous suspensions, 
tissues and ex vivo aorta by using an IV-OCT clinical equipment.  
6.2. Characterization of PbS QDs 
The IR-QDs used all along this work were PbS QDs (CANdots® Series C with a nominal 
emission wavelength of 1600 nm), and they were surface-functionalized with a PEG-ligand 
(DSPE-PEG-amine) in order to achieve dispersability in water. A carton of PbS QDs with PEG is 
drawn in Figure 6.2. Details of surface functionalization can be found in the Experimental 
techniques section. A representative TEM image of the IR-QDs is shown as Figure 6.2 (a). 
Statistical analysis of this and other TEM images reveals an average IR-QD size of 5.4 nm, with a 
size dispersion of ±2.3 nm, as can be appreciated from the size histogram included as an inset in 
Chapter 6. PbS QDs as contrast agents for cardiovascular bimodal imaging 
108 
 
Figure 6.2 (a). Therefore, taking into account the density of PbS (7.6 mg/cm3) and the volume of 
each PbS QDs is (4/3)×π×(2.7×10-7)3 cm3, the number of QDs per mL for initial content (0.6 
mg/mL) is 9.21×1017 NPs/mL. Figure 6.2 (b) shows the room temperature extinction cross section 
together with the emission spectrum of the IR-QDs. The extinction cross section clearly evidences 
the first exciton absorption peak at around 1420 nm. The non-negligible extinction at the OCT 
laser wavelength peak (also included in this figure) should also be noted. The OCT laser spectrum 
matches the extinction spectrum, and therefore, the PbS QDs can be excited by using a IV-OCT 
laser. The emission spectrum of IR-QDs is constituted by a single broad band centered at around 
1.55 µm (III-BW), so that it can be easily spectrally isolated from the IV-OCT laser radiation by 
using long pass filters. 
 
Figure 6.2 (a) Characteristic TEM image of the QDs used in this work. Inset shows the size histogram 
revealing an average size close to 5 nm. (b) Blue line corresponds to the extinction cross section of the QDs 
(Commercial PbS QDs without surface modification, the concentration of PbS is 10 mg/mL). The emission 
spectrum of the QDs is also included (red line). The orange line corresponds to the spectral distribution of 
the laser radiation generated by the IV-OCT catheter. 
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6.3. Bimodal OCT and fluorescence imaging of colloidal QDs 
 
Figure 6.3 Schematic representation of the experimental approaches used to test the capacity of IR-QDs 
for multimodal OCT+PL imaging in a fluid. 
 
Figure 6.4 (a) Cross-sectional OCT images of the tubing in the presence of three aqueous solutions of IR-
QDs, GNRs and GNSs. The cross sectional image in absence of any NPs is also included as “control image”. 
Scale bar, 1 mm. (b) Integrated OCT intensity normalized by the total mass of NPs as obtained for IR-QDs, 
GNRs and GNSs. (c) Integrated OCT intensity normalized by the total number of NPs as obtained for IR-
QDs, GNRs and GNSs.  
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The experimental arrangement depicted in Figure 6.3 is used to evaluate the bimodal OCT+PL 
imaging of colloidal QDs introduced in a tubing (simulating an artery). The IR-QDs were injected 
in the tubing in which contains the IV-OCT catheter, the static OCT was operated to evaluate the 
OCT contrast produced by the IR-QDs. Figure 6.4 (a), left side, shows the IV-OCT cross sectional 
image when the tubing was filled with a clean suspension of water, which was used as a control 
image for IV-OCT experiments. The cross sectional IV-OCT image obtained when the tubing was 
filled with an aqueous suspension of IR-QDs (0.06 mg/mL) is also included in Figure 6.4 (a). The 
contrast enhancement produced by the suspended IR-QDs is clearly evidenced. This fact 
unequivocally reveals the capacity of individual IR-QDs (in spite of their small sizes) to 
backscatter the 1.3 µm OCT laser radiation. The scattering properties of QDs in the visible domain 
were already theoretically postulated and experimentally evidenced by dark field microscopy 
previously.200 Nevertheless, this is the first time that such scattering ability is demonstrated in the 
infrared spectral region, and particularly under the IV-OCT excitation conditions. In order to 
compare the IV-OCT enhancement produced by IR-QDs in respect to that provided by metallic 
nanoparticles, Figure 6.4 (a) also includes cross sectional images obtained when the tubing was 
filled with an aqueous suspensions of GNPs. Two types of GNPs have been used here for 
comparison. GNRs (100 nm length and 10 nm width) with a plasmon resonance wavelength peak 
close to 1300 nm and GNSs (198 nm core and 16 nm shell) with a multimodal plasmonic band 
extending from 800 up to 1800 nm. Concentrations of the solutions of both GNRs and GNSs were 
0.06 mg/mL. Figure 6.4 (b) shows the IV-OCT signal enhancement (in respect to the control) 
normalized by the mass of contrast agents, as obtained for the three particles investigated. Figure 
6.4 (b) reveals that, for similar concentrations, IR-QDs show an IV-OCT contrast per mass unit 
enhancement smaller but comparable to that provided by GNPs. Figure 6.4 (c) shows the IV-OCT 
integrated intensity normalized to the number of particles. In this case, it is clear that the IV-OCT 
intensity generated by a single metallic nanoparticle is more than eight orders of magnitude larger 
than that provided by individual IR-QDs. Indeed, this was expected because of two main reasons. 
The first one is the large size difference: the volume of an individual GNS is more than four orders 
of magnitude larger than the volume of an individual IR-QDs. Secondly, for metallic nanoparticles 
the back-scattering is associated with the collective resonant excitations of charges (plasmon 
resonance overlaps with the IV-OCT laser radiation).148, 201 As a consequence, the back-scattering 
cross section of, for instance, GNSs with enough plasmon resonance at OCT laser wavelength are 
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as large as 7×10-11 cm2 per nanoparticle.179 The scattering cross section of IR-QDs has not been 
reported up to now, but theoretical studies predict that the scattering cross section of individual 
QDs is much smaller than the absorption cross section.202 This applies when the QD’s size is much 
smaller than the wavelength of the incident light, as it occurs in this work. The extinction cross 
section at 1.3 µm of our IR-QDs has been estimated to be close to 2.5×10-19 cm2.203 This is, indeed, 
eight orders of magnitude smaller than the scattering cross section of GNSs, in good accordance 
with the eight orders of magnitude differences experimentally obtained between the IV-OCT 
intensity provided by individual IR-QDs (1.8×10-16) and individual GNSs (5.4×10-8) (see Figure 
6.4 (c)). Despite the reduced IV-OCT signal, it is important to remark that the contrast generated 
by individual IR-QDs, although much weaker than that provided by individual metallic 
nanoparticles, is still well measurable by the clinical IV-OCT system.21  
 
Figure 6.5 (a) Cross sectional OCT and infrared as obtained for different concentrations of IR-QDs in the 
tubing. Scale bar, 1 mm. (b) Integrated OCT intensity as a function of the concentration of IR-QDs. Scale 
bar, 4 mm. (c) Integrated infrared luminescence intensity as a function of the concentration of IR-QDs. In 
(b) and (c) dots are experimental data and solid line is a guide for the eyes. 
Once the capacity of IR-QDs for providing IV-OCT contrast has been demonstrated, their ability 
to simultaneously produce PL contrast was evaluated by using an infrared fluorescence camera to 
image the tubing (see Figure 6.3). The infrared fluorescence camera was set above the tubing to 
take the infrared image, meanwhile, a long pass filter 1350 nm was put before the camera to 
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remove the OCT laser signal. The obtained infrared fluorescence images of a tubing filled with 
aqueous suspensions of IR-QDs at different concentrations are shown in Figure 6.5 (a), from 
which the presence of IR-QDs is evidenced. This indicates efficient absorption and re-emission of 
the 1.3 µm OCT laser radiation by IR-QDs. At this point, it is important to remark that the data 
included in Figure 6.4 and Figure 6.5 (a) clearly demonstrate the ability of our IR-QDs to produce, 
simultaneously, IV-OCT and IR luminescence images, all under just the single laser line excitation 
of the cardiovascular OCT system. The dependences of both integrated OCT and luminescence 
intensities (𝐼𝑂𝐶𝑇 and 𝐼𝑙𝑢𝑚, respectively) on the concentration of IR-QDs are shown in Figure 6.5 
(b) and (c). In both cases the integrated intensities increase monotonously with the IR-QD 
concentration, but with very different trends. On one hand, the IV-OCT intensity vs the IR-QDs’ 
concentration shows a linear dependence in a Log-Log representation. This implies that the IV-
OCT intensity (𝐼𝑂𝐶𝑇) can be written as 𝐼𝑂𝐶𝑇 = [𝑄𝐷𝑠]
𝑛, where [𝑄𝐷𝑠] is the concentration of IR-
QDs. Linear fitting of experimental data in the Log-Log representation provides, for this particular 
case, a value of 𝑛 = 0.3, so that the IV-OCT intensity increases with the concentration of IR-QDs 
following a sublinear trend. The reason explaining this sublinear trend is not clear at this point. 
Nevertheless it should be mentioned here that a similar trend was also observed for metallic 
nanoparticles,179 so that it is likely that the sublinearity is related to the way in which the processing 
and quantification of IV-OCT images are performed by the clinical equipment. On the other hand, 
the luminescence intensity generated by IR-QDs (when optically excited with the IV-OCT laser) 
was found to follow a linear trend with the concentration of IR-QDs (see Figure 6.5 (c)), as it was 
indeed expected. This opens the door to straightforward determination and quantification of 
intracoronary accumulation of QDs by just monitoring the infrared luminescence generated from 
the analyzed arteria under excitation with the IV-OCT catheter. 
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Figure 6.6 (a) Infrared fluorescence images of a catheter filled with an IR-QD suspension (0.6 mg/mL) as 
obtained for different tissue thickness. Scale bar, 4 mm. (b) Integrated infrared luminescence intensity as a 
function of the tissue thickness. Dots are experimental data obtained from the luminescence images in (a) 
and the red line is the best fit to an exponential decay. The penetration length provided by exponential fit 
is 0.8 mm. 
The potential application of infrared fluorescence imaging for sub-tissue localization of QDs in 
arteries would be determined by the effective penetration length (under excitation with the IV-
OCT catheter). In order to evaluate this important aspect, different thickness of the tissues varing 
from 0 up to 6 mm, were set above the tubing. Then the fluorescence images generated by the IV-
OCT catheter from a tubing filled a QDs/water solution were obtained for different tissue thickness 
by the IR camera as shown in Figure 6.6 (a), the fluorescence intensity decreases when increasing 
the tissue thickness, and the fluorescence image is almost invisible when the tissue thickness 
reached 3mm. The integrated fluorescence intensity (𝐼𝑙𝑢𝑚) as a function of the tissue thickness (𝑑) 
is shown in Figure 6.6 (b). According to previous stablished models of light propagation in tissues, 
the fluorescence intensity should follow a typical trend given by: 
 𝐼𝑙𝑢𝑚 = 𝐼0𝑒𝑥𝑝[− 𝑑 𝑙𝑝⁄ ] (6.1) 
where 𝐼0 is a constant and 𝑙𝑝 is the so-called optical penetration length. Experimental data fit well 
to this trend, providing an optical penetration length close to 0.8 mm. Indeed, this is quite close to 
the optical penetration lengths reported for different infrared emitting luminescence probes that 
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have been successfully used for high penetration and high resolution “in vivo” imaging.204-206 Note 
that the maximum depth at which IR-QDs can be detected depends on the background level of the 
IR camera. In comparison to our camera, working at 0 ºC, the use of an IR camera working at -80 
ºC (operating temperature of double Peltier cooled commercial cameras) would lead to a reduction 
in the background signal of more than one order of magnitude, and so making possible to detect 
IR-QDs at subcutaneous depths well in excess of 1 cm. 
At this point it should be mentioned that future optimization of the fluorescence and the 
scattering efficiencies of a nanostructure for bimodal OCT+PL imaging is not an easy task as they 
are exclusive processes. In fact, if a nanoparticle shows high scattering cross sections, then the 
amount of absorbed light (that determines the fluorescence intensity) will be reduced. Thus, a 
compromise has to be reached. Such compromise could be obtained in the future by using hybrid 
nanostructures combining, into a single unit, highly scattering units and bright fluorescent units. 
This could also be achieved through core/shell engineering (by creating a thin metallic shell on the 
surface of IR-QDs) or, alternatively, by linking IR-QDs and metallic nanoparticles through surface 
modification. In addition, I would also like to note that, with the experimental data available now, 
I cannot disregard the contribution of absorption-reemission of pump photons to the overall back-
scattering signal. Nevertheless, I consider that it would be a second order process when compared 
with the direct backscattering due to photon backscattering at the surface of IR-QDs. Furthermore, 
even in the case that these processes were taking place, they would not contribute to the observed 
OCT contrast due to the lack of coherence between pump and backscattered light. 
6.4. OCT and fluorescence bimodal imaging in tissues 
As commented in the introduction, one of the advantages of IV-OCT is its capacity to provide, 
in addition to a topographical image of an artery, information about tissue properties beyond the 
artery wall. Thus, a multimodal OCT+IR probe should be able not only to provide dual contrast 
when being in suspension (inside the artery) but it should also be capable of dual contrast when 
being located inside a tissue.60, 106, 207 The ability of our IR-QDs for OCT+PL dual contrast imaging 
in tissues was, therefore, also explored. 
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Figure 6.7 Schematic representation of the experimental approaches used to test the capacity of IR-QDs 
for multimodal OCT+PL imaging in a fluid. 
The experimental approach for dual contrast imaging in tissue is schematically drawn in Figure 
6.7. Instead of using the tubing (see Figure 6.3), a muscular tissue was used. The IR-QDs were 
injected in the tissue but near the IV-OCT catheter in order to detect the OCT contrast enhancement 
in tissue produced by the IR-QDs and at the same time, making an efficient excitation of the IR-
QDs by the OCT laser. A cross sectional IV-OCT image of the tissue before the QDs’ injection is 
shown in Figure 6.8 (a). It is constituted by a diffuse background, associated to the characteristic 
inhomogeneous refractive index of tissues. Figure 6.8 (c) shows the corresponding infrared 
fluorescence image of the tissue, demonstrating, as expected, no contrast at all. Indeed, this result 
indicates the negligible excitation of tissue auto-fluorescence by the 1.3 µm OCT laser. When IR-
QDs were injected into the tissue both OCT and luminescence images change appreciably in the 
injection area in respect to the control (no IR-QDs). Figure 6.8 (b) shows the cross sectional OCT 
image of the tissue after the injection of 200 µL of an aqueous suspension of IR-QDs (0.6 mg/mL). 
The location of the injected IR-QDs is indicated by a red arrow. The presence of IR-QDs in the 
tissue is observed by a clear increment in the OCT intensity. This is further evidenced in Figure 
6.8 (e) in which the OCT signal profile (obtained inside the tissue along the scan direction 
represented by the yellow arrows in Figure 6.8 (a) and (b)) was included. Comparison between 
the OCT intensity profiles obtained, before and after injection, clearly demonstrates a remarkable 
intensity enhancement at the location of the IR-QDs. Indeed, the OCT signal was increased by 
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almost 2.5 times due to the IR-QD induced backscattering. At the same time, the presence of IR-
QDs was simultaneously monitored by their infrared luminescence, as it is demonstrated in the 
infrared fluorescence image included as Figure 6.8 (d). Thus, the ability of IR-QDs for dual 
OCT+PL and fluorescence imaging inside tissues is clearly proved. This multimodal imaging 
capacity appears of special relevance for cardiovascular imaging, as it would allow for unequivocal 
identification of inner lesions beyond the artery contour by using adequately functionalized IR-
QDs. 
 
Figure 6.8 (a) Cross-sectional OCT image of a tissue before the injection of IR-QDs. Scale bar, 1 mm. (b) 
Cross-sectional image of the same tissue after the injection of IR-QDs. The location of the IR-QDs is 
indicated by the red arrow. The dashed red line indicates the position of the tissue-air interface. (c) Infrared 
fluorescence image of the tissue prior to the injection of IR-QDs. (d) Infrared fluorescence image of the 
tissue after the injection of IR-QDs. Scale bar, 4 mm. (e) OCT intensity profile as obtained along the yellow 
arrows indicated in (a) and (b). Data obtained before and after injection are included denoting the 
enhancement in the OCT signal due to the presence of IR-QDs. 
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6.5. OCT and fluorescence bimodal imaging in rabbit artery 
 
Figure 6.9 shows an optical picture of the experimental set-up used for multimodal OCT+PL imaging of 
an artery excised from a rabbit. The different parts are indicated and labelled.  
In order to finally test the potential application of our IR-QDs for multimodal cardiovascular 
imaging, ex vivo experiments were conducted. The aorta of a rabbit (whose dimensions are similar 
to human coronary arteries) was excised from a sacrificed rabbit. The branches were sealed by 
suture procedures and the IV-OCT catheter was introduced in the artery by using a cannula and 
metallic guide. Details about the experimental procedure can be found in Figure 6.9. The IR-QDs 
were injected in the artery by using a syringe, which connects to the cannula by a tubing. The IV-
OCT catheter was introduced and was scanned along the artery with a speed of 10 mm/s. During 
the scanning of the IV-OCT catheter the fluorescence generated by the IR-QDs in the artery was 
detected by the same InGaAs infrared camera used in previous experiments. This simple 
experimental set-up made possible the simultaneous acquisition of the OCT and infrared 
fluorescence images of the artery in real time. 
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Figure 6.10 Optical image of the aorta excised from a sacrificed rabbit. The position of the IV-OCT catheter 
during axial scanning is indicated by red arrow. The instantaneous (real time) and accumulative infrared 
fluorescence image generated by the IR-QDs inside the artery are also shown for the different positions of 
the IR-OCT catheter and named A, B, C, D and E. The corresponding OCT cross sectional images are also 
displayed together with the transverse OCT image of the artery. The shadow in OCT cross section images 
are due to the light blocked by the metallic guide. The scale bar for optical and fluorescence image is 4 mm, 
for OCT cross section image is 1 mm. 
Figure 6.10 shows the optical image of the rabbit aorta at different times during the IV-OCT 
scanning. The position of the OCT catheter at each time, which it is indicated by an arrow, can be 
elucidated thanks to a red laser (at 650 nm) that is integrated into the rotating fiber. The real time 
and accumulative fluorescence images obtained at different times are also included in Figure 6.10. 
In addition, for the sake of clarify, the accumulated fluorescence image are also include in this 
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figure. The fluorescence images are due to the emission of PbS QDs under excitation of IV-OCT 
catheter. IV-OCT cross-sectional images of the artery were simultaneously acquired, five 
representative OCT cross sectional images obtained at the different artery positions (indicated by 
A, B, C, D, E arrows) are also included in Figure 6.10. The shadow in the OCT cross section 
images are due to the OCT laser light blocked by the metallic guide. The OCT contrast in the artery 
indicated the existence of IR-QDs in the artery. In addition, an axial OCT image of the artery, 
which was obtained after the IV-OCT scanned the artery from 0 to 54 mm was included in Figure 
6.10. This image shows the morphology of the artery used in this experiment, the indentations in 
the artery (as indicated by A, B, C, and D arrows) are supposed to help the accumulation of the 
IR-QDs in the artery. A video of the measuring process in which the translation of the IV-OCT 
and the simultaneous acquisition of fluorescence image can be found online 
 (https://drive.google.com/file/d/0B5z1PgUYHn1eaTV1b08zUjRrMGM/view?usp=sharing). 
The fluorescence images clearly demonstrate how the PL generated by the IR-QDs inside the 
artery accurately reproduces its morphology. In addition, several bright spots (Indicated by A, B, 
C and D arrows) are observed, revealing the accumulation of IR-QDs inside the artery. When these 
images are compared with the OCT ones, it is possible to correlate these bright spots with the 
localization of the arterial branches that were clamped. This is evidenced by arrows in the OCT 
longitudinal image of the artery. Thus, I state that at these positions IR-QDs are accumulated. The 
experiments included in Figure 6.10, do not only reveal the potential use of IR-QDs for 
multimodal cardiovascular imaging, but also demonstrate that the synergy between fluorescence 
and OCT cardiovascular imaging could result in the appearance of advanced imaging and 
diagnosis tools. 
6.6. Conclusions 
In this section the capability of semiconductor quantum dots, emitting in the third biological 
window, for multimodal cardiovascular imaging has been demonstrated. Infrared emitting 
quantum dots were shown to be capable of providing simultaneous contrast in intracoronary optical 
coherence tomography and infrared fluorescence imaging all under 1.3 µm wavelength single 
beam laser excitation provided by a clinical catheter. It is demonstrated that , when a single infrared 
emitting quantum dot is optically excited by a 1.3 µm wavelength photon, the back-scattered 
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radiation is strong enough to produce a measurable contrast by a clinical OCT system. At the same 
time, the absorbed photons are efficiently re-emitted at 1.55 µm, making possible their 
simultaneous localization by fluorescence imaging. Dual fluorescence and optical coherence 
tomography imaging was demonstrated both in colloidal suspension and in tissues. Furthermore, 
a simple “proof of concept” demonstration at the ex vivo level showed the real potential of infrared 
emitting quantum dots for multimodal imaging of arteries, pointing out the synergy between 
fluorescence imaging and optical coherence tomography. 
Consequently, infrared emitting quantum dots appear as the first dual contrast agents for 
intracoronary imaging based on the use of already established optical coherence tomography 
catheters. The possibility of acquiring multimodal intracoronary imaging opens a new avenue 
towards the development of new diagnostic techniques based on multimodal imaging. 
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7.1. GNSs, best OCT contrast agent 
Different kinds of GNPs show different OCT contrast enhancement due to their different 
scattering properties, as OCT is based on the analysis of backscattered signals. The GNSs with 
size around 220 nm show a higher scattering cross section at the OCT laser wavelength (1.3 µm) 
than GNSTs and GNRs, thus the GNSs investigated in my thesis are considered as the best contrast 
agents for IV-OCT. 
7.2. Single GNSs visualization by IV-OCT 
The IV-OCT can be used to track single GNSs due to the high sensitivity of IV-OCT system 
and high scattering cross section of GNSs. 
7.3. GNSs can act as contrast agents for cell imaging and tissue contrast enhancement 
by IV-OCT 
The analysis of the intensity histogram for IV-OCT cross-sectional images of GNSs incubated 
in the HeLa and Jurkat cells allows the detection of living cells with GNSs attached. The number 
of detected cells with GNSs by IV-OCT as function of GNSs concentration demonstrated a 
saturation trend in high GNSs concentration. The internalization of the GNSs in the cells have 
been confirmed by TEM and DFM. 
The injection of GNSs in the tissue near the IV-OCT catheter shows a contrast enhancement, 
the OCT signal after subtract the background allow visualization of GNSs distribution in the tissue. 
7.4. PbS QDs could act as a dual contrast for cardiovascular imaging 
The broad absorption of PbS QDs allows the excitation of their luminescence by the OCT laser 
at 1.3 µm. After injection of PbS QDs in artery, their emission around the 1.55 µm after excitation 
by OCT laser could be used for fluorescence imaging of the artery in the third biological window. 
In addition, the assignable scattering properties of PbS QDs could be used for OCT contrast 
enhancement. The PbS QDs are thus promising contrast agents for fluorescence imaging and OCT 
of cardiovascular disease. 
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7.5. Future perspectives 
During the doctoral thesis, the OCT setup has been mainly used for evaluating the potential 
application of the NPs for cardiovascular imaging. The DFM is home built for visualization of the 
NPs and cells, and in future, to see the internalized process of NPs in the cells.  
In respect to the future work of contrast agent that have been used in my thesis, their basic 
properties have been demonstrated. The future work would be the functionalization of these 
contrast agents with special ligand so that they can be specially delivered to the cardiovascular 
disease sites, and the evaluation of these contrast agents for ex and in vivo imaging of the 
atherosclerosis process by OCT, fluorescence, and photoacoustic.  
More contrast agent needs to be developed with higher scattering cross section than GNSs. In 
addition, due to the strong scattering properties of the artery, absorption contrast agents are also 
needed in order to create negative contrast in the artery, which could decrease the OCT signal and 
thus indicate the cardiovascular disease sites.  
Due to the catheter based IV-OCT system, the functionalized fluorescence NPs could be used 
in the cardiovascular disease, as the catheter could not only introduce the light to the cardiovascular 
disease and also collect the light from these areas. Thus the limitation of the fluorescence NPs such 
as low penetration depth could be avoid. A combined OCT and fluorescence system needed to be 
widely used for cardiovascular disease research. 
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8.1. GNSs, mejor agente de contraste para OCT 
Los diferentes tipos de GNPs aumenta de forma distinta el contraste de OCT debido a sus 
diferentes propiedades de scattering, ya que el OCT se basa en el análisis de la señal de scattering. 
Los GNSs con un tamaño alrededor de 220 nm muestran una sección eficaz de scattering mayor 
que la de los GNRs y GNSTs a la longitud de onda del laser del OCT (1,3 µm), así que son los 
mejores agentes de contraste para OCT entre todas las partículas estudiadas en esta tesis. 
8.2. Visualización de GNSs individuales por IV-OCT 
El IV-OCT puede suarse para seguir GNSs individuales gracias a la alta sensibilidad del IV-
OCT y a la alta sección eficaz de scattering de los GNSs. 
8.3. Las GNSs pueden actuar como agentes de contraste para imagen celular y 
aumento del contraste en tejidos por IV-OCT 
El análisis del hostograma de intensidades de imágenes de OCT de GNSs incubadas en células 
HeLa y Jurkat permite la detección de células vivas a las que se han adherido GNSs. El número de 
células adheridas en función de la concentración de GNSs demostró una tendencia a la saturación 
para dispersiones concentradas de GNSs. La internalización de las GNSs se ha confirmado por 
TEM y DFM. 
La inyección de las GNSs en un tejido muestra el aumento de ocntraste en la señal de OCT una 
vez que se ha sustraído el fondo. Esto permite la visualización de la distribución de GNSs en el 
tejido. 
8.4. QDs de PbS pueden actuar como agentes de contraste duales para imagen 
cardiovascular 
La ancha banda de absorción de los QDs de PbS permiten la excitación de su luminiscencia con 
el laser del OCT a 1.3 µm. Tras inyectar los QDs de PbS en la larteria, su emisión a 1,55 µm puede 
usarse para obtener la imagen de fluorescencia en la tercera ventana biológica. Además, las 
destacables propiedades de scattering de los QDs de PbS puede usarse para obtener contraste por 
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OCT. Los QDs de PbS son, por tanto, unos prometedores agentes de contraste para imagen de 
fluorescencia y OCT en enfermedades cardiovasculares. 
8.5. Perspectivas futuras 
Durante la realización de esta tesis doctoral, la técnica de OCT se ha usado fundamentalmente 
para evaluar el potencial usal de NPs como agentes de contraste para imagen cardiovascular. Se 
ha desarrollado además un sistema de DFM para seguir el proceso de internalización de las NPs 
en las células. 
Respecto a las futuras aplicaciones de los agentes de contraste que se han usado en esta tesis, 
sus propiedades fundamentales han sido demostradas. El trabajo futuro deberá estar encaminado a 
la funcionalización de estos agentes de contraste con ligandos específicos, de forma que se dirijan 
específicamente a regiones patológicas, y a la evaluación de dichos agentes de contraste en 
imágenes in vivo y ex vivo de procesos de ateroesclerosis con medidas de OCT, fluorescencia y 
fotoacústico. 
Es necesario el desarrollo de más agentes de contraste con un scattering mayor que el de los 
GNSs. Además, debido al fuerte scattering que se produce en las paredes de la arteria, sería 
interesante el desarrollo de agentes e contraste basados en la absorción de luz, de forma que creen 
un contraste negativo en la arteria, disminuyendo la señal de OCT e indicando la localización de 
sitios patológicos en la arteria. 
Debido al sistema de IV-OCT acoplado en un catéter, la fluorescencia de las NPs puede ser 
recogida por el mismo catéter. De este modo, el problema de la baja penetración de la fluorescencia 
puede resolverse. Un sistema combinado de OCT y fluorescencia debe ser usado para el estudio 
de enfermedades cardiovasculares. 
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